clomipramine has been researched along with Anankastic Personality in 553 studies
Clomipramine: A tricyclic antidepressant similar to IMIPRAMINE that selectively inhibits the uptake of serotonin in the brain. It is readily absorbed from the gastrointestinal tract and demethylated in the liver to form its primary active metabolite, desmethylclomipramine.
clomipramine : A dibenzoazepine that is 10,11-dihydro-5H-dibenzo[b,f]azepine which is substituted by chlorine at position 3 and in which the hydrogen attached to the nitrogen is replaced by a 3-(dimethylamino)propyl group. One of the more sedating tricyclic antidepressants, it is used as the hydrochloride salt for the treatment of depression as well as obsessive-compulsive disorder and phobias.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Since it will be some time until data will be available comparing clomipramine and fluoxetine for the treatment of patients with obsessive-compulsive disorder (OCD), a meta-analysis of previous studies was performed in an attempt to gain some information about comparable efficacy and side effects of these two commonly used agents." | 10.16 | Clomipramine versus fluoxetine in obsessive-compulsive disorder: a retrospective comparison of side effects and efficacy. ( Baer, L; Greist, JH; Jenike, MA, 1990) |
| "Thirty-eight patients with primary obsessive-compulsive disorder participated in a 10-week, double-blind, placebo-controlled trial of the potent, selective serotonin reuptake inhibitor fluvoxamine." | 10.16 | A controlled trial of fluvoxamine in obsessive-compulsive disorder: implications for a serotonergic theory. ( Baer, L; Buttolph, L; Holland, A; Hyman, S; Jenike, MA; Minichiello, WE; Ricciardi, J; Seymour, R; Summergrad, P, 1990) |
| "The aim of this study was to investigate the influence of demethylation rate on the outcome of obsessive-compulsive disorder patients treated with clomipramine." | 9.20 | Clomipramine demethylation rate is important on the outcome of obsessive-compulsive disorder treatment. ( Bernik, MA; Gedanke Shavitt, R; Gorenstein, C; Lotufo Neto, F; Marcourakis, T, 2015) |
| "This open trial was conducted to evaluate the effectiveness of intravenous clomipramine (CMI) in refractory obsessive-compulsive disorder (OCD)." | 9.20 | Intravenous Clomipramine for Treatment-Resistant Obsessive-Compulsive Disorder. ( Karameh, WK; Khani, M, 2015) |
| "There is growing evidence that memantine, a noncompetitive N-methyl-D-aspartate receptor antagonist, may be applied as an add-on in treating patients suffering from obsessive-compulsive disorders (OCD)." | 9.17 | In a double-blind, randomized and placebo-controlled trial, adjuvant memantine improved symptoms in inpatients suffering from refractory obsessive-compulsive disorders (OCD). ( Afshar, H; Bajoghli, H; Brand, S; Hafezian, H; Haghighi, M; Holsboer-Trachsler, E; Jahangard, L; Mohammad-Beigi, H; Rahimi, A, 2013) |
| "Based on the evidence that aripiprazole added to serotonin reuptake inhibitors (SRIs) or clomipramine in treatment-resistant obsessive-compulsive disorder (OCD) has reported promising results, the present 16-week, double-blind, randomized, placebo-controlled trial had the aim to explore the efficacy of aripiprazole add-on pharmacotherapy on clinical symptoms and cognitive functioning in a sample of treatment-resistant OCD patients receiving SRIs." | 9.15 | Effect of aripiprazole augmentation of serotonin reuptake inhibitors or clomipramine in treatment-resistant obsessive-compulsive disorder: a double-blind, placebo-controlled study. ( Bruno, A; Micò, U; Muscatello, MR; Pandolfo, G; Romeo, VM; Santoro, V; Scimeca, G; Settineri, S; Spina, E; Zoccali, RA, 2011) |
| "Small studies have suggested that intravenous clomipramine (CMI) may be more effective and induce faster improvement in obsessive-compulsive disorder than do orally administered serotonin reuptake inhibitors." | 9.12 | Pulse-loaded intravenous clomipramine in treatment-resistant obsessive-compulsive disorder. ( Aboujaoude, E; Elliott, M; Gamel, N; Koran, LM; Sallee, FR; Shapira, NA; Ward, H, 2006) |
| "The purpose of the study was to test the relative and combined efficacy of clomipramine and exposure and ritual prevention in the treatment of obsessive-compulsive disorder (OCD) in adults." | 9.11 | Randomized, placebo-controlled trial of exposure and ritual prevention, clomipramine, and their combination in the treatment of obsessive-compulsive disorder. ( Campeas, R; Davies, S; Foa, EB; Franklin, ME; Huppert, JD; Kjernisted, K; Kozak, MJ; Liebowitz, MR; Rowan, V; Schmidt, AB; Simpson, HB; Tu, X, 2005) |
| "The objective of this study was to investigate, in a single-blind manner over a period of 12 weeks, the efficacy and tolerability of venlafaxine versus clomipramine in the treatment of obsessive-compulsive disorder (OCD)." | 9.10 | Venlafaxine versus clomipramine in the treatment of obsessive-compulsive disorder: a preliminary single-blind, 12-week, controlled study. ( Aguglia, E; Albert, U; Bogetto, F; Maina, G, 2002) |
| " citalopram administered with clomipramine, in treatment-resistant obsessive-compulsive disorder (OCD)." | 9.09 | Citalopram for treatment-resistant obsessive-compulsive disorder. ( Koran, LM; Paiva, RS; Pallanti, S; Quercioli, L, 1999) |
| "The aim of this prospectively randomized, double-blind, parallel group, multicentre study was to compare the efficacy and tolerability of fluvoxamine and clomipramine in patients suffering from obsessive-compulsive disorder (OCD) (DSM-III-R)." | 9.09 | Multicentre, double-blind, comparison of fluvoxamine and clomipramine in the treatment of obsessive-compulsive disorder. ( Maina, G; Mundo, E; Uslenghi, C, 2000) |
| "This study evaluates the clinical response to olanzapine used in association with selective serotonin reuptake inhibitors (SSRIs) or clomipramine in treatment-resistant obsessive-compulsive disorder (OCD)." | 9.09 | Olanzapine augmentation of serotonin uptake inhibitors in obsessive-compulsive disorder: an open study. ( Francobandiera, G, 2001) |
| "The current study examines the neuroendocrine response to intravenous clomipramine (IV CMI) in oral CMI-resistant obsessive-compulsive disorder (OCD) patients on day 1 and day 14 of treatment to identify predictors of response." | 9.09 | Neuroendocrine predictors of response to intravenous clomipramine therapy for refractory obsessive-compulsive disorder. ( Coplan, JD; de la Neuz, M; Fallon, BA; Goetz, RR; Hollander, E; Liebowitz, MR; Mathew, SJ; Perko, KA, 2001) |
| "The efficacy and tolerability of fluvoxamine (100-300 mg/day) and clomipramine (100-250 mg/day) were compared in a randomized, double-blind, parallel-group study of 79 patients with obsessive-compulsive disorder (OCD) without coexisting major depression." | 9.08 | Fluvoxamine versus clomipramine for obsessive-compulsive disorder: a double-blind comparison. ( Davidson, JR; Hollander, E; Jenike, MA; Koran, LM; McElroy, SL; Rasmussen, SA, 1996) |
| " Using data from Ciba-Geigy's multicenter 10-week clinical trial, we studied the relationship between early side effects and subsequent therapeutic response to clomipramine (CMI) in obsessive-compulsive disorder." | 9.08 | Relationship between early side effects and therapeutic effects of clomipramine therapy in obsessive-compulsive disorder. ( Ackerman, DL; Bystritsky, A; Greenland, S; Katz, RJ, 1996) |
| "The aim was to assess the effect of a flexible dose of paroxetine, compared with clomipramine and placebo, in obsessive-compulsive disorder (OCD)." | 9.08 | Paroxetine versus clomipramine in the treatment of obsessive-compulsive disorder. OCD Paroxetine Study Investigators. ( Judge, R; Zohar, J, 1996) |
| "The authors conducted a randomized, double-blind, placebo-controlled trial of intravenous versus oral pulse loading of clomipramine in patients with obsessive-compulsive disorder to test two hypotheses: 1) intravenous pulse loading will cause greater immediate improvement than oral pulse loading and 2) patients who respond to pulse loading will continue to improve during 8 weeks of oral clomipramine treatment." | 9.08 | Rapid benefit of intravenous pulse loading of clomipramine in obsessive-compulsive disorder. ( Koran, LM; Pallanti, S; Sallee, FR, 1997) |
| "A double-blind trial was carried out to assess the efficacy and safety of fluvoxamine, a selective serotonin reuptake inhibitor, in comparison with clomipramine, a classical tricyclic antidepressant, in the treatment of obsessive-compulsive disorder." | 9.08 | A double-blind study of fluvoxamine and clomipramine in the treatment of obsessive-compulsive disorder. ( Cassano, GB; Lensi, P; Marazziti, D; Milanfranchi, A; Ravagli, S, 1997) |
| "In a double-blind study, desipramine or placebo was added for 6 or 10 weeks to the treatment of 30 patients with obsessive-compulsive disorder whose symptoms were refractory to SSRI treatment (fluvoxamine, fluoxetine, or sertraline) alone." | 9.08 | Addition of desipramine to serotonin reuptake inhibitors in treatment-resistant obsessive-compulsive disorder. ( Anand, A; Barr, LC; Goodman, WK; McDougle, CJ; Price, LH, 1997) |
| "We compared gradually increased to pulse loaded doses of open-label, intravenous clomipramine (CMI) in patients with obsessive-compulsive disorder (OCD)." | 9.08 | Pulse loading versus gradual dosing of intravenous clomipramine in obsessive-compulsive disorder. ( Koran, LM; Paiva, RS; Pallanti, S; Quercioli, L, 1998) |
| "Medication management of obsessive-compulsive disorder (OCD) has consisted of monotherapy with either clomipramine (CMI) or selective serotonin reuptake inhibitors (SSRIs) such as fluvoxamine, paroxetine, or sertraline." | 9.08 | Combination treatment with clomipramine and selective serotonin reuptake inhibitors for obsessive-compulsive disorder in children and adolescents. ( Birmaher, B; Figueroa, Y; Keshavan, MS; Rosenberg, DR, 1998) |
| "Challenge with intravenous clomipramine (CMI) is serotonin selective and has been reported to transiently exacerbate symptoms in obsessive-compulsive disorder (OCD) patients, and to predict subsequent response to oral CMI therapy." | 9.08 | Intravenous clomipramine challenge in obsessive-compulsive disorder: predicting response to oral therapy at eight weeks. ( Carson, SW; Koran, LM; Pallanti, S; Sallee, FR; Sethuraman, G, 1998) |
| "Uncontrolled reports suggest that intravenous clomipramine hydrochloride may be effective for patients with obsessive-compulsive disorder (OCD) who are nonresponsive to oral clomipramine." | 9.08 | Intravenous clomipramine for obsessive-compulsive disorder refractory to oral clomipramine: a placebo-controlled study. ( Campeas, R; Davies, S; Fallon, BA; Goetz, D; Klein, DF; Liebowitz, MR; Marshall, R; Schneier, FR, 1998) |
| "There have been many attempts to find predictors of the therapeutic response to the clomipramine treatment of obsessive-compulsive disorder." | 9.07 | Predictors of treatment response in obsessive-compulsive disorder: multivariate analyses from a multicenter trial of clomipramine. ( Ackerman, DL; Bystritsky, A; Greenland, S; Katz, RJ; Morgenstern, H, 1994) |
| "To determine whether clomipramine hydrochloride, a serotonin reuptake blocker with unique anti-obsessional properties, is differentially effective for obsessive-compulsive and stereotyped motor behaviors in autistic disorder compared with placebo and with the noradrenergic tricyclic antidepressant agent, desipramine hydrochloride." | 9.07 | A double-blind comparison of clomipramine, desipramine, and placebo in the treatment of autistic disorder. ( Gordon, CT; Hamburger, SD; Nelson, JE; Rapoport, JL; State, RC, 1993) |
| "A double-blind clinical trial of clomipramine versus phenelzine was carried out on 30 patients suffering from DSM-III obsessive-compulsive disorder." | 9.07 | Clomipramine versus phenelzine in obsessive-compulsive disorder. A controlled clinical trial. ( Bulbena, A; Marcos, T; Menchón, JM; Olivares, J; Vallejo, J, 1992) |
| "We used the Structured Interview for DSM-III Personality Disorders to diagnose DSM-III personality disorders systematically in 55 patients with obsessive-compulsive disorder in the active-treatment cell of a controlled trial of clomipramine hydrochloride." | 9.07 | Effect of axis II diagnoses on treatment outcome with clomipramine in 55 patients with obsessive-compulsive disorder. ( Baer, L; Black, DW; Greist, J; Jenike, MA; Rosenfeld, R; Treece, C, 1992) |
| "In this study, 14 patients with obsessive-compulsive disorder (OCD) who had received at least 3 months of treatment with clomipramine were treated with the anxiolytic agent buspirone in a 10-week, double-blind study." | 9.07 | A double-blind study of adjuvant buspirone hydrochloride in clomipramine-treated patients with obsessive-compulsive disorder. ( Bernstein, SE; Bihari, K; Hill, JL; L'Heureux, F; Murphy, DL; Pigott, TA, 1992) |
| "Two double-blind studies at 21 centers evaluated the therapeutic efficacy, safety, and tolerability of up to 300 mg/d of clomipramine hydrochloride or an equivalent number of placebo capsules in the treatment of 520 patients with obsessive-compulsive disorder, of whom 239 had had the disorder for at least 2 years (study 1) and 281 had been ill for at least 1 year (study 2)." | 9.07 | Clomipramine in the treatment of patients with obsessive-compulsive disorder. The Clomipramine Collaborative Study Group. ( , 1991) |
| "In this study, 16 patients with obsessive-compulsive disorder (OCD) who had partially improved during at least 6 months of treatment with clomipramine were sequentially treated with triiodothyronine and lithium carbonate in an 8-week double-blind cross-over study." | 9.07 | A controlled comparison of adjuvant lithium carbonate or thyroid hormone in clomipramine-treated patients with obsessive-compulsive disorder. ( Bernstein, SE; Grover, GN; Hill, JL; L'Heureux, F; Murphy, DL; Pato, MT; Pigott, TA, 1991) |
| "Twenty-six children and adolescents with severe primary obsessive-compulsive disorder receiving long-term clomipramine hydrochloride maintenance treatment (mean +/- SD, 17." | 9.07 | A double-blind desipramine substitution during long-term clomipramine treatment in children and adolescents with obsessive-compulsive disorder. ( Cheslow, DL; Hamburger, SD; Lenane, MC; Leonard, HL; Rapoport, JL; Rettew, DC; Swedo, SE, 1991) |
| "Eighteen outpatients with obsessive-compulsive disorder were treated with either buspirone, a partial serotonin agonist, or clomipramine, a serotonin uptake inhibitor, in a double-blind, random-assignment study." | 9.07 | Controlled comparison of buspirone and clomipramine in obsessive-compulsive disorder. ( Bernstein, S; Grover, GN; Hill, JL; Murphy, DL; Pato, MT; Pigott, TA, 1991) |
| "The effects of clomipramine hydrochloride (CMI) versus placebo upon DSM-III-defined obsessive-compulsive disorder (OCD) were assessed in a 10-week double-blind multicenter trial and in a corresponding 1-year double-blind extension study." | 9.06 | Clomipramine in obsessive-compulsive disorder. ( DeVeaugh-Geiss, J; Katz, RJ; Landau, P, 1990) |
| "Treatment with fluoxetine hydrochloride was compared with treatment with clomipramine hydrochloride in two groups of patients with obsessive-compulsive disorder using two different experimental designs." | 9.06 | Controlled comparisons of clomipramine and fluoxetine in the treatment of obsessive-compulsive disorder. Behavioral and biological results. ( Bernstein, SE; Grover, GN; Hill, JL; Murphy, DL; Pato, MT; Pigott, TA; Tolliver, TJ, 1990) |
| "Ten patients with DSM-III-R obsessive-compulsive disorder (OCD) who were being treated chronically with clomipramine (270 +/- 20 mg/day) were studied to determine the minimum dose of clomipramine needed to maintain therapeutic benefit." | 9.06 | A clomipramine dosage reduction study in the course of long-term treatment of obsessive-compulsive disorder patients. ( Hill, JL; Murphy, DL; Pato, MT, 1990) |
| "Clomipramine has been reported to be effective in the treatment of obsessive-compulsive disorder (OCD)." | 9.06 | Treatment of adolescent obsessive-compulsive disorder with a clomipramine-fluoxetine combination. ( Simeon, JG; Thatte, S; Wiggins, D, 1990) |
| "Clomipramine was significantly superior to placebo in a 10-week double-blind, placebo-controlled trial in 27 outpatients who met DSM-III-R criteria for obsessive-compulsive disorder." | 9.06 | Obsessive-compulsive disorder: a double-blind, placebo-controlled trial of clomipramine in 27 patients. ( Baer, L; Holland, A; Jenike, MA; Seymour, R; Summergrad, P; Weilburg, JB, 1989) |
| "Forty-eight children and adolescents with severe primary obsessive-compulsive disorder completed a 10-week double-blind crossover trial of clomipramine hydrochloride (mean dose [+/- SD], 150 +/- 53 mg/d) and desipramine hydrochloride (mean dose [+/- SD], 153 +/- 55 mg/d)." | 9.06 | Treatment of obsessive-compulsive disorder with clomipramine and desipramine in children and adolescents. A double-blind crossover comparison. ( Cheslow, DL; Hamburger, SD; Koby, EV; Lenane, MC; Leonard, HL; Rapoport, JL; Swedo, SE, 1989) |
| "Data from several previous studies link clomipramine's potent serotonergic effects to its clinical efficacy in reducing the symptoms of obsessive-compulsive disorder (OCD)." | 9.06 | Clomipramine in obsessive-compulsive disorder. Further evidence for a serotonergic mechanism of action. ( Benkelfat, C; Grover, G; Hill, JL; Insel, TR; Murphy, DL; Zohar, J, 1989) |
| "To evaluate the need for maintenance drug therapy in patients with obsessive-compulsive disorder, the authors assessed 21 patients with obsessive-compulsive disorder who manifested sustained improvement during 5 to 27 months of clomipramine treatment and who agreed to participate in a double-blind discontinuation study." | 9.06 | Return of symptoms after discontinuation of clomipramine in patients with obsessive-compulsive disorder. ( Murphy, DL; Pato, MT; Zohar, J; Zohar-Kadouch, R, 1988) |
| "A double-blind comparative study of clomipramine and fluvoxamine was performed in 50 patients suffering from anxiety disorders (DSM-III)." | 9.06 | Effect of serotonin uptake inhibitors in anxiety disorders; a double-blind comparison of clomipramine and fluvoxamine. ( den Boer, JA; Kahn, RS; Kamerbeek, WD; Verhoeven, WM; Westenberg, HG, 1987) |
| "Clomipramine is a potent serotonin reuptake blocker that decreases the symptoms of obsessive-compulsive disorder (OCD)." | 9.06 | Serotonergic responsivity in obsessive-compulsive disorder. Effects of chronic clomipramine treatment. ( Hill, JL; Insel, TR; Murphy, DL; Zohar, J; Zohar-Kadouch, RC, 1988) |
| "A double-blind placebo-controlled study of 5-HTP and clomipramine was carried out on 45 patients suffering from anxiety disorders (DSM-III)." | 9.06 | Effect of a serotonin precursor and uptake inhibitor in anxiety disorders; a double-blind comparison of 5-hydroxytryptophan, clomipramine and placebo. ( Gispen-de Wied, CC; Kahn, RS; Kamerbeek, WD; Verhoeven, WM; Westenberg, HG, 1987) |
| "Forty-six patients with obsessive-compulsive disorder undergoing a double-blind controlled study of clomipramine and placebo were interviewed to assess changes in sexual function." | 9.06 | Anorgasmia from clomipramine in obsessive-compulsive disorder. A controlled trial. ( Lelliott, PT; Marks, IM; Monteiro, WO; Noshirvani, HF, 1987) |
| "Concentrations of the serotonin metabolite 5-hydroxyindoleacetic acid (5-HIAA), the dopamine metabolite homovanillic acid, and the noradrenaline metabolite 4-hydroxy-3-methoxyphenyl glycol were measured in CSF before and after three weeks' treatment of severe obsessive-compulsive disorder with clomipramine hydrochloride." | 9.05 | Clomipramine treatment of obsessive-compulsive disorder. II. Biochemical aspects. ( Asberg, M; Bertilsson, L; Mellström, B; Sjöqvist, F; Thorén, P; Träskman, L, 1980) |
| "Patients with obsessive-compulsive disorder who met DSM-III criteria and who had been ill for at least one year were studied in a double-blind, randomized, crossover comparison of the tricyclic antidepressant clomipramine hydrochloride and the monoamine oxidase inhibitor clorgyline hydrochloride." | 9.05 | Obsessive-compulsive disorder. A double-blind trial of clomipramine and clorgyline. ( Alterman, I; Cohen, RM; Insel, TR; Kilts, C; Linnoila, M; Murphy, DL, 1983) |
| "The effect of clomipramine hydrochloride in severe obsessive-compulsive disorder (OCD) was compared with that of nortriptyline hydrochloride and placebo in a five-week randomized, double-blind trial." | 9.05 | Clomipramine treatment of obsessive-compulsive disorder. I. A controlled clinical trial. ( Asberg, M; Cronholm, B; Jörnestedt, L; Thorén, P; Träskman, L, 1980) |
| "Twenty-three outpatients with primary obsessive-compulsive disorder (OCD) were started in a 12-week double-blind clinical trial of clomipramine (CLI) (n = 11) and imipramine (IMI) (n = 12)." | 9.05 | Clomipramine and imipramine in obsessive-compulsive disorder. ( Neziroglu, F; Volavka, J; Yaryura-Tobias, JA, 1985) |
| "3 years) with severe, primary obsessive-compulsive disorder completed a ten-week, double-blind, controlled trial of clomipramine hydrochloride (mean dosage, 141 mg/day) or placebo, each of which was administered for five weeks." | 9.05 | Clomipramine treatment of childhood obsessive-compulsive disorder. A double-blind controlled study. ( Berg, CJ; Flament, MF; Kilts, C; Linnoila, M; Mellström, B; Rapoport, JL; Sceery, W, 1985) |
| "We conducted a meta-analysis to examine the following: the time course of response to selective serotonin reuptake inhibitors (SSRIs) and clomipramine in pediatric obsessive-compulsive disorder (OCD); whether higher doses of SSRIs are associated with an improved response in pediatric OCD; differences in efficacy among SSRI agents; differences in efficacy between SSRIs and clomipramine; and whether the time course and magnitude of response to SSRIs are different in pediatric and adult patients with OCD." | 8.93 | Systematic Review and Meta-Analysis: Early Treatment Responses of Selective Serotonin Reuptake Inhibitors and Clomipramine in Pediatric Obsessive-Compulsive Disorder. ( Bloch, MH; Jakubovski, E; Varigonda, AL, 2016) |
| "The most common effective treatments for obsessive-compulsive disorder include clomipramine, fluoxetine, and exposure-based behavior therapy." | 8.78 | Clomipramine, fluoxetine, and behavior therapy in the treatment of obsessive-compulsive disorder: a meta-analysis. ( Cox, BJ; Lee, PS; Morrison, B; Swinson, RP, 1993) |
| "Clomipramine (CIMI) is an effective treatment for obsessive-compulsive disorder in patients who have failed to respond to trials of selective serotonin transport inhibitors (eg, sertraline)." | 8.31 | Personalized Medicine in the Treatment of a Patient With Obsessive-Compulsive Disorder With Clomipramine. ( Preskorn, SH; Rode, R, 2023) |
| "Quinpirole (QNP) sensitization is one of the commonly used animal models of obsessive-compulsive disorder (OCD)." | 7.85 | Detrimental effect of clomipramine on hippocampus-dependent learning in an animal model of obsessive-compulsive disorder induced by sensitization with d2/d3 agonist quinpirole. ( Hatalova, H; Pistikova, A; Radostova, D; Stuchlik, A; Vales, K, 2017) |
| "A small body of literature suggests that clomipramine may usefully augment selective serotonin reuptake inhibitor (SSRI) treatment in obsessive-compulsive disorder (OCD) patients who do not respond to SSRI monotherapy." | 7.79 | Augmenting selective serotonin reuptake inhibitors with clomipramine in obsessive-compulsive disorder: benefits and risks. ( Andrade, C, 2013) |
| "The aim of this study was to explore the possible relationship between plasma clomipramine and its major metabolite (N-desmethylclomipramine) levels and related parameters, and clinical features in patients with obsessive-compulsive disorder (OCD)." | 7.78 | Plasma clomipramine levels in adult patients with obsessive-compulsive disorder. ( Baroni, S; Catena-Dell'Osso, M; Faravelli, L; Giannaccini, G; Marazziti, D; Massimetti, G; Palego, L, 2012) |
| "We describe a 41-year old man with obsessive-compulsive neurosis who developed acute renal failure (ARF) due to acute interstitial nephritis (AIN) during 6 weeks of treatment with clomipramine hydrochloride (CPH)." | 7.74 | Reversible acute renal failure associated with clomipramine-induced interstitial nephritis. ( Akimoto, T; Ando, Y; Inoue, M; Kusano, E; Muto, S; Onishi, A; Saito, O; Yamamoto, H, 2007) |
| "To the authors' knowledge there is as of yet no study demonstrating in vivo alterations in human serotonin transporters (SERT) during clomipramine treatment in patients with obsessive-compulsive disorder." | 7.74 | Changes in thalamus-hypothalamus serotonin transporter availability during clomipramine administration in patients with obsessive-compulsive disorder. ( Aigner, M; Gutierrez-Lobos, K; Hornik, K; Pirker, W; Stompe, T; Thau, K; Wenzel, T; Zettinig, G; Zitterl, W; Zitterl-Eglseer, K, 2008) |
| "The authors present a case of obsessive-compulsive disorder (OCD) resistant to conventional treatments, which improved following nicotine augmentation administered as 4 mg chewing gum." | 7.73 | Nicotine augmentation for refractory obsessive-compulsive disorder. A case report. ( Biondi, M; Garavini, A; Pasquini, M, 2005) |
| "To report on the possible development of serotonin syndrome in a patient receiving clomipramine after clozapine was withdrawn from the treatment regimen." | 7.71 | Possible serotonin syndrome associated with clomipramine after withdrawal of clozapine. ( Dewan, V; Zerjav-Lacombe, S, 2001) |
| "Clomipramine was effective and well-tolerated in controlling signs of obsessive-compulsive disorder and/or separation anxiety and/or noise phobia in 16 of 24 assessable cases, when used in combination with behaviour modification, and improvement in clinical signs was noted in 5 others." | 7.71 | Use of clomipramine in treatment of obsessive-compulsive disorder, separation anxiety and noise phobia in dogs: a preliminary, clinical study. ( Lindeman, MJ; Seksel, K, 2001) |
| "A study was undertaken to assess the clinical response in cats diagnosed with anxiety-related or obsessive-compulsive disorders to a treatment regimen that included clomipramine and behaviour modification." | 7.70 | Use of clomipramine in the treatment of anxiety-related and obsessive-compulsive disorders in cats. ( Lindeman, MJ; Seksel, K, 1998) |
| "We report a severe case of obsessive-compulsive disorder (OCD) that responded to very high doses of citalopram (160 mg/day) after a poor response to clomipramine 250 mg/day for several years, alone or in combination with buspirone 30 mg/day or flupenthixol 4 mg/day." | 7.70 | Response to high doses of citalopram in treatment-resistant obsessive-compulsive disorder. ( Bejerot, S; Bodlund, O, 1998) |
| "Clomipramine appeared much more effective and better tolerated than fluoxetine in this very old patient despite its potential anticholinergic effect and the coexistence of Alzheimer disease." | 7.70 | Treatment of obsessive-compulsive disorder using clomipramine in a very old patient. ( Trappler, B, 1999) |
| "The CSF levels of corticotropin-releasing hormone, vasopressin, somatostatin, and oxytocin and of the monoamine metabolites 5-hydroxyindoleacetic acid, homovanillic acid, and 3-methoxy-4-hydroxyphenylglycol were measured in 17 children and adolescents with obsessive-compulsive disorder before and after long-term treatment with clomipramine." | 7.69 | Changes in cerebrospinal fluid neurochemistry during treatment of obsessive-compulsive disorder with clomipramine. ( Altemus, M; Leonard, HL; Potter, WZ; Rapoport, JL; Richter, D; Rubinow, DR; Swedo, SE, 1994) |
| "Studies on predictive factors of the obsessive-compulsive disorder response to pharmacologic treatment, specifically clomipramine, are relatively scarce." | 7.68 | A predictive study of obsessive-compulsive disorder response to clomipramine. ( Alarcon, RD; Libb, JW; Spitler, D, 1993) |
| "In a preliminary trial, five oral-clomipramine-refractory patients with obsessive-compulsive disorder (OCD) were treated openly with 14 intravenous clomipramine infusions each." | 7.68 | Open trial of intravenous clomipramine in five treatment-refractory patients with obsessive-compulsive disorder. ( Campeas, R; Davies, S; Fallon, BA; Feerick, J; Goetz, D; Hatterer, J; Hollander, E; Liebowitz, MR; Schneier, FR, 1992) |
| "This report provides preliminary evidence for the efficacy of clomipramine in the treatment of young adults with autistic disorder." | 7.68 | Clomipramine in autism: preliminary evidence of efficacy. ( Bregman, J; Cohen, DJ; Goodman, WK; McDougle, CJ; Nielsen, J; Price, LH; Volkmar, FR; Ward-O'Brien, D, 1992) |
| "Two patients suffering from severe obsessive-compulsive disorder which had proven refractory to clomipramine and/or phenelzine treatment were successfully treated with fluoxetine, a new drug with a strong serotonin uptake inhibiting action." | 7.68 | Fluoxetine treatment of obsessive-compulsive disorder. ( Ledwidge, B; Solyom, C; Solyom, L, 1991) |
| "Clomipramine is a newly marketed tricyclic antidepressant drug prescribed for obsessive-compulsive disorder (OCD)." | 7.68 | Clomipramine for obsessive-compulsive disorder: prescribing guidelines. ( James, WA; Lippmann, SB, 1991) |
| "A 62 year old woman presented with a long history of obsessive-compulsive disorder, the symptoms of which were not adequately controlled by oral clomipramine." | 7.68 | Intravenous clomipramine and obsessive-compulsive disorder. ( Gorecki, DK; Meldrum, LH; Remillard, AJ; Thakur, AK, 1991) |
| "Basal prolactin concentrations were measured before treatment in 18 children and adolescents with obsessive-compulsive disorder as well as in 15 of these patients after 4 and 8 weeks of clomipramine treatment." | 7.68 | Prolactin in childhood obsessive-compulsive disorder: clinical correlates and response to clomipramine. ( Cantwell, DP; Hanna, GL; McCracken, JT, 1991) |
| "Trazodone (TZ) was administered to nine patients suffering from obsessive-compulsive disorder (OCD), who failed to respond to either clomipramine (CMI) or to CMI plus lithium carbonate." | 7.68 | Trazodone treatment in clomipramine-resistant obsessive-compulsive disorder. ( Aizenberg, D; Hermesh, H; Munitz, H, 1990) |
| "The clinical significance of the effects of pharmacotherapy and the relationship between plasma tricyclic concentrations and outcome in 33 obsessive-compulsive disorder (OCD) patients who completed 10 weeks of treatment with clomipramine (239." | 7.68 | The relationship of plasma clomipramine and N-desmethylclomipramine to response in obsessive-compulsive disorder. ( Jones, B; Mavissakalian, M; Olson, S; Perel, JM, 1990) |
| "Clomipramine treatment was associated with significant decreases in TSH and T3 concentrations." | 6.71 | Elevated thyroid indices in children and adolescents with obsessive-compulsive disorder: effects of clomipramine treatment. ( Hanna, GL; McCracken, JT, 2005) |
| " The mean dosage of clomipramine was 2." | 6.69 | Behavior therapy versus clomipramine for the treatment of obsessive-compulsive disorder in children and adolescents. ( Buitelaar, JK; de Haan, E; Hoogduin, KA; Keijsers, GP, 1998) |
| "Clonazepam improvement was unrelated to changes in anxiety and occurred early in treatment." | 6.67 | Clomipramine, clonazepam, and clonidine treatment of obsessive-compulsive disorder. ( Agras, WS; Hewlett, WA; Vinogradov, S, 1992) |
| "Treatment with clomipramine resulted in significantly greater improvement in symptoms than desipramine, as indicated by physicians' ratings of the women's clinical progress on a scale in which lower scores indicate improvement (mean [+/- SD] scores: at base line, 10." | 6.66 | A double-blind comparison of clomipramine and desipramine in the treatment of trichotillomania (hair pulling) ( Cheslow, DL; Goldberger, EL; Lenane, MC; Leonard, HL; Rapoport, JL; Swedo, SE, 1989) |
| "A 0." | 6.38 | Clomipramine for obsessive-compulsive disorder. ( Feinberg, M, 1991) |
| "To examine the efficacy and tolerability of clomipramine compared with the selective serotonin reuptake inhibitors (SSRIs) in the treatment of obsessive-compulsive disorder (OCD), bearing in mind the recent Expert Consensus Guidelines recommendation to use clomipramine after 2 to 3 failed SSRI trials." | 6.19 | On the pharmacotherapy of obsessive-compulsive disorder: is a consensus possible? ( Borgeat, F; Freeston, MH; Todorov, C, 2000) |
| "Since it will be some time until data will be available comparing clomipramine and fluoxetine for the treatment of patients with obsessive-compulsive disorder (OCD), a meta-analysis of previous studies was performed in an attempt to gain some information about comparable efficacy and side effects of these two commonly used agents." | 6.16 | Clomipramine versus fluoxetine in obsessive-compulsive disorder: a retrospective comparison of side effects and efficacy. ( Baer, L; Greist, JH; Jenike, MA, 1990) |
| "Thirty-eight patients with primary obsessive-compulsive disorder participated in a 10-week, double-blind, placebo-controlled trial of the potent, selective serotonin reuptake inhibitor fluvoxamine." | 6.16 | A controlled trial of fluvoxamine in obsessive-compulsive disorder: implications for a serotonergic theory. ( Baer, L; Buttolph, L; Holland, A; Hyman, S; Jenike, MA; Minichiello, WE; Ricciardi, J; Seymour, R; Summergrad, P, 1990) |
| "Clomipramine was the first antidepressant to show a degree of efficacy." | 5.31 | Sertraline: new indication. May help children with obsessive-compulsive disorder. ( , 2002) |
| "The aim of this study was to investigate the influence of demethylation rate on the outcome of obsessive-compulsive disorder patients treated with clomipramine." | 5.20 | Clomipramine demethylation rate is important on the outcome of obsessive-compulsive disorder treatment. ( Bernik, MA; Gedanke Shavitt, R; Gorenstein, C; Lotufo Neto, F; Marcourakis, T, 2015) |
| "This open trial was conducted to evaluate the effectiveness of intravenous clomipramine (CMI) in refractory obsessive-compulsive disorder (OCD)." | 5.20 | Intravenous Clomipramine for Treatment-Resistant Obsessive-Compulsive Disorder. ( Karameh, WK; Khani, M, 2015) |
| "There is growing evidence that memantine, a noncompetitive N-methyl-D-aspartate receptor antagonist, may be applied as an add-on in treating patients suffering from obsessive-compulsive disorders (OCD)." | 5.17 | In a double-blind, randomized and placebo-controlled trial, adjuvant memantine improved symptoms in inpatients suffering from refractory obsessive-compulsive disorders (OCD). ( Afshar, H; Bajoghli, H; Brand, S; Hafezian, H; Haghighi, M; Holsboer-Trachsler, E; Jahangard, L; Mohammad-Beigi, H; Rahimi, A, 2013) |
| "Based on the evidence that aripiprazole added to serotonin reuptake inhibitors (SRIs) or clomipramine in treatment-resistant obsessive-compulsive disorder (OCD) has reported promising results, the present 16-week, double-blind, randomized, placebo-controlled trial had the aim to explore the efficacy of aripiprazole add-on pharmacotherapy on clinical symptoms and cognitive functioning in a sample of treatment-resistant OCD patients receiving SRIs." | 5.15 | Effect of aripiprazole augmentation of serotonin reuptake inhibitors or clomipramine in treatment-resistant obsessive-compulsive disorder: a double-blind, placebo-controlled study. ( Bruno, A; Micò, U; Muscatello, MR; Pandolfo, G; Romeo, VM; Santoro, V; Scimeca, G; Settineri, S; Spina, E; Zoccali, RA, 2011) |
| "The high percentage (between 40% and 60%) of resistance to first-line drugs, such as clomipramine or selective serotonin reuptake inhibitors, is a major problem in the pharmacologic management of obsessive-compulsive disorder (OCD)." | 5.13 | Effectiveness of long-term augmentation with citalopram to clomipramine in treatment-resistant OCD patients. ( Carlini, M; Catena Dell'osso, M; Consoli, G; Golia, F; Marazziti, D; Mungai, F; Pfanner, C; Presta, S, 2008) |
| "High doses of antidepressants, particularly clomipramine and selective serotonin reuptake inhibitors (SSRIs), are the well-established treatment for obsessive-compulsive disorder (OCD), but manic/hypomanic episodes are potential adverse events associated with this treatment." | 5.12 | First manic/hypomanic episode in obsessive-compulsive disorder patients treated with antidepressants: A systematic review. ( Alemany-Navarro, M; Alonso, P; Bertolín, S; Crespo, JM; Jiménez-Murcia, S; Menchón, JM; Real, E; Segalàs, C; Soria, V, 2021) |
| "Small studies have suggested that intravenous clomipramine (CMI) may be more effective and induce faster improvement in obsessive-compulsive disorder than do orally administered serotonin reuptake inhibitors." | 5.12 | Pulse-loaded intravenous clomipramine in treatment-resistant obsessive-compulsive disorder. ( Aboujaoude, E; Elliott, M; Gamel, N; Koran, LM; Sallee, FR; Shapira, NA; Ward, H, 2006) |
| "The purpose of the study was to test the relative and combined efficacy of clomipramine and exposure and ritual prevention in the treatment of obsessive-compulsive disorder (OCD) in adults." | 5.11 | Randomized, placebo-controlled trial of exposure and ritual prevention, clomipramine, and their combination in the treatment of obsessive-compulsive disorder. ( Campeas, R; Davies, S; Foa, EB; Franklin, ME; Huppert, JD; Kjernisted, K; Kozak, MJ; Liebowitz, MR; Rowan, V; Schmidt, AB; Simpson, HB; Tu, X, 2005) |
| "To assess how different criteria for relapse affect inferences about relapse in obsessive-compulsive disorder (OCD), a post hoc analysis of relapse was conducted using data from a multisite randomized controlled trial comparing clomipramine (CMI), exposure and ritual prevention (EX/RP), and its combination (EX/RP+CMI) in adults with OCD." | 5.11 | Standard criteria for relapse are needed in obsessive-compulsive disorder. ( Cheng, J; Foa, EB; Franklin, ME; Liebowitz, MR; Simpson, HB, 2005) |
| "The objective of this study was to investigate, in a single-blind manner over a period of 12 weeks, the efficacy and tolerability of venlafaxine versus clomipramine in the treatment of obsessive-compulsive disorder (OCD)." | 5.10 | Venlafaxine versus clomipramine in the treatment of obsessive-compulsive disorder: a preliminary single-blind, 12-week, controlled study. ( Aguglia, E; Albert, U; Bogetto, F; Maina, G, 2002) |
| "Differences between the side effect profiles of clomipramine (CMI) and the selective serotonin reuptake inhibitors may be important factors in both treatment outcome and patient selection in obsessive-compulsive disorder (OCD)." | 5.09 | Side effects as predictors of drug response in obsessive-compulsive disorder. ( Ackerman, DL; Bystritsky, A; Greenland, S, 1999) |
| " citalopram administered with clomipramine, in treatment-resistant obsessive-compulsive disorder (OCD)." | 5.09 | Citalopram for treatment-resistant obsessive-compulsive disorder. ( Koran, LM; Paiva, RS; Pallanti, S; Quercioli, L, 1999) |
| "The aim of this prospectively randomized, double-blind, parallel group, multicentre study was to compare the efficacy and tolerability of fluvoxamine and clomipramine in patients suffering from obsessive-compulsive disorder (OCD) (DSM-III-R)." | 5.09 | Multicentre, double-blind, comparison of fluvoxamine and clomipramine in the treatment of obsessive-compulsive disorder. ( Maina, G; Mundo, E; Uslenghi, C, 2000) |
| "This study evaluates the clinical response to olanzapine used in association with selective serotonin reuptake inhibitors (SSRIs) or clomipramine in treatment-resistant obsessive-compulsive disorder (OCD)." | 5.09 | Olanzapine augmentation of serotonin uptake inhibitors in obsessive-compulsive disorder: an open study. ( Francobandiera, G, 2001) |
| "The current study examines the neuroendocrine response to intravenous clomipramine (IV CMI) in oral CMI-resistant obsessive-compulsive disorder (OCD) patients on day 1 and day 14 of treatment to identify predictors of response." | 5.09 | Neuroendocrine predictors of response to intravenous clomipramine therapy for refractory obsessive-compulsive disorder. ( Coplan, JD; de la Neuz, M; Fallon, BA; Goetz, RR; Hollander, E; Liebowitz, MR; Mathew, SJ; Perko, KA, 2001) |
| "The efficacy and tolerability of fluvoxamine (100-300 mg/day) and clomipramine (100-250 mg/day) were compared in a randomized, double-blind, parallel-group study of 79 patients with obsessive-compulsive disorder (OCD) without coexisting major depression." | 5.08 | Fluvoxamine versus clomipramine for obsessive-compulsive disorder: a double-blind comparison. ( Davidson, JR; Hollander, E; Jenike, MA; Koran, LM; McElroy, SL; Rasmussen, SA, 1996) |
| "There is evidence of the clinical efficacy and safety of clomipramine and the newer selective serotonin reuptake inhibitors (SSRIs) for the treatment of obsessive-compulsive disorder (OCD)." | 5.08 | Double-blind comparison of fluoxetine versus clomipramine in the treatment of obsessive compulsive disorder. ( Bourgeois, M; Cottraux, J; Gómez-Pérez, JC; Hernández, M; López-Ibor, JJ; Note, I; Saiz, J; Viñas, R, 1996) |
| " Using data from Ciba-Geigy's multicenter 10-week clinical trial, we studied the relationship between early side effects and subsequent therapeutic response to clomipramine (CMI) in obsessive-compulsive disorder." | 5.08 | Relationship between early side effects and therapeutic effects of clomipramine therapy in obsessive-compulsive disorder. ( Ackerman, DL; Bystritsky, A; Greenland, S; Katz, RJ, 1996) |
| "The aim was to assess the effect of a flexible dose of paroxetine, compared with clomipramine and placebo, in obsessive-compulsive disorder (OCD)." | 5.08 | Paroxetine versus clomipramine in the treatment of obsessive-compulsive disorder. OCD Paroxetine Study Investigators. ( Judge, R; Zohar, J, 1996) |
| "The authors conducted a randomized, double-blind, placebo-controlled trial of intravenous versus oral pulse loading of clomipramine in patients with obsessive-compulsive disorder to test two hypotheses: 1) intravenous pulse loading will cause greater immediate improvement than oral pulse loading and 2) patients who respond to pulse loading will continue to improve during 8 weeks of oral clomipramine treatment." | 5.08 | Rapid benefit of intravenous pulse loading of clomipramine in obsessive-compulsive disorder. ( Koran, LM; Pallanti, S; Sallee, FR, 1997) |
| "A double-blind trial was carried out to assess the efficacy and safety of fluvoxamine, a selective serotonin reuptake inhibitor, in comparison with clomipramine, a classical tricyclic antidepressant, in the treatment of obsessive-compulsive disorder." | 5.08 | A double-blind study of fluvoxamine and clomipramine in the treatment of obsessive-compulsive disorder. ( Cassano, GB; Lensi, P; Marazziti, D; Milanfranchi, A; Ravagli, S, 1997) |
| "In a double-blind study, desipramine or placebo was added for 6 or 10 weeks to the treatment of 30 patients with obsessive-compulsive disorder whose symptoms were refractory to SSRI treatment (fluvoxamine, fluoxetine, or sertraline) alone." | 5.08 | Addition of desipramine to serotonin reuptake inhibitors in treatment-resistant obsessive-compulsive disorder. ( Anand, A; Barr, LC; Goodman, WK; McDougle, CJ; Price, LH, 1997) |
| "We compared gradually increased to pulse loaded doses of open-label, intravenous clomipramine (CMI) in patients with obsessive-compulsive disorder (OCD)." | 5.08 | Pulse loading versus gradual dosing of intravenous clomipramine in obsessive-compulsive disorder. ( Koran, LM; Paiva, RS; Pallanti, S; Quercioli, L, 1998) |
| "Medication management of obsessive-compulsive disorder (OCD) has consisted of monotherapy with either clomipramine (CMI) or selective serotonin reuptake inhibitors (SSRIs) such as fluvoxamine, paroxetine, or sertraline." | 5.08 | Combination treatment with clomipramine and selective serotonin reuptake inhibitors for obsessive-compulsive disorder in children and adolescents. ( Birmaher, B; Figueroa, Y; Keshavan, MS; Rosenberg, DR, 1998) |
| "Challenge with intravenous clomipramine (CMI) is serotonin selective and has been reported to transiently exacerbate symptoms in obsessive-compulsive disorder (OCD) patients, and to predict subsequent response to oral CMI therapy." | 5.08 | Intravenous clomipramine challenge in obsessive-compulsive disorder: predicting response to oral therapy at eight weeks. ( Carson, SW; Koran, LM; Pallanti, S; Sallee, FR; Sethuraman, G, 1998) |
| "Uncontrolled reports suggest that intravenous clomipramine hydrochloride may be effective for patients with obsessive-compulsive disorder (OCD) who are nonresponsive to oral clomipramine." | 5.08 | Intravenous clomipramine for obsessive-compulsive disorder refractory to oral clomipramine: a placebo-controlled study. ( Campeas, R; Davies, S; Fallon, BA; Goetz, D; Klein, DF; Liebowitz, MR; Marshall, R; Schneier, FR, 1998) |
| "In subjects with obsessive-compulsive disorder (OCD), lower pre-treatment metabolism in the right orbitofrontal cortex (OFC) and anterior cingulate gyrus (AC) has been associated with a better response to clomipramine." | 5.08 | FDG-PET predictors of response to behavioral therapy and pharmacotherapy in obsessive compulsive disorder. ( Baxter, LR; Brody, AL; Maidment, K; Phelps, ME; Saxena, S; Schwartz, JM; Stoessel, PW, 1998) |
| "There have been many attempts to find predictors of the therapeutic response to the clomipramine treatment of obsessive-compulsive disorder." | 5.07 | Predictors of treatment response in obsessive-compulsive disorder: multivariate analyses from a multicenter trial of clomipramine. ( Ackerman, DL; Bystritsky, A; Greenland, S; Katz, RJ; Morgenstern, H, 1994) |
| "To determine whether clomipramine hydrochloride, a serotonin reuptake blocker with unique anti-obsessional properties, is differentially effective for obsessive-compulsive and stereotyped motor behaviors in autistic disorder compared with placebo and with the noradrenergic tricyclic antidepressant agent, desipramine hydrochloride." | 5.07 | A double-blind comparison of clomipramine, desipramine, and placebo in the treatment of autistic disorder. ( Gordon, CT; Hamburger, SD; Nelson, JE; Rapoport, JL; State, RC, 1993) |
| "A double-blind clinical trial of clomipramine versus phenelzine was carried out on 30 patients suffering from DSM-III obsessive-compulsive disorder." | 5.07 | Clomipramine versus phenelzine in obsessive-compulsive disorder. A controlled clinical trial. ( Bulbena, A; Marcos, T; Menchón, JM; Olivares, J; Vallejo, J, 1992) |
| "We used the Structured Interview for DSM-III Personality Disorders to diagnose DSM-III personality disorders systematically in 55 patients with obsessive-compulsive disorder in the active-treatment cell of a controlled trial of clomipramine hydrochloride." | 5.07 | Effect of axis II diagnoses on treatment outcome with clomipramine in 55 patients with obsessive-compulsive disorder. ( Baer, L; Black, DW; Greist, J; Jenike, MA; Rosenfeld, R; Treece, C, 1992) |
| "In this study, 14 patients with obsessive-compulsive disorder (OCD) who had received at least 3 months of treatment with clomipramine were treated with the anxiolytic agent buspirone in a 10-week, double-blind study." | 5.07 | A double-blind study of adjuvant buspirone hydrochloride in clomipramine-treated patients with obsessive-compulsive disorder. ( Bernstein, SE; Bihari, K; Hill, JL; L'Heureux, F; Murphy, DL; Pigott, TA, 1992) |
| "Two double-blind studies at 21 centers evaluated the therapeutic efficacy, safety, and tolerability of up to 300 mg/d of clomipramine hydrochloride or an equivalent number of placebo capsules in the treatment of 520 patients with obsessive-compulsive disorder, of whom 239 had had the disorder for at least 2 years (study 1) and 281 had been ill for at least 1 year (study 2)." | 5.07 | Clomipramine in the treatment of patients with obsessive-compulsive disorder. The Clomipramine Collaborative Study Group. ( , 1991) |
| "In this study, 16 patients with obsessive-compulsive disorder (OCD) who had partially improved during at least 6 months of treatment with clomipramine were sequentially treated with triiodothyronine and lithium carbonate in an 8-week double-blind cross-over study." | 5.07 | A controlled comparison of adjuvant lithium carbonate or thyroid hormone in clomipramine-treated patients with obsessive-compulsive disorder. ( Bernstein, SE; Grover, GN; Hill, JL; L'Heureux, F; Murphy, DL; Pato, MT; Pigott, TA, 1991) |
| "Twenty-six children and adolescents with severe primary obsessive-compulsive disorder receiving long-term clomipramine hydrochloride maintenance treatment (mean +/- SD, 17." | 5.07 | A double-blind desipramine substitution during long-term clomipramine treatment in children and adolescents with obsessive-compulsive disorder. ( Cheslow, DL; Hamburger, SD; Lenane, MC; Leonard, HL; Rapoport, JL; Rettew, DC; Swedo, SE, 1991) |
| "Twenty-five adult subjects with severe morbid onychophagia (nail biting) and no history of obsessive-compulsive disorder were enrolled in a 10-week double-blind cross-over trial of clomipramine hydrochloride and desipramine hydrochloride." | 5.07 | A double-blind comparison of clomipramine and desipramine treatment of severe onychophagia (nail biting). ( Lenane, MC; Leonard, HL; Rapoport, JL; Rettew, DC; Swedo, SE, 1991) |
| "Eighteen outpatients with obsessive-compulsive disorder were treated with either buspirone, a partial serotonin agonist, or clomipramine, a serotonin uptake inhibitor, in a double-blind, random-assignment study." | 5.07 | Controlled comparison of buspirone and clomipramine in obsessive-compulsive disorder. ( Bernstein, S; Grover, GN; Hill, JL; Murphy, DL; Pato, MT; Pigott, TA, 1991) |
| "The authors evaluated platelet tritiated imipramine binding in 22 outpatients with obsessive-compulsive disorder (OCD) and 22 psychiatrically normal controls matched for age and gender." | 5.06 | Tritiated imipramine binding in obsessive-compulsive volunteers and psychiatrically normal controls. ( Black, DW; Kelly, M; Myers, C; Noyes, R, 1990) |
| "The effects of clomipramine hydrochloride (CMI) versus placebo upon DSM-III-defined obsessive-compulsive disorder (OCD) were assessed in a 10-week double-blind multicenter trial and in a corresponding 1-year double-blind extension study." | 5.06 | Clomipramine in obsessive-compulsive disorder. ( DeVeaugh-Geiss, J; Katz, RJ; Landau, P, 1990) |
| "Treatment with fluoxetine hydrochloride was compared with treatment with clomipramine hydrochloride in two groups of patients with obsessive-compulsive disorder using two different experimental designs." | 5.06 | Controlled comparisons of clomipramine and fluoxetine in the treatment of obsessive-compulsive disorder. Behavioral and biological results. ( Bernstein, SE; Grover, GN; Hill, JL; Murphy, DL; Pato, MT; Pigott, TA; Tolliver, TJ, 1990) |
| "Ten patients with DSM-III-R obsessive-compulsive disorder (OCD) who were being treated chronically with clomipramine (270 +/- 20 mg/day) were studied to determine the minimum dose of clomipramine needed to maintain therapeutic benefit." | 5.06 | A clomipramine dosage reduction study in the course of long-term treatment of obsessive-compulsive disorder patients. ( Hill, JL; Murphy, DL; Pato, MT, 1990) |
| "Clomipramine has been reported to be effective in the treatment of obsessive-compulsive disorder (OCD)." | 5.06 | Treatment of adolescent obsessive-compulsive disorder with a clomipramine-fluoxetine combination. ( Simeon, JG; Thatte, S; Wiggins, D, 1990) |
| "Clomipramine was significantly superior to placebo in a 10-week double-blind, placebo-controlled trial in 27 outpatients who met DSM-III-R criteria for obsessive-compulsive disorder." | 5.06 | Obsessive-compulsive disorder: a double-blind, placebo-controlled trial of clomipramine in 27 patients. ( Baer, L; Holland, A; Jenike, MA; Seymour, R; Summergrad, P; Weilburg, JB, 1989) |
| "Forty-eight children and adolescents with severe primary obsessive-compulsive disorder completed a 10-week double-blind crossover trial of clomipramine hydrochloride (mean dose [+/- SD], 150 +/- 53 mg/d) and desipramine hydrochloride (mean dose [+/- SD], 153 +/- 55 mg/d)." | 5.06 | Treatment of obsessive-compulsive disorder with clomipramine and desipramine in children and adolescents. A double-blind crossover comparison. ( Cheslow, DL; Hamburger, SD; Koby, EV; Lenane, MC; Leonard, HL; Rapoport, JL; Swedo, SE, 1989) |
| "Twenty nondepressed outpatients with DSM-III obsessive-compulsive disorder entered a 10-week placebo-controlled study of clomipramine and underwent a 1-mg dexamethasone suppression test (DST) at baseline; 11 had a repeat DST at the end of treatment: Nonsuppression was rare." | 5.06 | HPA axis disturbance in obsessive-compulsive disorder. ( Black, DW; Coryell, WH; Kelly, MW; Noyes, R, 1989) |
| "Data from several previous studies link clomipramine's potent serotonergic effects to its clinical efficacy in reducing the symptoms of obsessive-compulsive disorder (OCD)." | 5.06 | Clomipramine in obsessive-compulsive disorder. Further evidence for a serotonergic mechanism of action. ( Benkelfat, C; Grover, G; Hill, JL; Insel, TR; Murphy, DL; Zohar, J, 1989) |
| "To evaluate the need for maintenance drug therapy in patients with obsessive-compulsive disorder, the authors assessed 21 patients with obsessive-compulsive disorder who manifested sustained improvement during 5 to 27 months of clomipramine treatment and who agreed to participate in a double-blind discontinuation study." | 5.06 | Return of symptoms after discontinuation of clomipramine in patients with obsessive-compulsive disorder. ( Murphy, DL; Pato, MT; Zohar, J; Zohar-Kadouch, R, 1988) |
| "A double-blind comparative study of clomipramine and fluvoxamine was performed in 50 patients suffering from anxiety disorders (DSM-III)." | 5.06 | Effect of serotonin uptake inhibitors in anxiety disorders; a double-blind comparison of clomipramine and fluvoxamine. ( den Boer, JA; Kahn, RS; Kamerbeek, WD; Verhoeven, WM; Westenberg, HG, 1987) |
| "Clomipramine is a potent serotonin reuptake blocker that decreases the symptoms of obsessive-compulsive disorder (OCD)." | 5.06 | Serotonergic responsivity in obsessive-compulsive disorder. Effects of chronic clomipramine treatment. ( Hill, JL; Insel, TR; Murphy, DL; Zohar, J; Zohar-Kadouch, RC, 1988) |
| "A double-blind placebo-controlled study of 5-HTP and clomipramine was carried out on 45 patients suffering from anxiety disorders (DSM-III)." | 5.06 | Effect of a serotonin precursor and uptake inhibitor in anxiety disorders; a double-blind comparison of 5-hydroxytryptophan, clomipramine and placebo. ( Gispen-de Wied, CC; Kahn, RS; Kamerbeek, WD; Verhoeven, WM; Westenberg, HG, 1987) |
| "Forty-six patients with obsessive-compulsive disorder undergoing a double-blind controlled study of clomipramine and placebo were interviewed to assess changes in sexual function." | 5.06 | Anorgasmia from clomipramine in obsessive-compulsive disorder. A controlled trial. ( Lelliott, PT; Marks, IM; Monteiro, WO; Noshirvani, HF, 1987) |
| "Most of the controlled studies on the efficacy of medical treatments of obsessive-compulsive disorder (OCD) have involved clomipramine, a tricyclic antidepressant reputed to have anti-obsessional properties." | 5.06 | Effects of imipramine on depression and obsessive-compulsive symptoms. ( Dugger, D; Foa, EB; Kozak, MJ; Steketee, G, 1987) |
| "Concentrations of the serotonin metabolite 5-hydroxyindoleacetic acid (5-HIAA), the dopamine metabolite homovanillic acid, and the noradrenaline metabolite 4-hydroxy-3-methoxyphenyl glycol were measured in CSF before and after three weeks' treatment of severe obsessive-compulsive disorder with clomipramine hydrochloride." | 5.05 | Clomipramine treatment of obsessive-compulsive disorder. II. Biochemical aspects. ( Asberg, M; Bertilsson, L; Mellström, B; Sjöqvist, F; Thorén, P; Träskman, L, 1980) |
| "Patients with obsessive-compulsive disorder who met DSM-III criteria and who had been ill for at least one year were studied in a double-blind, randomized, crossover comparison of the tricyclic antidepressant clomipramine hydrochloride and the monoamine oxidase inhibitor clorgyline hydrochloride." | 5.05 | Obsessive-compulsive disorder. A double-blind trial of clomipramine and clorgyline. ( Alterman, I; Cohen, RM; Insel, TR; Kilts, C; Linnoila, M; Murphy, DL, 1983) |
| "The effect of clomipramine hydrochloride in severe obsessive-compulsive disorder (OCD) was compared with that of nortriptyline hydrochloride and placebo in a five-week randomized, double-blind trial." | 5.05 | Clomipramine treatment of obsessive-compulsive disorder. I. A controlled clinical trial. ( Asberg, M; Cronholm, B; Jörnestedt, L; Thorén, P; Träskman, L, 1980) |
| "Twenty-three outpatients with primary obsessive-compulsive disorder (OCD) were started in a 12-week double-blind clinical trial of clomipramine (CLI) (n = 11) and imipramine (IMI) (n = 12)." | 5.05 | Clomipramine and imipramine in obsessive-compulsive disorder. ( Neziroglu, F; Volavka, J; Yaryura-Tobias, JA, 1985) |
| "3 years) with severe, primary obsessive-compulsive disorder completed a ten-week, double-blind, controlled trial of clomipramine hydrochloride (mean dosage, 141 mg/day) or placebo, each of which was administered for five weeks." | 5.05 | Clomipramine treatment of childhood obsessive-compulsive disorder. A double-blind controlled study. ( Berg, CJ; Flament, MF; Kilts, C; Linnoila, M; Mellström, B; Rapoport, JL; Sceery, W, 1985) |
| "We conducted a meta-analysis to examine the following: the time course of response to selective serotonin reuptake inhibitors (SSRIs) and clomipramine in pediatric obsessive-compulsive disorder (OCD); whether higher doses of SSRIs are associated with an improved response in pediatric OCD; differences in efficacy among SSRI agents; differences in efficacy between SSRIs and clomipramine; and whether the time course and magnitude of response to SSRIs are different in pediatric and adult patients with OCD." | 4.93 | Systematic Review and Meta-Analysis: Early Treatment Responses of Selective Serotonin Reuptake Inhibitors and Clomipramine in Pediatric Obsessive-Compulsive Disorder. ( Bloch, MH; Jakubovski, E; Varigonda, AL, 2016) |
| "In the last decades, the treatment of obsessive-compulsive disorder (OCD) has been revolutioned by the introduction into the clinical practice of the selective serotonin (5-HT) reuptake inhibitors (SSRIs), following the observation of the unique response of OCD patients to clomipramine." | 4.86 | Past, present and future drugs for the treatment of obsessive-compulsive disorder. ( Baroni, S; Catena Dell'Osso, M; Consoli, G; Marazziti, D, 2010) |
| "Convincing evidence from placebo-referenced randomized controlled trials supports efficacy for clomipramine and selective serotonin reuptake inhibitors for acute treatment of obsessive-compulsive disorder." | 4.84 | Sustained response versus relapse: the pharmacotherapeutic goal for obsessive-compulsive disorder. ( Fineberg, NA; Ipser, J; Pallanti, S; Pampaloni, I; Stein, DJ, 2007) |
| "To critically review the antiobsessional properties of serotonin-norepinephrine reuptake inhibitors (SNRIs) (venlafaxine and clomipramine) in the treatment of obsessive-compulsive disorder (OCD) as an alternative to selective serotonin reuptake inhibitors (SSRIs), which are currently considered the first-line treatment of OCD." | 4.83 | Serotonin-norepinephrine reuptake inhibitors in the treatment of obsessive-compulsive disorder: A critical review. ( Allen, A; Dell'Osso, B; Hollander, E; Nestadt, G, 2006) |
| " These studies have shown clomipramine and serotonin-reuptake inhibitors to be very effective in the therapy of obsessive-compulsive disorders in childhood and adolescence." | 4.82 | [Pharmacotherapy of compulsive disorders in childhood and adolescence]. ( Mehler-Wex, C; Warnke, A; Wewetzer, Ch, 2003) |
| "Meta-analytic reviews of placebo-controlled studies for obsessive-compulsive disorder have found that clomipramine is more effective than drugs with more selective actions on serotonin reuptake, whereas in most direct comparisons, clomipramine's superiority has been less obvious." | 4.81 | Multivariate meta-analysis of controlled drug studies for obsessive-compulsive disorder. ( Ackerman, DL; Greenland, S, 2002) |
| "MEDLINE search (1966 to present) of OCD treatment with clomipramine or SSRI antidepressant medication using the key words obsessive-compulsive disorder, serotonin reuptake inhibitors, clomipramine, and pharmacology." | 4.80 | A review of the efficacy of selective serotonin reuptake inhibitors in obsessive-compulsive disorder. ( Pigott, TA; Seay, SM, 1999) |
| "The largest body of work supporting the use of medications for childhood anxiety came from studies of obsessive-compulsive disorder, where clomipramine and fluoxetine have been found effective in systematic studies." | 4.79 | Current knowledge of medications for the treatment of childhood anxiety disorders. ( Allen, AJ; Leonard, H; Swedo, SE, 1995) |
| "The most common effective treatments for obsessive-compulsive disorder include clomipramine, fluoxetine, and exposure-based behavior therapy." | 4.78 | Clomipramine, fluoxetine, and behavior therapy in the treatment of obsessive-compulsive disorder: a meta-analysis. ( Cox, BJ; Lee, PS; Morrison, B; Swinson, RP, 1993) |
| "The chemistry, pharmacology, pharmacokinetics, adverse effects, and dosage of clomipramine hydrochloride are described, and clinical studies of the use of clomipramine in treating obsessive-compulsive disorder (OCD), other psychiatric conditions, and chronic pain are reviewed." | 4.78 | Clomipramine: an antiobsessional tricyclic antidepressant. ( Austin, LS; Davis, SK; Peters, MD, 1990) |
| "Involvement of the brain serotonin (5-HT) neurotransmitter system in obsessive-compulsive disorder (OCD) was originally suggested on the basis of therapeutic effects found with the semiselective serotonin uptake inhibitor, clomipramine." | 4.77 | Obsessive-compulsive disorder as a 5-HT subsystem-related behavioural disorder. ( Benkelfat, C; Insel, TR; Murphy, DL; Pato, MT; Pigott, TA; Zohar, J, 1989) |
| "Clomipramine (CIMI) is an effective treatment for obsessive-compulsive disorder in patients who have failed to respond to trials of selective serotonin transport inhibitors (eg, sertraline)." | 4.31 | Personalized Medicine in the Treatment of a Patient With Obsessive-Compulsive Disorder With Clomipramine. ( Preskorn, SH; Rode, R, 2023) |
| "Quinpirole (QNP) sensitization is one of the commonly used animal models of obsessive-compulsive disorder (OCD)." | 3.85 | Detrimental effect of clomipramine on hippocampus-dependent learning in an animal model of obsessive-compulsive disorder induced by sensitization with d2/d3 agonist quinpirole. ( Hatalova, H; Pistikova, A; Radostova, D; Stuchlik, A; Vales, K, 2017) |
| "OCD-like behaviors are emerging during adolescence, but sucrose consumption and fat bingeing in CMI-treated animals significantly precedes the appearance of anxiety and perseveration." | 3.81 | Developmental emergence of an obsessive-compulsive phenotype and binge behavior in rats. ( Andersen, SL; Einhorn, P; Freund, N; Norman, KJ; Thompson, BS, 2015) |
| "A small body of literature suggests that clomipramine may usefully augment selective serotonin reuptake inhibitor (SSRI) treatment in obsessive-compulsive disorder (OCD) patients who do not respond to SSRI monotherapy." | 3.79 | Augmenting selective serotonin reuptake inhibitors with clomipramine in obsessive-compulsive disorder: benefits and risks. ( Andrade, C, 2013) |
| "The aim of this study was to explore the possible relationship between plasma clomipramine and its major metabolite (N-desmethylclomipramine) levels and related parameters, and clinical features in patients with obsessive-compulsive disorder (OCD)." | 3.78 | Plasma clomipramine levels in adult patients with obsessive-compulsive disorder. ( Baroni, S; Catena-Dell'Osso, M; Faravelli, L; Giannaccini, G; Marazziti, D; Massimetti, G; Palego, L, 2012) |
| "Clomipramine was superior to placebo in reducing both obsessive-compulsive symptoms considered together (g = 1." | 3.78 | Efficacy of drug treatment in obsessive-compulsive disorder. A meta-analytic review. ( Bellantuono, C; Piccinelli, M; Pini, S; Wilkinson, G, 1995) |
| " We genotyped 41 obsessive-compulsive disorder (OCD) outpatients, classified as good-responders (n=27) and poor-responders (n=14) to treatment with clomipramine according to the Yale Brown Obsessive-Compulsive Scale (YBOCS)." | 3.77 | Association study between genetic monoaminergic polymorphisms and OCD response to clomipramine treatment. ( Cordeiro, Q; Miguel, EC; Miguita, K; Shavitt, RG; Vallada, H, 2011) |
| "Fluoxetine's efficacy has been principally based on convincing open-label studies and clinical practice." | 3.77 | Serotonergic antidepressants and their efficacy in obsessive compulsive disorder. ( Dominguez, RA, 1992) |
| "Sertraline is a non-tricyclic, potent and selective serotonin reuptake inhibitor (SSRI) which is currently approved for the treatment of depression in several countries, including the UK and the USA." | 3.77 | Sertraline in the treatment of obsessive compulsive disorder: two double-blind, placebo-controlled studies. ( Chouinard, G, 1992) |
| "Clomipramine appears to produce some short term benefit with exposure therapy in patients with obsessive compulsive disorder." | 3.76 | Clomipramine. An overview of its pharmacological properties and a review of its therapeutic use in obsessive compulsive disorder and panic disorder. ( Benfield, P; McTavish, D, 1990) |
| "Clomipramine was approved by the Food and Drug Administration and released for general use in early 1990 under the brand name Anafranil." | 3.76 | Pharmacotherapy of obsessive-compulsive disorder. ( Crismon, ML; Jermain, DM, 1990) |
| " Using cognitive-behavioural therapy, clomipramine and enteral nutrition, weight gain and disappearance of restrictive and obsessive-compulsive behaviours were obtained." | 3.75 | Obsessive compulsive disorder as a cause of atypical eating disorder: a case report. ( Dechelotte, P; Garcia, FD; Houy-Durand, E; Thibaut, F, 2009) |
| "Treatment with clomipramine, a tricyclic antidepressant, has proved useful for obsessional patients either as an adjunct to behavior therapy or as a primary treatment for patients who are not amenable to behavioral interventions." | 3.75 | Obsessive-compulsive disorder. ( Insel, TR, 1985) |
| "We describe a 41-year old man with obsessive-compulsive neurosis who developed acute renal failure (ARF) due to acute interstitial nephritis (AIN) during 6 weeks of treatment with clomipramine hydrochloride (CPH)." | 3.74 | Reversible acute renal failure associated with clomipramine-induced interstitial nephritis. ( Akimoto, T; Ando, Y; Inoue, M; Kusano, E; Muto, S; Onishi, A; Saito, O; Yamamoto, H, 2007) |
| "To the authors' knowledge there is as of yet no study demonstrating in vivo alterations in human serotonin transporters (SERT) during clomipramine treatment in patients with obsessive-compulsive disorder." | 3.74 | Changes in thalamus-hypothalamus serotonin transporter availability during clomipramine administration in patients with obsessive-compulsive disorder. ( Aigner, M; Gutierrez-Lobos, K; Hornik, K; Pirker, W; Stompe, T; Thau, K; Wenzel, T; Zettinig, G; Zitterl, W; Zitterl-Eglseer, K, 2008) |
| "The authors present a case of obsessive-compulsive disorder (OCD) resistant to conventional treatments, which improved following nicotine augmentation administered as 4 mg chewing gum." | 3.73 | Nicotine augmentation for refractory obsessive-compulsive disorder. A case report. ( Biondi, M; Garavini, A; Pasquini, M, 2005) |
| " She has also been under treatment for obsessive and compulsive neurosis and depression for two years and complained of constipation that was the side effect of the drug clomipramine HCL." | 3.73 | [Case report: taeniasis, is it a cause of psychiatric and neural symptoms?]. ( Aksoy, U; Inceboz, T; Yalçin, G, 2006) |
| "A young man with a 13 year history of Tourette disorder and obsessive-compulsive disorder developed mania on clomipramine." | 3.72 | Quetiapine treatment in a patient with Tourette's syndrome, obsessive-compulsive disorder and drug-induced mania. ( Matur, Z; Uçok, A, 2003) |
| "To report on the possible development of serotonin syndrome in a patient receiving clomipramine after clozapine was withdrawn from the treatment regimen." | 3.71 | Possible serotonin syndrome associated with clomipramine after withdrawal of clozapine. ( Dewan, V; Zerjav-Lacombe, S, 2001) |
| "Clomipramine was effective and well-tolerated in controlling signs of obsessive-compulsive disorder and/or separation anxiety and/or noise phobia in 16 of 24 assessable cases, when used in combination with behaviour modification, and improvement in clinical signs was noted in 5 others." | 3.71 | Use of clomipramine in treatment of obsessive-compulsive disorder, separation anxiety and noise phobia in dogs: a preliminary, clinical study. ( Lindeman, MJ; Seksel, K, 2001) |
| "Alterations in arginine vasopressin regulation and secretion have been proposed as one possible biochemical abnormality in patients with obsessive-compulsive disorder." | 3.71 | Vasopressin-dependent flank marking in golden hamsters is suppressed by drugs used in the treatment of obsessive-compulsive disorder. ( Ferris, CF; Koppel, G; Messenger, T; Rasmussen, MF, 2001) |
| "Clomipramine (CMI) is a typical tricyclic antidepressant with a wide clinical spectrum, being used in major depressive, panic and obsessive-compulsive disorders." | 3.71 | Simultaneous determination of clomipramine and its desmethyl and hydroxy metabolites in plasma of patients by high-performance liquid chromatography after solid-phase extraction. ( Bareggi, SR; Bellodi, L; Mundo, E; Pirola, R, 2002) |
| "A study was undertaken to assess the clinical response in cats diagnosed with anxiety-related or obsessive-compulsive disorders to a treatment regimen that included clomipramine and behaviour modification." | 3.70 | Use of clomipramine in the treatment of anxiety-related and obsessive-compulsive disorders in cats. ( Lindeman, MJ; Seksel, K, 1998) |
| "We report a severe case of obsessive-compulsive disorder (OCD) that responded to very high doses of citalopram (160 mg/day) after a poor response to clomipramine 250 mg/day for several years, alone or in combination with buspirone 30 mg/day or flupenthixol 4 mg/day." | 3.70 | Response to high doses of citalopram in treatment-resistant obsessive-compulsive disorder. ( Bejerot, S; Bodlund, O, 1998) |
| "Clomipramine appeared much more effective and better tolerated than fluoxetine in this very old patient despite its potential anticholinergic effect and the coexistence of Alzheimer disease." | 3.70 | Treatment of obsessive-compulsive disorder using clomipramine in a very old patient. ( Trappler, B, 1999) |
| "A pharmacokinetic interaction between the selective serotonin reuptake inhibitor citalopram and a tricyclic antidepressant, clomipramine, was noted in a patient treated for major depression and obsessive-compulsive disorder." | 3.70 | Citalopram: an interaction study with clomipramine in a patient heterozygous for CYP2D6 genotype. ( Bechtel, PR; Bizouard, P; Broly, F; Haffen, E; Sechter, D; Vandel, P; Vandel, S, 1999) |
| "(1) Sertraline, a selective serotonin reuptake inhibitor (SSRI), is now licensed in France for the treatment of obsessive-compulsive disorder in adults." | 3.70 | Sertraline and obsessive compulsive disorder: new indication. Limited assessment. ( , 2000) |
| "The CSF levels of corticotropin-releasing hormone, vasopressin, somatostatin, and oxytocin and of the monoamine metabolites 5-hydroxyindoleacetic acid, homovanillic acid, and 3-methoxy-4-hydroxyphenylglycol were measured in 17 children and adolescents with obsessive-compulsive disorder before and after long-term treatment with clomipramine." | 3.69 | Changes in cerebrospinal fluid neurochemistry during treatment of obsessive-compulsive disorder with clomipramine. ( Altemus, M; Leonard, HL; Potter, WZ; Rapoport, JL; Richter, D; Rubinow, DR; Swedo, SE, 1994) |
| "Cerebral perfusion in a previously untreated patient with obsessive-compulsive disorder was studied qualitatively and semi-quantitatively with SPECT before, and during and 6 wk after treatment with clomipramine." | 3.69 | Drug therapy and cerebral perfusion in obsessive-compulsive disorder. ( Carreras, JL; Jiménez-Vicioso, A; Martín-Loeches, M; Molina, V; Montz, R; Rubia, FJ, 1995) |
| "Out of ten consecutive patients with DSM-III-R obsessive-compulsive disorder without any previous history of bipolarity, three patients showed antidepressant-induced hypomania (clomipramine, one patient; fluvoxamine, two patients) within the first 5 to 8 weeks of the drug treatment." | 3.69 | Antidepressant-induced hypomania in obsessive-compulsive disorder. ( Barsi, J; Belsõ, N; György, S; Pestality, P; Rihmer, Z, 1996) |
| "Studies on predictive factors of the obsessive-compulsive disorder response to pharmacologic treatment, specifically clomipramine, are relatively scarce." | 3.68 | A predictive study of obsessive-compulsive disorder response to clomipramine. ( Alarcon, RD; Libb, JW; Spitler, D, 1993) |
| " The aim of the present study was to investigate whether platelet MBR are altered in untreated obsessive-compulsive disorder (OCD) patients and whether chronic treatment with clomipramine (CMI) regulates these receptors." | 3.68 | The platelet benzodiazepine receptor is unaltered in obsessive-compulsive disorder. ( Dar, DE; Gavish, M; Hermesh, H; Karp, L; Munitz, H; Weizman, R, 1993) |
| "To investigate the effects of drug treatment in childhood-onset obsessive-compulsive disorder (OCD), we repeated positron emission tomographic scans in 13 adults with OCD (eight taking clomipramine, two taking fluoxetine, and three taking no drug) after at least 1 year of pharmacotherapy." | 3.68 | Cerebral glucose metabolism in childhood-onset obsessive-compulsive disorder. Revisualization during pharmacotherapy. ( Goldberger, EL; Grady, CL; Leonard, HL; Pietrini, P; Rapoport, JL; Rapoport, SI; Rettew, DC; Schapiro, MB; Swedo, SE, 1992) |
| "In a preliminary trial, five oral-clomipramine-refractory patients with obsessive-compulsive disorder (OCD) were treated openly with 14 intravenous clomipramine infusions each." | 3.68 | Open trial of intravenous clomipramine in five treatment-refractory patients with obsessive-compulsive disorder. ( Campeas, R; Davies, S; Fallon, BA; Feerick, J; Goetz, D; Hatterer, J; Hollander, E; Liebowitz, MR; Schneier, FR, 1992) |
| "This report provides preliminary evidence for the efficacy of clomipramine in the treatment of young adults with autistic disorder." | 3.68 | Clomipramine in autism: preliminary evidence of efficacy. ( Bregman, J; Cohen, DJ; Goodman, WK; McDougle, CJ; Nielsen, J; Price, LH; Volkmar, FR; Ward-O'Brien, D, 1992) |
| "Clomipramine hydrochloride, a tricyclic antidepressant that blocks serotonin and norepinephrine reuptake, is indicated in the treatment of Obsessive-Compulsive Disorder." | 3.68 | Tourette's syndrome and treatment with clomipramine hydrochloride. ( Donahoe, DH; Fortune, T; Llorena, R; Meador, M, 1991) |
| "Two patients suffering from severe obsessive-compulsive disorder which had proven refractory to clomipramine and/or phenelzine treatment were successfully treated with fluoxetine, a new drug with a strong serotonin uptake inhibiting action." | 3.68 | Fluoxetine treatment of obsessive-compulsive disorder. ( Ledwidge, B; Solyom, C; Solyom, L, 1991) |
| "Clomipramine is a newly marketed tricyclic antidepressant drug prescribed for obsessive-compulsive disorder (OCD)." | 3.68 | Clomipramine for obsessive-compulsive disorder: prescribing guidelines. ( James, WA; Lippmann, SB, 1991) |
| "Positron emission tomography and 18-F-fluorodeoxyglucose were used to study resting cerebral glucose metabolism in 10 adult women with trichotillomania and 20 age-matched female controls." | 3.68 | Regional cerebral glucose metabolism of women with trichotillomania. ( Grady, CL; Leonard, HL; Rapoport, JL; Rapoport, SI; Schapiro, MB; Swedo, SE, 1991) |
| "A 62 year old woman presented with a long history of obsessive-compulsive disorder, the symptoms of which were not adequately controlled by oral clomipramine." | 3.68 | Intravenous clomipramine and obsessive-compulsive disorder. ( Gorecki, DK; Meldrum, LH; Remillard, AJ; Thakur, AK, 1991) |
| "Basal prolactin concentrations were measured before treatment in 18 children and adolescents with obsessive-compulsive disorder as well as in 15 of these patients after 4 and 8 weeks of clomipramine treatment." | 3.68 | Prolactin in childhood obsessive-compulsive disorder: clinical correlates and response to clomipramine. ( Cantwell, DP; Hanna, GL; McCracken, JT, 1991) |
| "Trazodone (TZ) was administered to nine patients suffering from obsessive-compulsive disorder (OCD), who failed to respond to either clomipramine (CMI) or to CMI plus lithium carbonate." | 3.68 | Trazodone treatment in clomipramine-resistant obsessive-compulsive disorder. ( Aizenberg, D; Hermesh, H; Munitz, H, 1990) |
| "The clinical significance of the effects of pharmacotherapy and the relationship between plasma tricyclic concentrations and outcome in 33 obsessive-compulsive disorder (OCD) patients who completed 10 weeks of treatment with clomipramine (239." | 3.68 | The relationship of plasma clomipramine and N-desmethylclomipramine to response in obsessive-compulsive disorder. ( Jones, B; Mavissakalian, M; Olson, S; Perel, JM, 1990) |
| "Two episodes of urinary retention occurred in a 15-year-old male following administration of clomipramine given for obsessive-compulsive disorder." | 3.67 | Clomipramine-induced urinary dysfunction in an obsessive-compulsive adolescent. ( Aizenberg, D; Hermesh, H; Lapidot, M; Munitz, H; Weizman, A, 1987) |
| "In a small series of patients, suffering from obsessional disorders, it was found that there seems to be a type of depression which occurs during the course of clomipramine therapy." | 3.65 | Depressive reactions in the course of clomipramine therapy used in the treatment of obsessional conditions. ( Capstick, N, 1975) |
| "A multicentre clinical trial of clomipramine in the treatment of obsessional and phobic disorders in general practice is described." | 3.65 | An investigation into the use of anafranil in phobic and obsessional disorders. ( Waxman, D, 1975) |
| "Clomipramine treatment was associated with significant decreases in TSH and T3 concentrations." | 2.71 | Elevated thyroid indices in children and adolescents with obsessive-compulsive disorder: effects of clomipramine treatment. ( Hanna, GL; McCracken, JT, 2005) |
| " The mean dosage of clomipramine was 2." | 2.69 | Behavior therapy versus clomipramine for the treatment of obsessive-compulsive disorder in children and adolescents. ( Buitelaar, JK; de Haan, E; Hoogduin, KA; Keijsers, GP, 1998) |
| " EEG, ECG, and laboratory parameters and adverse effects reported by the patients, as well as global clinical improvement, were assessed." | 2.68 | Combination treatment with clomipramine and fluvoxamine: drug monitoring, safety, and tolerability data. ( Härtter, S; Hiemke, C; Leal, M; Szegedi, A; Wetzel, H, 1996) |
| "The aim of this study was to investigate whether obsessive-compulsive patients previously treated successfully with clomipramine or fluvoxamine could tolerate reduction of the daily dosage without worsening of the clinical condition." | 2.68 | Long-term pharmacotherapy of obsessive-compulsive disorder: a double-blind controlled study. ( Bareggi, SR; Bellodi, L; Mundo, E; Pirola, R; Smeraldi, E, 1997) |
| "Canine acral lick dermatitis is a naturally occurring disorder in which excessive licking of paws or flank can produce ulcers and infection that require medical treatment." | 2.67 | Drug treatment of canine acral lick. An animal model of obsessive-compulsive disorder. ( Kriete, M; Rapoport, JL; Ryland, DH, 1992) |
| "Trichotillomania is a neglected neuropsychiatric disorder that only recently has received research attention." | 2.67 | Trichotillomania. An obsessive compulsive spectrum disorder? ( Leonard, HL; Swedo, SE, 1992) |
| "Clonazepam improvement was unrelated to changes in anxiety and occurred early in treatment." | 2.67 | Clomipramine, clonazepam, and clonidine treatment of obsessive-compulsive disorder. ( Agras, WS; Hewlett, WA; Vinogradov, S, 1992) |
| "Clomipramine treatment was associated with statistically significant improvement on several measures of obsessive compulsive symptoms." | 2.67 | Clomipramine and obsessive compulsive disorder: a placebo-controlled double-blind study of 32 patients. ( Barklage, NE; Greist, JH; Gutzmann, LD; Jefferson, JW; March, JS; Rosenfeld, R, 1990) |
| "1." | 2.67 | Early response with clomipramine in obsessive compulsive disorder--a placebo controlled study. ( Fineberg, N; Montgomery, DB; Montgomery, SA, 1990) |
| "Treatment with clomipramine resulted in significantly greater improvement in symptoms than desipramine, as indicated by physicians' ratings of the women's clinical progress on a scale in which lower scores indicate improvement (mean [+/- SD] scores: at base line, 10." | 2.66 | A double-blind comparison of clomipramine and desipramine in the treatment of trichotillomania (hair pulling) ( Cheslow, DL; Goldberger, EL; Lenane, MC; Leonard, HL; Rapoport, JL; Swedo, SE, 1989) |
| "The clomipramine effect was maximum from weeks 10 to 18 and diminished thereafter." | 2.65 | Clomipramine and exposure for obsessive-compulsive rituals: i. ( Cobb, J; Marks, IM; Mawson, D; McDonald, R; Stern, RS, 1980) |
| "Patients were assessed for phobias, obsessions, general psychiatric symptoms and side-effects and each was rated on a special symptom inventory at 0, 2, 4 and 6 weeks of treatment." | 2.64 | A clinical trial of clomipramine and diazepam in the treatment of phobic and obsessional illness. ( Waxman, D, 1977) |
| " In addition, pharmacological treatments should be maintained for years, so that the clinicians should take into account the pharmacokinetic changes in the long-term, which may be responsible for dangerous side effects or interactions." | 2.61 | Pharmacokinetics of serotonergic drugs: focus on OCD. ( Avella, MT; Basile, L; Dell'Osso, L; Marazziti, D; Mucci, F, 2019) |
| "Clomipramine and the SSRIs have been found to be effective across the range of symptoms, both in acute and longer-term studies." | 2.43 | Evidence-based pharmacotherapy of obsessive-compulsive disorder. ( Fineberg, NA; Gale, TM, 2005) |
| "Independently of the presence of tics, there are several different augmentation strategies for resistant cases with drugs that interfere in the dopamine, serotonin, opioid and gonadal hormone systems." | 2.42 | How to treat OCD in patients with Tourette syndrome. ( Brotto, SA; Diniz, JB; Ferrão, YA; Miguel, EC; Shavitt, RG, 2003) |
| "If clomipramine or citalopram have been used, an appropriate strategy consists in giving the same drug intravenously." | 2.41 | Management of treatment resistant obsessive-compulsive disorder. Algorithms for pharmacotherapy. ( Albert, U; Bergesio, C; Bogetto, F; Maina, G; Pessina, E, 2002) |
| " Pharmacologic therapy usually includes clomipramine or antidepressant treatment with selective serotonin reuptake inhibitors, but in dosage ranges higher than those typically used in the treatment of depression." | 2.40 | Recognition and treatment of obsessive-compulsive disorder. ( Eddy, MF; Walbroehl, GS, 1998) |
| "Only for Tourette's Disorder, Trichotillomania and possibly Sydenham's Chorea have there been convincing biological evidence for continuity with OCD." | 2.39 | [The "obsessive-compulsive spectrum": a useful concept?]. ( Rapoport, JL, 1994) |
| "The frequent comorbidity of OCD and Sydenham's chorea and similar postulates of basal ganglia dysfunction for both disorders suggest that Sydenham's chorea may serve as a medical model for OCD." | 2.39 | Childhood movement disorders and obsessive compulsive disorder. ( Leonard, HL; Swedo, SE, 1994) |
| " Further research in the treatment of OCD is required on comparative efficacy of SRIs, the choice of SRI agents following initial nonresponse, and effects resulting from the long-term use of SRIs." | 2.39 | OCD: where the serotonin selectivity story begins. ( Pigott, TA, 1996) |
| "A case of a calendar savant with infantile autism and Tourette syndrome is presented." | 2.38 | A calendar savant with autism and Tourette syndrome. Response to treatment and thoughts on the interrelationships of these conditions. ( Nelson, EC; Pribor, EF, 1993) |
| "A 0." | 2.38 | Clomipramine for obsessive-compulsive disorder. ( Feinberg, M, 1991) |
| "Clomipramine has been found superior to placebo or other psychoactive drugs in 5 controlled studies." | 2.37 | Antidepressant drugs in anxiety disorders. ( Modigh, K, 1987) |
| "Patients with Tourette's syndrome often develop multiple psychopathological symptoms beyond the basic symptoms (motor and vocal tics)." | 1.31 | [Disguised Tourette's syndrome. A contribution to the differential diagnosis on phobia and fear]. ( Barnett, W; Bednarz, K; Haisch, S, 2002) |
| "Clomipramine was significantly more efficacious for treatment in dogs than was amitriptyline." | 1.31 | Clinical features and outcome in dogs and cats with obsessive-compulsive disorder: 126 cases (1989-2000). ( Dunham, AE; Overall, KL, 2002) |
| "When clomipramine was changed to fluoxetine, the OCD symptoms were responsive even at a starting dosage of 20 mg/day." | 1.31 | Clomipramine-resistant, fluoxetine-responsive obsessive compulsive disorder: a case report. ( Paholpak, S, 2002) |
| "Drug treatment with clomipramine and, to a lesser extent, with selective serotonin reuptake inhibitors was associated with hypomanic switches in OCD-bipolar patients, especially in those not concomitantly treated with mood stabilizers." | 1.31 | Obsessive-compulsive-bipolar comorbidity: a systematic exploration of clinical features and treatment outcome. ( Akiskal, HS; Frare, F; Hantouche, E; Perugi, G; Toni, C; Travierso, MC, 2002) |
| "Sertraline was first developed and approved for the treatment of depression." | 1.31 | Sertraline in the treatment of anxiety disorders. ( Hirschfeld, RM, 2000) |
| "In this open case series, the dose-response relationship of atypical antipsychotic augmentation in the treatment of obsessive compulsive disorder (OCD), and the dose-severity relationship in atypical anti psychotic-induced OC symptoms were examined." | 1.31 | Serotonin and dopamine antagonism in obsessive-compulsive disorder: effect of atypical antipsychotic drugs. ( Lapierre, Y; Ramasubbu, R; Ravindran, A, 2000) |
| "Clomipramine was the first antidepressant to show a degree of efficacy." | 1.31 | Sertraline: new indication. May help children with obsessive-compulsive disorder. ( , 2002) |
| "Serotonin syndrome is the result of the drug interaction that enhances serotonergic tone in the central nervous system." | 1.30 | Serotonin syndrome presenting with migrainelike stroke. ( Molaie, M, 1997) |
| "A girl with high functioning autism who developed transsexualism is described." | 1.30 | Gender identity disorder in a girl with autism--a case report. ( Landén, M; Rasmussen, P, 1997) |
| "We report a case of clomipramine-induced tardive dyskinesia (TD) in the setting of chronic use of dextroamphetamine without prior use of neuroleptics, in which the movements persisted after discontinuation of the clomipramine." | 1.29 | Antidepressant-induced tardive dyskinesia: review and case report. ( Clayton, AH, 1995) |
| "Four clomipramine-treated breastfeeding mother-infant pairs were assessed for serum concentrations of clomipramine, N-desmethylclomipramine, and corresponding 8-hydroxymetabolites." | 1.29 | Serum clomipramine and metabolite levels in four nursing mother-infant pairs. ( Foglia, JP; Perel, JM; Wisner, KL, 1995) |
| " Chronic administration of the selective serotonin re-uptake inhibitors fluoxetine and clomipramine (CMI) at 5 mg/kg per day and fluvoxamine at 10 mg/kg twice a day significantly decreased schedule-induced polydipsia (SIP) on day 15 and throughout the remainder of the study compared to control rats." | 1.29 | Selective serotonin re-uptake inhibitors decrease schedule-induced polydipsia in rats: a potential model for obsessive compulsive disorder. ( Corbett, R; Cornfeldt, M; Dunn, RW; Smith, C; Szewczak, M; Woods, A, 1993) |
| "Clomipramine treatment was subsequently discontinued in two patients (off-on-off design), whereas it was discontinued and then reinstituted in three patients (off-on-off-on design)." | 1.29 | Clomipramine treatment of obsessive compulsive symptomatology in schizophrenic patients. ( Benjamin, J; Kaplan, Z; Zohar, J, 1993) |
| "When treated with clomipramine 100 mg daily (plasma level 85 ng/mL), obsessive-compulsive symptoms but not the hallucinations improved significantly, and racing thoughts and grandiosity developed later." | 1.29 | Differential response of psychotic and obsessive symptoms to risperidone in an adolescent. ( Dryden-Edwards, RC; Reiss, AL, 1996) |
| "Symptoms were divided into paraphilias, nonparaphilic sexual addictions, and sexual obsessions." | 1.28 | Serotonergic medications for sexual obsessions, sexual addictions, and paraphilias. ( Anthony, DT; Fallon, BA; Hollander, E; Klein, DF; Liebowitz, MR; Schneier, FR; Stein, DJ, 1992) |
| "Fenfluramine is a serotonin releaser and reuptake blocker which is marketed as an anorectic agent." | 1.28 | Fenfluramine augmentation of serotonin reuptake blockade antiobsessional treatment. ( DeCaria, CM; Hollander, E; Klein, DF; Liebowitz, MR; Schneier, FR; Schneier, HA, 1990) |
| "Depression was by far the most important factor." | 1.26 | Cortisol in the CSF of depressed and suicidal patients. ( Asberg, M; Bertilsson, L; Lantto, O; Schalling, D; Träskman, L; Tybring, G, 1980) |
| " The third patient manipulated dosage times to diminish the orgastic problem." | 1.26 | Sexual dysfunction and clomipramine. ( Einarson, TR; Quirk, KC, 1982) |
| " Plasma concentrations of both the parent compound and its metabolite rose with dose and within 7-14 days of constant dosage reached steady states." | 1.26 | Plasma concentrations of clomipramine and desmethylclomipramine in obsessive-compulsive neurosis. ( Luscombe, DK; Marks, IM; Mawson, D; Stern, RS; Wright, J, 1980) |
| "Good results have been obtained in the treatment of depression, and obsessive/compulsive/phobic states, and mixed patients." | 1.26 | Clinical experience in the treatment of obsessional states (2). ( Rack, PH, 1977) |
| " Dosage was 20 mg clomipramine during the first three days of treatment, increasing gradually over the next few weeks to a maximum daily dose of 200 mg clomipramine unless side-effects dictated a lower dose." | 1.26 | Pharmacokinetic studies in obsessional patients. ( Luscombe, DK; Marks, IM, 1977) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 138 (24.95) | 18.7374 |
| 1990's | 252 (45.57) | 18.2507 |
| 2000's | 103 (18.63) | 29.6817 |
| 2010's | 52 (9.40) | 24.3611 |
| 2020's | 8 (1.45) | 2.80 |
| Authors | Studies |
|---|---|
| Mathews, C | 1 |
| White, R | 1 |
| Papadopoulos, M | 1 |
| Tibrewal, P | 1 |
| Pittenger, C | 2 |
| de Oliveira, MVS | 1 |
| de Barros, PMF | 1 |
| de Mathis, MA | 1 |
| Boavista, R | 1 |
| Chacon, P | 1 |
| Echevarria, MAN | 1 |
| Ferrão, YA | 3 |
| Vattimo, EFQ | 1 |
| Lopes, AC | 1 |
| Torres, AR | 2 |
| Diniz, JB | 5 |
| Fontenelle, LF | 4 |
| Rosário, MCD | 1 |
| Shavitt, RG | 7 |
| Miguel, EC | 8 |
| da Silva, RMF | 1 |
| Costa, DLDC | 1 |
| Preskorn, SH | 1 |
| Rode, R | 1 |
| Beaulieu, AM | 1 |
| Tabasky, E | 1 |
| Osser, DN | 1 |
| Velikić, V | 1 |
| Wippel, A | 1 |
| Freidl, M | 1 |
| Kayser, RR | 1 |
| Bertolín, S | 1 |
| Alonso, P | 3 |
| Segalàs, C | 3 |
| Real, E | 1 |
| Alemany-Navarro, M | 1 |
| Soria, V | 1 |
| Jiménez-Murcia, S | 2 |
| Crespo, JM | 1 |
| Menchón, JM | 5 |
| Brown, JT | 1 |
| Schneiderhan, M | 1 |
| Eum, S | 1 |
| Bishop, JR | 1 |
| Amerio, A | 1 |
| Tonna, M | 2 |
| Odone, A | 1 |
| Ghaemi, SN | 1 |
| Faye, A | 1 |
| Kirpekar, V | 1 |
| Tadke, R | 1 |
| Gawande, S | 1 |
| Bhave, S | 1 |
| Tofte, A | 1 |
| Narang, P | 1 |
| Lippmann, S | 1 |
| Marazziti, D | 10 |
| Avella, MT | 1 |
| Basile, L | 1 |
| Mucci, F | 1 |
| Dell'Osso, L | 3 |
| Haghighi, M | 1 |
| Jahangard, L | 1 |
| Mohammad-Beigi, H | 1 |
| Bajoghli, H | 1 |
| Hafezian, H | 1 |
| Rahimi, A | 1 |
| Afshar, H | 1 |
| Holsboer-Trachsler, E | 1 |
| Brand, S | 1 |
| Weidt, S | 1 |
| Rufer, M | 1 |
| Brühl, A | 1 |
| Baumann-Vogel, H | 1 |
| Delsignore, A | 1 |
| Voderholzer, U | 1 |
| Hauer, M | 1 |
| Stattrop, U | 1 |
| Costa, DL | 1 |
| Cassab, RC | 1 |
| Pereira, CA | 3 |
| Humble, MB | 1 |
| Uvnäs-Moberg, K | 1 |
| Engström, I | 1 |
| Bejerot, S | 2 |
| Andrade, C | 3 |
| Marcourakis, T | 1 |
| Bernik, MA | 1 |
| Lotufo Neto, F | 1 |
| Gedanke Shavitt, R | 1 |
| Gorenstein, C | 1 |
| Veale, D | 2 |
| Miles, S | 1 |
| Smallcombe, N | 1 |
| Ghezai, H | 1 |
| Goldacre, B | 1 |
| Hodsoll, J | 1 |
| Gama-Marques, J | 1 |
| Jesus, G | 1 |
| Brissos, S | 1 |
| Fineberg, NA | 5 |
| Reghunandanan, S | 2 |
| Simpson, HB | 7 |
| Phillips, KA | 1 |
| Richter, MA | 1 |
| Matthews, K | 1 |
| Stein, DJ | 8 |
| Sareen, J | 1 |
| Brown, A | 2 |
| Sookman, D | 2 |
| Arco, L | 1 |
| Freund, N | 1 |
| Thompson, BS | 1 |
| Norman, KJ | 1 |
| Einhorn, P | 1 |
| Andersen, SL | 2 |
| Karameh, WK | 1 |
| Khani, M | 1 |
| Hu, XZ | 1 |
| Ma, JD | 1 |
| Huang, P | 1 |
| Shan, XW | 1 |
| Zhang, ZH | 1 |
| Zhang, JH | 1 |
| Ouyang, H | 1 |
| Kou, SJ | 1 |
| Li, ZR | 1 |
| Wang, SF | 1 |
| Zhao, HZ | 1 |
| Wang, H | 1 |
| Wang, CH | 1 |
| Cecconi, A | 1 |
| Franco, E | 1 |
| de Agustín, JA | 1 |
| Vilchez, JP | 1 |
| Palacios-Rubio, J | 1 |
| Sánchez-Enrique, C | 1 |
| Fernández-Ortiz, A | 1 |
| Macaya, C | 1 |
| Fernández-Jiménez, R | 1 |
| Kar, SK | 1 |
| Garg, K | 1 |
| Poppe, C | 1 |
| Müller, ST | 1 |
| Greil, W | 1 |
| Walder, A | 1 |
| Grohmann, R | 1 |
| Stübner, S | 1 |
| Feng, B | 2 |
| Zhang, ZJ | 1 |
| Zhu, RM | 1 |
| Yuan, GZ | 1 |
| Luo, LY | 1 |
| McAlonan, GM | 1 |
| Xu, FZ | 2 |
| Chen, J | 2 |
| Liu, LY | 2 |
| Lv, YY | 1 |
| Wong, HK | 1 |
| Zhang, Y | 1 |
| Zhu, LX | 1 |
| Hatalova, H | 1 |
| Radostova, D | 1 |
| Pistikova, A | 1 |
| Vales, K | 1 |
| Stuchlik, A | 1 |
| Varigonda, AL | 1 |
| Jakubovski, E | 1 |
| Bloch, MH | 2 |
| Margetić, B | 1 |
| Aukst-Margetić, B | 1 |
| Jakovljević, M | 1 |
| Mungai, F | 2 |
| Masala, I | 1 |
| Baroni, S | 3 |
| Vivarelli, L | 1 |
| Ambrogi, F | 1 |
| Catena Dell'Osso, M | 3 |
| Consoli, G | 4 |
| Massimetti, G | 2 |
| Ravindran, LN | 1 |
| Jung, SM | 1 |
| Ravindran, AV | 2 |
| Agarwal, A | 1 |
| Biswas, D | 2 |
| Sadhu, R | 1 |
| Jaurrieta, N | 1 |
| Del Pino Alonso, M | 1 |
| Alvarez-Moya, EM | 1 |
| Labad, J | 2 |
| Granero, R | 1 |
| Vallejo, J | 5 |
| Uzun, O | 1 |
| Agarwal, AL | 1 |
| Sharma, V | 2 |
| Golia, F | 1 |
| Presta, S | 2 |
| Pfanner, C | 2 |
| Carlini, M | 2 |
| Hounie, AG | 1 |
| Pimentel, I | 1 |
| Koran, LM | 9 |
| Dainesi, SM | 1 |
| Ross, S | 1 |
| Fallon, BA | 6 |
| Petkova, E | 4 |
| Feinstein, S | 1 |
| Liebowitz, MR | 19 |
| Zohar, J | 11 |
| Hermesh, H | 7 |
| Pacan, P | 1 |
| Grzesiak, M | 1 |
| Reich, A | 1 |
| Szepietowski, JC | 1 |
| Landeros-Weisenberger, A | 1 |
| Kelmendi, B | 1 |
| Wegner, R | 1 |
| Nudel, J | 1 |
| Dombrowski, P | 1 |
| Krystal, JH | 1 |
| Goodman, WK | 11 |
| Leckman, JF | 2 |
| Coric, V | 1 |
| Mendhekar, DN | 1 |
| Garcia, FD | 1 |
| Houy-Durand, E | 1 |
| Thibaut, F | 1 |
| Dechelotte, P | 1 |
| Pasquini, M | 2 |
| Berardelli, I | 1 |
| Biondi, M | 3 |
| Greene-Colozzi, EA | 1 |
| Sonntag, KC | 1 |
| Kordon, A | 2 |
| Zurowski, B | 1 |
| Wahl, K | 1 |
| Hohagen, F | 2 |
| Muscatello, MR | 1 |
| Bruno, A | 1 |
| Pandolfo, G | 1 |
| Micò, U | 1 |
| Scimeca, G | 1 |
| Romeo, VM | 1 |
| Santoro, V | 1 |
| Settineri, S | 1 |
| Spina, E | 1 |
| Zoccali, RA | 1 |
| Williams, MT | 1 |
| Farris, SG | 1 |
| Turkheimer, E | 1 |
| Pinto, A | 1 |
| Ozanick, K | 1 |
| Franklin, ME | 4 |
| Liebowitz, M | 2 |
| Foa, EB | 8 |
| Miguita, K | 1 |
| Cordeiro, Q | 1 |
| Vallada, H | 1 |
| Jain, M | 1 |
| Aggarwal, A | 1 |
| Khandelwal, A | 1 |
| Gentile, S | 1 |
| Shanahan, NA | 1 |
| Velez, LP | 1 |
| Masten, VL | 1 |
| Dulawa, SC | 1 |
| Faravelli, L | 1 |
| Giannaccini, G | 1 |
| Palego, L | 2 |
| Catena-Dell'Osso, M | 1 |
| Fossaluza, V | 1 |
| Koran, L | 2 |
| Vloet, TD | 1 |
| Simons, M | 1 |
| Herpertz-Dahlmann, B | 1 |
| Nakamae, T | 1 |
| Okada, T | 1 |
| McGuire, JF | 1 |
| Lewin, AB | 1 |
| Horng, B | 1 |
| Murphy, TK | 1 |
| Storch, EA | 1 |
| Pampaloni, I | 2 |
| Kreiss, DS | 1 |
| Coffman, CF | 1 |
| Fiacco, NR | 1 |
| Granger, JC | 1 |
| Helton, BM | 1 |
| Jackson, JC | 1 |
| Kim, LV | 1 |
| Mistry, RS | 1 |
| Mizer, TM | 1 |
| Palmer, LV | 1 |
| Vacca, JA | 1 |
| Winkler, SS | 1 |
| Zimmer, BA | 1 |
| Sesia, T | 1 |
| Bizup, B | 1 |
| Grace, AA | 1 |
| Giger, JN | 1 |
| Davidhizar, R | 1 |
| Poole, VL | 1 |
| Bednarz, K | 1 |
| Haisch, S | 1 |
| Barnett, W | 1 |
| Albert, U | 3 |
| Aguglia, E | 1 |
| Maina, G | 8 |
| Bogetto, F | 7 |
| Overall, KL | 2 |
| Dunham, AE | 1 |
| Paholpak, S | 1 |
| Matsui, T | 1 |
| Matsunaga, H | 1 |
| Ohya, K | 1 |
| Iwasaki, Y | 1 |
| Koshimune, K | 1 |
| Miyata, A | 1 |
| Kiriike, N | 1 |
| Perugi, G | 1 |
| Toni, C | 1 |
| Frare, F | 1 |
| Travierso, MC | 1 |
| Hantouche, E | 1 |
| Akiskal, HS | 1 |
| Safranko, I | 1 |
| Fernández-Guasti, A | 3 |
| Ulloa, RE | 3 |
| Nicolini, H | 3 |
| Hembree, EA | 1 |
| Riggs, DS | 1 |
| Kozak, MJ | 4 |
| Brotto, SA | 1 |
| Sumitani, S | 1 |
| Ohmori, T | 1 |
| Kaplan, A | 1 |
| Hollander, E | 18 |
| Granenov, GM | 1 |
| Mosolov, SN | 1 |
| Wewetzer, Ch | 1 |
| Mehler-Wex, C | 1 |
| Warnke, A | 1 |
| Matur, Z | 1 |
| Uçok, A | 1 |
| Broocks, A | 1 |
| Geller, DA | 1 |
| Biederman, J | 3 |
| Stewart, SE | 1 |
| Mullin, B | 1 |
| Martin, A | 1 |
| Spencer, T | 1 |
| Faraone, SV | 1 |
| El-Sayegh, S | 1 |
| Bea, S | 1 |
| Agelopoulos, A | 1 |
| Cordioli, AV | 1 |
| Basso de Sousa, M | 1 |
| Bochi, DB | 1 |
| Hoshino, Y | 1 |
| Gale, TM | 1 |
| Salvi, V | 1 |
| Sallinen, BJ | 1 |
| Nangle, DW | 1 |
| O'Grady, AC | 1 |
| Pallanti, S | 7 |
| do Rosário-Campos, MC | 1 |
| Mendlowicz, MV | 2 |
| Versiani, M | 2 |
| Garavini, A | 1 |
| Davies, S | 3 |
| Campeas, R | 4 |
| Huppert, JD | 3 |
| Kjernisted, K | 1 |
| Rowan, V | 1 |
| Schmidt, AB | 2 |
| Tu, X | 1 |
| Picardi, A | 1 |
| Cheng, J | 2 |
| McCracken, JT | 2 |
| Hanna, GL | 2 |
| Kalaf, J | 1 |
| Domingues, AM | 1 |
| Wang, P | 1 |
| Chen, W | 1 |
| Yu, E | 1 |
| Poyurovsky, M | 2 |
| Weizman, R | 3 |
| Weizman, A | 3 |
| Aboujaoude, E | 1 |
| Ward, H | 2 |
| Shapira, NA | 1 |
| Sallee, FR | 3 |
| Gamel, N | 1 |
| Elliott, M | 1 |
| Grover, S | 1 |
| Gupta, N | 1 |
| Vulink, NC | 2 |
| Denys, D | 3 |
| Bus, L | 2 |
| Westenberg, HG | 5 |
| Anderson, SW | 1 |
| Booker, MB | 1 |
| Dell'Osso, B | 2 |
| Nestadt, G | 1 |
| Allen, A | 1 |
| Jiménez, S | 1 |
| Gallelli, L | 1 |
| De Fazio, S | 1 |
| Corace, E | 1 |
| De Sarro, G | 1 |
| Garcia, CS | 1 |
| De Fazio, P | 1 |
| Inceboz, T | 1 |
| Yalçin, G | 1 |
| Aksoy, U | 1 |
| Altamura, AC | 1 |
| Mundo, E | 8 |
| Gulsun, M | 1 |
| Gulcat, Z | 1 |
| Aydin, H | 1 |
| Avila, M | 1 |
| O'Kearney, R | 1 |
| Math, SB | 1 |
| Janardhan Reddy, YC | 1 |
| Friedman, S | 1 |
| Abdallah, TA | 1 |
| Oumaya, M | 1 |
| Rouillon, F | 1 |
| Guelfi, JD | 1 |
| Andrés, S | 1 |
| Lázaro, L | 1 |
| Salamero, M | 1 |
| Boget, T | 1 |
| Penadés, R | 1 |
| Castro-Fornieles, J | 1 |
| da Rocha, FF | 1 |
| Correa, H | 1 |
| Marchesi, C | 1 |
| Maggini, C | 1 |
| Onishi, A | 1 |
| Yamamoto, H | 1 |
| Akimoto, T | 1 |
| Saito, O | 1 |
| Inoue, M | 1 |
| Ando, Y | 1 |
| Muto, S | 1 |
| Kusano, E | 1 |
| Huppert, J | 1 |
| Foa, E | 1 |
| Ipser, J | 1 |
| Tundo, A | 1 |
| Salvati, L | 1 |
| Busto, G | 1 |
| Di Spigno, D | 1 |
| Falcini, R | 1 |
| Ledley, DR | 1 |
| Cahill, S | 1 |
| Vermes, D | 1 |
| Hembree, E | 1 |
| Franklin, M | 1 |
| Hahn, CG | 1 |
| Amiaz, R | 1 |
| Fostick, L | 1 |
| Gershon, A | 1 |
| Zitterl, W | 1 |
| Aigner, M | 1 |
| Stompe, T | 1 |
| Zitterl-Eglseer, K | 1 |
| Gutierrez-Lobos, K | 1 |
| Wenzel, T | 1 |
| Zettinig, G | 1 |
| Hornik, K | 1 |
| Pirker, W | 1 |
| Thau, K | 1 |
| Mavissakalian, M | 4 |
| Cobb, J | 3 |
| Träskman, L | 3 |
| Tybring, G | 1 |
| Asberg, M | 3 |
| Bertilsson, L | 2 |
| Lantto, O | 1 |
| Schalling, D | 1 |
| Thorén, P | 2 |
| Mellström, B | 2 |
| Sjöqvist, F | 1 |
| Insel, TR | 13 |
| Murphy, DL | 21 |
| Cohen, RM | 3 |
| Alterman, I | 2 |
| Kilts, C | 4 |
| Linnoila, M | 3 |
| Michelson, L | 2 |
| Marks, I | 4 |
| Ananth, J | 7 |
| Feldman, J | 1 |
| Zahn, TP | 1 |
| Rasmussen, SA | 2 |
| Mueller, EA | 2 |
| Gillin, JC | 2 |
| Siever, LJ | 2 |
| Apter, A | 1 |
| Bernhout, E | 1 |
| Tyano, S | 1 |
| Klug, B | 1 |
| Stroebel, CF | 1 |
| Szarek, BL | 2 |
| Glueck, BC | 1 |
| Warneke, LB | 3 |
| Stern, R | 3 |
| Bolton, D | 1 |
| Collins, S | 1 |
| Steinberg, D | 1 |
| Coombe, PD | 1 |
| Marks, IM | 12 |
| Stern, RS | 5 |
| Mawson, D | 5 |
| McDonald, R | 1 |
| Rapoport, J | 1 |
| Elkins, R | 2 |
| Mikkelsen, E | 1 |
| Rapoport, JL | 25 |
| Lipsky, A | 1 |
| Pecknold, JC | 2 |
| van den Steen, N | 1 |
| Engelsmann, F | 1 |
| Ramm, L | 1 |
| Roy, BF | 1 |
| Insel, T | 1 |
| Potter, WZ | 3 |
| Quirk, KC | 1 |
| Einarson, TR | 1 |
| Perera, HV | 1 |
| Luscombe, DK | 5 |
| Wright, J | 2 |
| Snyder, S | 1 |
| Cronholm, B | 1 |
| Jörnestedt, L | 1 |
| Clayton, AH | 1 |
| McDougle, CJ | 8 |
| Price, LH | 9 |
| Altemus, M | 1 |
| Swedo, SE | 16 |
| Leonard, HL | 17 |
| Richter, D | 1 |
| Rubinow, DR | 1 |
| Barak, Y | 1 |
| Ring, A | 1 |
| Levy, D | 1 |
| Granek, I | 1 |
| Szor, H | 1 |
| Elizur, A | 1 |
| Castle, DJ | 1 |
| Hand, I | 1 |
| Volk, S | 1 |
| Ravizza, L | 4 |
| Barzega, G | 4 |
| Bellino, S | 4 |
| Berman, I | 1 |
| Sapers, BL | 1 |
| Chang, HH | 1 |
| Losonczy, MF | 1 |
| Schmildler, J | 1 |
| Green, AI | 1 |
| Allen, AJ | 1 |
| Leonard, H | 2 |
| Sternbach, H | 1 |
| Thornton, LA | 1 |
| Piccinelli, M | 1 |
| Pini, S | 1 |
| Bellantuono, C | 1 |
| Wilkinson, G | 1 |
| Greist, JH | 9 |
| Jefferson, JW | 3 |
| Kobak, KA | 1 |
| Katzelnick, DJ | 1 |
| Serlin, RC | 1 |
| DeVeaugh-Geiss, J | 10 |
| Wisner, KL | 1 |
| Perel, JM | 3 |
| Foglia, JP | 1 |
| Woods, A | 1 |
| Smith, C | 1 |
| Szewczak, M | 1 |
| Dunn, RW | 1 |
| Cornfeldt, M | 1 |
| Corbett, R | 1 |
| Como, PG | 1 |
| Kaplan, Z | 1 |
| Benjamin, J | 1 |
| Baxter, LR | 2 |
| Dominguez, RA | 5 |
| Mestre, SM | 1 |
| Ackerman, DL | 4 |
| Greenland, S | 4 |
| Bystritsky, A | 4 |
| Morgenstern, H | 1 |
| Katz, RJ | 6 |
| Baer, L | 6 |
| Ricciardi, J | 2 |
| Keuthen, N | 1 |
| Pettit, AR | 1 |
| Buttolph, ML | 1 |
| Otto, M | 1 |
| Minichiello, W | 1 |
| Jenike, MA | 7 |
| Deltito, JA | 1 |
| Sewell, DD | 1 |
| Lopez, WM | 1 |
| Paulsen, J | 1 |
| Gilbert, P | 1 |
| Kim, SW | 8 |
| Dysken, MW | 8 |
| Pheley, AM | 1 |
| Hoover, KM | 2 |
| Faravelli, C | 1 |
| Freeman, CP | 1 |
| Trimble, MR | 2 |
| Deakin, JF | 1 |
| Stokes, TM | 1 |
| Ashford, JJ | 1 |
| Waikar, SV | 1 |
| Mattes, JA | 1 |
| Abel, JL | 1 |
| Nofzinger, EA | 1 |
| Reynolds, CF | 1 |
| Jackson, CW | 1 |
| Morton, WA | 1 |
| Lydiard, RB | 4 |
| Mazmanian, D | 1 |
| Lacy, TJ | 1 |
| Khatain, KG | 1 |
| Cox, BJ | 1 |
| Swinson, RP | 1 |
| Morrison, B | 1 |
| Lee, PS | 1 |
| Azari, NP | 1 |
| Pietrini, P | 2 |
| Horwitz, B | 1 |
| Pettigrew, KD | 1 |
| Schapiro, MB | 3 |
| Josephson, SC | 1 |
| Lenane, MC | 7 |
| Hoehn-Saric, R | 1 |
| McLeod, DR | 1 |
| Zimmerli, WD | 1 |
| Hipsley, PA | 1 |
| Nelson, EC | 1 |
| Pribor, EF | 1 |
| DeCaria, CM | 2 |
| Saoud, JB | 1 |
| Klein, DF | 7 |
| Ronchi, P | 3 |
| Bellodi, L | 9 |
| Alarcon, RD | 3 |
| Libb, JW | 1 |
| Spitler, D | 1 |
| Cerqueira, AT | 1 |
| Tejera, CA | 1 |
| Mayerhoff, DI | 1 |
| Ramos-Lorenzi, J | 1 |
| Karp, L | 1 |
| Dar, DE | 1 |
| Munitz, H | 5 |
| Gavish, M | 1 |
| Escobar, R | 1 |
| Bernardo, M | 3 |
| Jefferys, D | 1 |
| Sichel, DA | 1 |
| Cohen, LS | 1 |
| Dimmock, JA | 1 |
| Rosenbaum, JF | 1 |
| Kuskowski, MA | 1 |
| Malone, SM | 1 |
| Okaya, AJ | 1 |
| Christensen, KJ | 2 |
| Ambrosini, PJ | 1 |
| Bianchi, MD | 1 |
| Rabinovich, H | 1 |
| Elia, J | 1 |
| Rettew, DC | 6 |
| Hamburger, SD | 4 |
| Bartko, JJ | 1 |
| Gordon, CT | 1 |
| State, RC | 1 |
| Nelson, JE | 1 |
| Browne, M | 1 |
| Horn, E | 1 |
| Jones, TT | 1 |
| Molina, V | 2 |
| Montz, R | 1 |
| Martín-Loeches, M | 2 |
| Jiménez-Vicioso, A | 1 |
| Carreras, JL | 1 |
| Rubia, FJ | 2 |
| Thomsen, PH | 1 |
| Mikkelsen, HU | 1 |
| Smeraldi, E | 4 |
| March, JS | 4 |
| Jarry, JL | 1 |
| Vaccarino, FJ | 1 |
| Sandler, NH | 1 |
| Pigott, TA | 8 |
| Szegedi, A | 1 |
| Wetzel, H | 1 |
| Leal, M | 1 |
| Härtter, S | 1 |
| Hiemke, C | 1 |
| Rubin, RT | 1 |
| Villanueva-Meyer, J | 1 |
| Trajmar, PG | 1 |
| Mena, I | 1 |
| Nijhawan, PK | 1 |
| Katz, G | 1 |
| Winter, S | 1 |
| McElroy, SL | 1 |
| Davidson, JR | 1 |
| Garland, EJ | 1 |
| Weiss, M | 1 |
| Mueller, K | 1 |
| Maloney, A | 1 |
| López-Ibor, JJ | 2 |
| Saiz, J | 2 |
| Cottraux, J | 1 |
| Note, I | 1 |
| Viñas, R | 3 |
| Bourgeois, M | 1 |
| Hernández, M | 2 |
| Gómez-Pérez, JC | 1 |
| Berk, M | 1 |
| Koopowitz, LF | 1 |
| Szabo, CP | 1 |
| Carpenter, LL | 1 |
| Epperson, CN | 1 |
| Judge, R | 1 |
| Laor, N | 1 |
| Barber, Y | 1 |
| Notti, I | 1 |
| Djaldetti, M | 1 |
| Bessler, H | 1 |
| Rihmer, Z | 1 |
| Barsi, J | 1 |
| Belsõ, N | 1 |
| Pestality, P | 1 |
| György, S | 1 |
| Frare, P | 1 |
| Lebel, A | 1 |
| Bareggi, SR | 4 |
| Pirola, R | 4 |
| Alzaid, K | 1 |
| Jones, BD | 1 |
| Oesterheld, J | 1 |
| Kallepalli, BR | 1 |
| Fineberg, N | 4 |
| Wever, C | 1 |
| Rey, JM | 1 |
| Parker, G | 1 |
| Barrett, E | 1 |
| Cavedini, P | 2 |
| Erzegovesi, S | 2 |
| Abramowitz, JS | 1 |
| Howland, RH | 1 |
| Bouwer, C | 2 |
| Niehaus, DJ | 1 |
| Gangdev, PS | 1 |
| van Heerden, B | 1 |
| Kablinger, A | 1 |
| Murphy, T | 1 |
| Hayashi, N | 1 |
| Dryden-Edwards, RC | 1 |
| Reiss, AL | 1 |
| Kurokawa, K | 1 |
| Tanino, R | 1 |
| Milanfranchi, A | 2 |
| Ravagli, S | 2 |
| Lensi, P | 2 |
| Cassano, GB | 2 |
| Barr, LC | 3 |
| Anand, A | 1 |
| Moshe, K | 1 |
| Iulian, I | 1 |
| Seth, K | 1 |
| Eli, L | 1 |
| Joseph, Z | 1 |
| Molaie, M | 1 |
| Landén, M | 1 |
| Rasmussen, P | 1 |
| Flament, MF | 5 |
| Bisserbe, JC | 1 |
| Puig, A | 1 |
| Gemignani, A | 1 |
| Pidrman, V | 1 |
| Tůma, I | 1 |
| Cavallini, MC | 2 |
| Di Bella, D | 1 |
| Pasquale, L | 1 |
| Henin, M | 1 |
| Schaller, JL | 1 |
| Behar, D | 1 |
| Chamberlain, T | 1 |
| Eddy, MF | 1 |
| Walbroehl, GS | 1 |
| Paiva, RS | 2 |
| Quercioli, L | 2 |
| Seksel, K | 2 |
| Lindeman, MJ | 2 |
| Figueroa, Y | 1 |
| Rosenberg, DR | 1 |
| Birmaher, B | 1 |
| Keshavan, MS | 1 |
| Lawrie, SM | 1 |
| Carson, SW | 1 |
| Sethuraman, G | 1 |
| Schneier, FR | 6 |
| Marshall, R | 1 |
| Goetz, D | 2 |
| de Haan, E | 2 |
| Hoogduin, KA | 1 |
| Buitelaar, JK | 1 |
| Keijsers, GP | 1 |
| Noorbala, AA | 1 |
| Hosseini, SH | 1 |
| Mohammadi, MR | 1 |
| Akhondzadeh, S | 1 |
| Bodlund, O | 1 |
| Brody, AL | 1 |
| Saxena, S | 1 |
| Schwartz, JM | 1 |
| Stoessel, PW | 1 |
| Maidment, K | 1 |
| Phelps, ME | 1 |
| Szechtman, H | 1 |
| Sulis, W | 1 |
| Eilam, D | 1 |
| Seay, SM | 1 |
| Mottard, JP | 1 |
| de la Sablonnière, JF | 1 |
| Trappler, B | 1 |
| Mataix-Cols, D | 2 |
| Rauch, SL | 1 |
| Manzo, PA | 1 |
| Haffen, E | 1 |
| Vandel, P | 1 |
| Broly, F | 1 |
| Vandel, S | 1 |
| Sechter, D | 1 |
| Bizouard, P | 1 |
| Bechtel, PR | 1 |
| Baving, L | 1 |
| Schmidt, MH | 1 |
| Uslenghi, C | 1 |
| Todorov, C | 1 |
| Freeston, MH | 1 |
| Borgeat, F | 1 |
| Juarbe-Díaz, SV | 1 |
| Kumar, TC | 1 |
| Khanna, S | 1 |
| Iwata, Y | 1 |
| Kotani, Y | 1 |
| Hoshino, R | 1 |
| Takei, N | 1 |
| Iyo, M | 1 |
| Mori, N | 1 |
| Hirschfeld, RM | 1 |
| Kawahara, T | 1 |
| Ueda, Y | 1 |
| Mitsuyama, Y | 1 |
| Ramasubbu, R | 1 |
| Ravindran, A | 1 |
| Lapierre, Y | 1 |
| Zerjav-Lacombe, S | 1 |
| Dewan, V | 1 |
| Sanz, M | 1 |
| Calcedo, A | 1 |
| Francobandiera, G | 1 |
| Pifarre, J | 1 |
| Torres, L | 1 |
| Salgado, P | 1 |
| Al-Sughayir, MA | 1 |
| Ferris, CF | 1 |
| Rasmussen, MF | 1 |
| Messenger, T | 1 |
| Koppel, G | 1 |
| Cheung, EF | 1 |
| Duggal, HS | 1 |
| Dutta, S | 1 |
| Sinha, VK | 1 |
| Diaferia, G | 1 |
| Locatelli, M | 2 |
| Rosario-Campos, MC | 1 |
| Mercadante, MT | 1 |
| Prado, HS | 1 |
| Sada, P | 1 |
| Zamignani, D | 1 |
| Mathew, SJ | 1 |
| Coplan, JD | 1 |
| Perko, KA | 1 |
| Goetz, RR | 1 |
| de la Neuz, M | 1 |
| Bergesio, C | 1 |
| Pessina, E | 1 |
| Amin, MM | 1 |
| Ban, TA | 1 |
| Klingner, A | 1 |
| Karabanow, O | 1 |
| Cobb, JP | 1 |
| Jones, RB | 1 |
| Sternberg, MP | 1 |
| Solyom, L | 5 |
| Bryntwick, S | 1 |
| Krishnappa, U | 1 |
| Rachman, S | 1 |
| Grey, S | 1 |
| McDonald, B | 1 |
| Sartory, G | 1 |
| Gringras, M | 1 |
| Singh, AN | 1 |
| Sexena, B | 1 |
| Gent, M | 1 |
| Capstick, N | 4 |
| Rack, PH | 2 |
| Waxman, D | 2 |
| Yaryura-Tobias, JA | 2 |
| Neziroglu, F | 2 |
| Wyndowe, J | 1 |
| Escobar, JI | 1 |
| Gomez, O | 1 |
| Tuason, VB | 1 |
| Philpott, R | 1 |
| Silva, FR | 1 |
| Wijewickrama, HS | 1 |
| Allen, JJ | 1 |
| Hartelius, H | 1 |
| Marshall, WK | 1 |
| Micev, V | 1 |
| Kelly, D | 1 |
| Jalenques, I | 2 |
| Coudert, AJ | 2 |
| Förstl, H | 1 |
| Pohlmann-Eden, B | 1 |
| Rothenberger, A | 1 |
| Kruesi, MJ | 1 |
| Listwak, SJ | 1 |
| Berrettini, W | 1 |
| Stipetic, M | 1 |
| Hamburger, S | 1 |
| Gold, PW | 1 |
| Zohar-Kadouch, RC | 2 |
| Kindler, S | 2 |
| Ryland, DH | 1 |
| Kriete, M | 1 |
| Anthony, DT | 1 |
| Maruno, CA | 1 |
| Hart, LL | 1 |
| Olivares, J | 1 |
| Marcos, T | 1 |
| Bulbena, A | 1 |
| Cryan, EM | 1 |
| Butcher, GJ | 1 |
| Webb, MG | 1 |
| Cruz, R | 1 |
| Black, DW | 4 |
| Treece, C | 1 |
| Rosenfeld, R | 2 |
| Greist, J | 1 |
| Carrasco, JL | 1 |
| Hewlett, WA | 1 |
| Vinogradov, S | 1 |
| Agras, WS | 1 |
| Chouinard, G | 2 |
| Scarone, S | 1 |
| Colombo, C | 1 |
| Livian, S | 1 |
| Abbruzzese, M | 1 |
| Scotti, G | 1 |
| Montgomery, SA | 4 |
| Bullock, T | 2 |
| Montgomery, D | 1 |
| Vieta, E | 2 |
| Goldberger, EL | 2 |
| Rapoport, SI | 2 |
| Grady, CL | 2 |
| Montgomery, DB | 2 |
| Pato, MT | 9 |
| Gluhoski, V | 1 |
| Charney, DS | 1 |
| Wilens, TE | 1 |
| Steingard, R | 1 |
| Moroz, G | 2 |
| Cantwell, D | 1 |
| Fontaine, R | 3 |
| Reichler, R | 1 |
| Katz, R | 5 |
| Landau, P | 7 |
| L'Heureux, F | 2 |
| Hill, JL | 8 |
| Bihari, K | 2 |
| Bernstein, SE | 3 |
| Kuskowski, M | 2 |
| Harper, G | 1 |
| Hoogduin, CA | 1 |
| Feerick, J | 1 |
| Hatterer, J | 1 |
| Volkmar, FR | 1 |
| Ward-O'Brien, D | 1 |
| Nielsen, J | 1 |
| Bregman, J | 1 |
| Cohen, DJ | 1 |
| Pandey, GN | 1 |
| Davis, JM | 1 |
| Keyser, JJ | 1 |
| Bark, N | 1 |
| Lindenmayer, JP | 1 |
| Graae, F | 1 |
| Gitow, A | 1 |
| Piacentini, J | 1 |
| Jaffer, M | 1 |
| Casey, DA | 1 |
| Johnson, BR | 1 |
| Lucas, JP | 1 |
| Donahoe, DH | 1 |
| Meador, M | 1 |
| Fortune, T | 1 |
| Llorena, R | 1 |
| Solyom, C | 1 |
| Ledwidge, B | 1 |
| George, MS | 1 |
| Vazquez Rodriguez, AM | 1 |
| Arranz Peña, MI | 1 |
| Lopez Ibor, JJ | 1 |
| Garcia Aguilera, M | 1 |
| Moreno, I | 1 |
| Vecino Morales, AM | 1 |
| Austin, LS | 4 |
| Ballenger, JC | 2 |
| Cohen, BM | 1 |
| Laraia, MT | 2 |
| Zealberg, JJ | 3 |
| Fossey, MD | 2 |
| Ellinwood, EH | 1 |
| Zhao, JP | 1 |
| Grover, GN | 3 |
| James, WA | 1 |
| Lippmann, SB | 1 |
| Cheslow, DL | 3 |
| Grindlinger, HM | 1 |
| Ramsay, E | 1 |
| Tamimi, RR | 1 |
| Mavissakalian, MR | 3 |
| Thakur, AK | 1 |
| Remillard, AJ | 1 |
| Meldrum, LH | 1 |
| Gorecki, DK | 1 |
| Whitley, GG | 1 |
| Wolff, RP | 1 |
| Wolff, LS | 1 |
| Judd, FK | 1 |
| Chua, P | 1 |
| Lynch, C | 1 |
| Norman, T | 1 |
| Bernstein, S | 1 |
| Cantwell, DP | 1 |
| O'Sullivan, G | 1 |
| Noshirvani, H | 2 |
| Monteiro, W | 2 |
| Lelliott, P | 2 |
| Lee, S | 1 |
| Feinberg, M | 1 |
| de Montigny, C | 1 |
| Blier, P | 1 |
| Schechter, JB | 1 |
| Myers, MF | 1 |
| Schneier, HA | 1 |
| DeCaria, C | 1 |
| Fairbanks, J | 2 |
| Fallon, B | 1 |
| Aizenberg, D | 3 |
| Hyman, S | 1 |
| Holland, A | 2 |
| Minichiello, WE | 1 |
| Buttolph, L | 1 |
| Summergrad, P | 2 |
| Seymour, R | 2 |
| Hakkarainen, H | 2 |
| Kelly, M | 1 |
| Myers, C | 1 |
| Noyes, R | 3 |
| McTavish, D | 1 |
| Benfield, P | 1 |
| Peters, MD | 1 |
| Davis, SK | 1 |
| Gutzmann, LD | 1 |
| Barklage, NE | 1 |
| Jermain, DM | 1 |
| Crismon, ML | 1 |
| Goodman, W | 1 |
| Rasmussen, S | 1 |
| Tolliver, TJ | 1 |
| Campeas, RB | 2 |
| Papp, LA | 2 |
| Hatterer, JA | 1 |
| Sandberg, D | 1 |
| Cameron, OG | 1 |
| Wasielewski, P | 1 |
| Simeon, JG | 1 |
| Thatte, S | 1 |
| Wiggins, D | 1 |
| Baldwin, D | 1 |
| Green, M | 1 |
| Jones, B | 3 |
| Olson, S | 3 |
| Price, J | 1 |
| Grunhaus, LJ | 1 |
| Ratzoni, G | 1 |
| Brandt, N | 1 |
| Lauffer, M | 1 |
| Nightingale, SL | 1 |
| Koby, E | 1 |
| Berg, CJ | 4 |
| Zahn, T | 1 |
| Cox, C | 1 |
| Denckla, M | 1 |
| Lenane, M | 1 |
| Gehris, TL | 1 |
| Kathol, RG | 1 |
| Benkelfat, C | 3 |
| Nordahl, TE | 1 |
| Semple, WE | 1 |
| King, AC | 1 |
| Johnston, H | 1 |
| Gutzman, LD | 1 |
| Teeuwisse, JM | 1 |
| Nolen, WA | 1 |
| Jacobson, AF | 1 |
| de la Gandara, J | 1 |
| Goldstein, BJ | 2 |
| Steinbook, RM | 1 |
| Warneke, L | 2 |
| Winchel, R | 1 |
| Klumker, A | 1 |
| Weilburg, JB | 1 |
| Koby, EV | 1 |
| Basoglu, M | 3 |
| Diamond, BI | 1 |
| Borison, RL | 1 |
| Coryell, WH | 1 |
| Kelly, MW | 1 |
| Hoffnung, RA | 1 |
| Molcho, A | 1 |
| Lelliott, PT | 3 |
| Monteiro, WO | 3 |
| Murray, JB | 1 |
| Noshirvani, HF | 2 |
| Grover, G | 1 |
| Kahne, GJ | 1 |
| Wray, RW | 1 |
| Fyer, AJ | 1 |
| Gorman, JM | 1 |
| Sandberg, DP | 1 |
| Thorneloe, WF | 1 |
| Zohar-Kadouch, R | 1 |
| De Veaugh-Geiss, J | 1 |
| Keck, PE | 1 |
| Lipinski, JF | 1 |
| White, K | 1 |
| den Boer, JA | 1 |
| Kamerbeek, WD | 2 |
| Verhoeven, WM | 2 |
| Kahn, RS | 2 |
| Kasvikis, Y | 2 |
| Tolbert, LC | 1 |
| Cohen, D | 1 |
| Kamlana, SH | 1 |
| Gray, P | 1 |
| Fay, M | 1 |
| Goethe, JW | 1 |
| Swedo, S | 1 |
| Coffey, M | 1 |
| Cheslow, D | 1 |
| Gispen-de Wied, CC | 1 |
| Modigh, K | 1 |
| Golden, RN | 1 |
| Morris, JE | 1 |
| Sack, DA | 1 |
| Taniguchi, G | 1 |
| Caballero, R | 1 |
| Sondheimer, A | 1 |
| Morstyn, R | 1 |
| Pascual, J | 1 |
| Combarros, O | 1 |
| Berciano, J | 1 |
| Primeau, F | 1 |
| Lake, CR | 1 |
| Lei, BS | 1 |
| Cui, YH | 1 |
| Lipsedge, MS | 1 |
| Prothero, W | 1 |
| Steketee, G | 1 |
| Dugger, D | 1 |
| Lapidot, M | 1 |
| Turner, SM | 1 |
| Jacob, R | 1 |
| Volavka, J | 1 |
| Sceery, W | 1 |
| Flament, M | 1 |
| Greenberg, D | 1 |
| Shahar, A | 1 |
| Lopez-Ibor Aliño, JJ | 1 |
| Lopez-Ibor Aliño, JM | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Memantine for Refractory OCD Patients: a Pragmatic Double Blind, Randomized, Parallel Group, Placebo Controlled, Monocentric Trial[NCT05015595] | Phase 3 | 20 participants (Anticipated) | Interventional | 2021-09-01 | Not yet recruiting | ||
| Transcutaneous Electrical Acupoint Stimulation (TEAS) and Dense Cranial Electroacupuncture Stimulation (DCEAS) for Psychiatric Sequelae and Related Biomarkers in Women Victims of Domestic Violence: a Randomized Controlled Trial[NCT05102253] | 110 participants (Anticipated) | Interventional | 2022-07-13 | Recruiting | |||
| Pharmacological Augmentation Strategies for Obsessive Compulsive Disorder Patients Non-respondent to First Line Medication Treatment: a Double Blind Placebo Controlled Study[NCT00466609] | Phase 4 | 54 participants (Actual) | Interventional | 2007-05-31 | Completed | ||
| Safety and Effectiveness of Capsulotomy in Refractory Obsessive-Compulsive Disorder[NCT02375152] | Phase 2/Phase 3 | 30 participants (Anticipated) | Interventional | 2015-04-30 | Recruiting | ||
| Combining Acceptance and Commitment Therapy With Exposure and Response Prevention to Enhance Treatment Engagement in Obsessive-Compulsive Disorder[NCT03343106] | 58 participants (Actual) | Interventional | 2011-07-12 | Completed | |||
| Augment in Treatment-resistent Obsessive-compulsive Disorder: an Open-label Trial[NCT00590642] | 30 participants (Anticipated) | Observational | 2006-04-30 | Completed | |||
| Stimulation magnétique transcrânienne répétitive Dans le Traitement Des Troubles Obsessionnels Compulsifs[NCT02884674] | 56 participants (Anticipated) | Interventional | 2015-05-31 | Recruiting | |||
| Adjunct Cortical Stimulation With Deep Brain Stimulation (DBS) to Treat Obsessive Compulsive Disorder (OCD)[NCT04958096] | 15 participants (Anticipated) | Interventional | 2021-08-01 | Recruiting | |||
| Clinical, Neurocognitive and Neuroimaging Variables Associated With Response to Treatment in Patients With OCD[NCT03993535] | Phase 4 | 250 participants (Actual) | Interventional | 2018-10-10 | Active, not recruiting | ||
| An Open-Label Trial of Epidiolex in the Treatment of Obsessive Compulsive Disorder and Related Disorders: Proof of Concept Study[NCT04978428] | Phase 2 | 15 participants (Anticipated) | Interventional | 2022-04-14 | Recruiting | ||
| Quetiapine Augmentation Versus Clomipramine Augmentation of Selective Serotonin Reuptake Inhibitors for Obsessive-compulsive Disorder Patients That do Not Respond to a SSRI Trial: a Randomized Open-trial.[NCT00564564] | Phase 4 | 21 participants (Actual) | Interventional | 2006-01-31 | Completed | ||
| [NCT00004310] | Phase 2 | 76 participants | Interventional | 1999-10-31 | Active, not recruiting | ||
| Single-Group Crossover Trial Comparing Behavioral Treatment to Memantine in Body Focused Repetitive Behaviors[NCT05796752] | Phase 2/Phase 3 | 28 participants (Anticipated) | Interventional | 2023-06-01 | Not yet recruiting | ||
| A Double-Blind, Placebo Controlled Study of Aripiprazole in Body Focused Repetitive Behaviors[NCT05545891] | Phase 2 | 100 participants (Anticipated) | Interventional | 2023-12-31 | Not yet recruiting | ||
| A Double-Blind, Placebo-Controlled Study of Dronabinol in Trichotillomania and Other Body Focused Repetitive Behaviors[NCT03530800] | Phase 2/Phase 3 | 50 participants (Actual) | Interventional | 2018-10-01 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
The entire study lasts 10 weeks. Every two weeks subjects will take the NIMH-TSS. The change in scores from baseline to after 10 weeks will be assessed. The scale itself assesses severity of trichotillomania symptoms. The NIMH-TSS score ranges from 0 to 20, with 0 being no symptoms and 20 being the most severe. (NCT03530800)
Timeframe: Assessed every two weeks up to 10 weeks, baseline data reported
| Intervention | score on a scale (Mean) |
|---|---|
| Dronabinol | 12.38 |
| Placebo | 10.63 |
The entire study lasts 10 weeks. Every two weeks subjects will take the SP-SAS. The change in scores from baseline to after 10 weeks will be assessed. The scale itself assesses severity of skin-picking symptoms. The SP-SAS score ranges from 0 to 48, with 0 being no symptoms and 48 being the most severe. (NCT03530800)
Timeframe: Assessed every two weeks up to 10 weeks, baseline reported
| Intervention | score on a scale (Mean) |
|---|---|
| Dronabinol | 24.44 |
| Placebo | 28.5 |
125 reviews available for clomipramine and Anankastic Personality
| Article | Year |
|---|---|
Obsessive-Compulsive Disorders.
Topics: Adult; Clomipramine; Cognitive Behavioral Therapy; Humans; Obsessive-Compulsive Disorder; Quality of | 2021 |
The Pharmacological Treatment of Obsessive-Compulsive Disorder.
Topics: Antidepressive Agents; Clomipramine; Humans; Obsessive-Compulsive Disorder; Psychotherapy; Selective | 2023 |
Brazilian Research Consortium on Obsessive-Compulsive Spectrum Disorders guidelines for the treatment of adult obsessive-compulsive disorder. Part I: pharmacological treatment.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Brazil; Clomipramine; Humans; Obsessive-Compulsive Disord | 2023 |
The psychopharmacology algorithm project at the Harvard South Shore Program: An algorithm for adults with obsessive-compulsive disorder.
Topics: Adult; Algorithms; Antidepressive Agents; Antipsychotic Agents; Aripiprazole; Clomipramine; Humans; | 2019 |
Pharmacotherapy for Treatment-Resistant Obsessive-Compulsive Disorder.
Topics: Clomipramine; Humans; Obsessive-Compulsive Disorder; Selective Serotonin Reuptake Inhibitors; Treatm | 2020 |
First manic/hypomanic episode in obsessive-compulsive disorder patients treated with antidepressants: A systematic review.
Topics: Antidepressive Agents; Clomipramine; Humans; Mania; Obsessive-Compulsive Disorder; Selective Seroton | 2021 |
Serum clomipramine and desmethylclomipramine levels in a CYP2C19 and CYP2D6 intermediate metabolizer.
Topics: Adult; Antidepressive Agents, Tricyclic; Clomipramine; Cytochrome P-450 CYP2C19; Cytochrome P-450 CY | 2017 |
Pharmacokinetics of serotonergic drugs: focus on OCD.
Topics: Clomipramine; Humans; Obsessive-Compulsive Disorder; Selective Serotonin Reuptake Inhibitors; Time F | 2019 |
[Obsessive compulsive disorder--intrusive thoughts, impulses and repetitive behaviours as an expression of a significant disease].
Topics: Antidepressive Agents, Tricyclic; Caregivers; Clomipramine; Cognitive Behavioral Therapy; Comorbidit | 2013 |
[To identify and treat obsessive-compulsive disorders: an overview].
Topics: Acceptance and Commitment Therapy; Clomipramine; Cognitive Behavioral Therapy; Combined Modality The | 2013 |
Atypical antipsychotic augmentation in SSRI treatment refractory obsessive-compulsive disorder: a systematic review and meta-analysis.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Clomipramine; Dibenzothiazepines; Double | 2014 |
Obsessive-compulsive disorder (OCD): Practical strategies for pharmacological and somatic treatment in adults.
Topics: Antipsychotic Agents; Clomipramine; Cognitive Behavioral Therapy; Combined Modality Therapy; Deep Br | 2015 |
Systematic Review and Meta-Analysis: Early Treatment Responses of Selective Serotonin Reuptake Inhibitors and Clomipramine in Pediatric Obsessive-Compulsive Disorder.
Topics: Child; Clomipramine; Humans; Obsessive-Compulsive Disorder; Randomized Controlled Trials as Topic; S | 2016 |
Intravenous anti-obsessive agents: a review.
Topics: Antidepressive Agents; Citalopram; Clinical Trials as Topic; Clomipramine; Drug Administration Sched | 2010 |
Treatment strategies for obsessive-compulsive disorder.
Topics: Clinical Trials as Topic; Clomipramine; Cognitive Behavioral Therapy; Combined Modality Therapy; Dee | 2010 |
Past, present and future drugs for the treatment of obsessive-compulsive disorder.
Topics: Antidepressive Agents; Clomipramine; Glutamic Acid; Humans; Obsessive-Compulsive Disorder; Receptors | 2010 |
[Evidence-based pharmacotherapy and other somatic treatment approaches for obsessive-compulsive disorder: state of the art].
Topics: Antidepressive Agents, Tricyclic; Antipsychotic Agents; Clomipramine; Cognitive Behavioral Therapy; | 2011 |
Efficacy of antidepressant medications in children and adolescents with obsessive-compulsive disorder: a systematic appraisal.
Topics: Adolescent; Antidepressive Agents; Child; Clomipramine; Humans; Obsessive-Compulsive Disorder; Resea | 2011 |
[Psychotherapeutic and pharmacological treatment of pediatric obsessive-compulsive disorder].
Topics: Adolescent; Antipsychotic Agents; Child; Clomipramine; Cognitive Behavioral Therapy; Combined Modali | 2012 |
[Diversity of obsessive-compulsive disorder and pharmacotherapy associated with obsessive-compulsive spectrum disorders].
Topics: Antipsychotic Agents; Autistic Disorder; Body Dysmorphic Disorders; Clomipramine; Comorbidity; Disru | 2011 |
Treatment strategies of obsessive-compulsive disorder and panic disorder/agoraphobia.
Topics: Agoraphobia; Alprazolam; Anti-Anxiety Agents; Antidepressive Agents, Tricyclic; Clomipramine; Cognit | 2012 |
[The mental disorder and obsessive-compulsive spectrum disorders in childhood ].
Topics: Antipsychotic Agents; Child; Child Development Disorders, Pervasive; Clomipramine; Cognitive Behavio | 2011 |
The nature, assessment, and treatment of obsessive-compulsive disorder.
Topics: Adolescent; Adult; Antidepressive Agents; Child; Clomipramine; Cognitive Behavioral Therapy; Drug Th | 2012 |
Pharmacotherapy of obsessive-compulsive disorder: evidence-based treatment and beyond.
Topics: Antipsychotic Agents; Clomipramine; Evidence-Based Medicine; Humans; Obsessive-Compulsive Disorder; | 2013 |
Breakthrough in psychiatric care: pharmacological treatment of obsessive-compulsive disorders with implications for nursing care.
Topics: Antidepressive Agents; Clomipramine; Compulsive Personality Disorder; Diagnosis, Differential; Disru | 2002 |
How to treat OCD in patients with Tourette syndrome.
Topics: Behavior Therapy; Clomipramine; Humans; Neurosurgical Procedures; Obsessive-Compulsive Disorder; Pra | 2003 |
[The treatment of OCD].
Topics: Antipsychotic Agents; Behavior Therapy; Clomipramine; Drug Therapy, Combination; Fluvoxamine; Humans | 2003 |
A review of pharmacologic treatments for obsessive-compulsive disorder.
Topics: Antidepressive Agents, Tricyclic; Chronic Disease; Clinical Trials as Topic; Clomipramine; Comorbidi | 2003 |
[The usage of different antidepressants in therapy of obsessive-compulsive disorders].
Topics: Antidepressive Agents; Clomipramine; Female; Fluvoxamine; Humans; Male; Obsessive-Compulsive Disorde | 2003 |
[Pharmacotherapy of compulsive disorders in childhood and adolescence].
Topics: Adolescent; Adult; Antidepressive Agents, Tricyclic; Child; Clinical Trials as Topic; Clomipramine; | 2003 |
[Obsessive-compulsive disorders in general practice. How the obsessive-compulsive neurotic is revealed by skin and hair].
Topics: Adolescent; Adult; Anti-Anxiety Agents; Antidepressive Agents, Second-Generation; Antidepressive Age | 2003 |
Which SSRI? A meta-analysis of pharmacotherapy trials in pediatric obsessive-compulsive disorder.
Topics: Adolescent; Age Factors; Child; Clomipramine; Humans; Obsessive-Compulsive Disorder; Personality Inv | 2003 |
Obsessive-compulsive disorder: unearthing a hidden problem.
Topics: Behavior Therapy; Clomipramine; Humans; Obsessive-Compulsive Disorder; Selective Serotonin Reuptake | 2003 |
[Obsessive-compulsive disorder in childhood and adolescence].
Topics: Adolescent; Age of Onset; Antidepressive Agents, Tricyclic; Child; Clomipramine; Diagnosis, Differen | 2003 |
Evidence-based pharmacotherapy of obsessive-compulsive disorder.
Topics: Antidepressive Agents, Tricyclic; Clomipramine; Drug Therapy, Combination; Evidence-Based Medicine; | 2005 |
A qualitative analysis of nonresponse: management of treatment-refractory obsessive-compulsive disorder.
Topics: Adrenergic Uptake Inhibitors; Citalopram; Clomipramine; Deep Brain Stimulation; Electric Stimulation | 2004 |
Pharmacotherapy of obsessive-compulsive disorder and obsessive-compulsive spectrum disorders.
Topics: Brain; Clomipramine; Cognitive Behavioral Therapy; Fluvoxamine; Humans; Obsessive-Compulsive Disorde | 2006 |
Pharmacotherapy of obsessive-compulsive disorder and obsessive-compulsive spectrum disorders.
Topics: Brain; Clomipramine; Cognitive Behavioral Therapy; Fluvoxamine; Humans; Obsessive-Compulsive Disorde | 2006 |
Pharmacotherapy of obsessive-compulsive disorder and obsessive-compulsive spectrum disorders.
Topics: Brain; Clomipramine; Cognitive Behavioral Therapy; Fluvoxamine; Humans; Obsessive-Compulsive Disorde | 2006 |
Pharmacotherapy of obsessive-compulsive disorder and obsessive-compulsive spectrum disorders.
Topics: Brain; Clomipramine; Cognitive Behavioral Therapy; Fluvoxamine; Humans; Obsessive-Compulsive Disorde | 2006 |
Serotonin-norepinephrine reuptake inhibitors in the treatment of obsessive-compulsive disorder: A critical review.
Topics: Adrenergic Uptake Inhibitors; Clomipramine; Controlled Clinical Trials as Topic; Cyclohexanols; Doub | 2006 |
Diagnosis and treatment of obsessive-compulsive disorder and related disorders.
Topics: Chronic Disease; Clomipramine; Humans; Obsessive-Compulsive Disorder; Psychotherapy; Selective Serot | 2007 |
Benefits of cognitive-behavioural therapy for children and youth with obsessive-compulsive disorder: re-examination of the evidence.
Topics: Adolescent; Anti-Anxiety Agents; Child; Clomipramine; Cognitive Behavioral Therapy; Combined Modalit | 2007 |
Issues in the pharmacological treatment of obsessive-compulsive disorder.
Topics: Clomipramine; Cognitive Behavioral Therapy; Combined Modality Therapy; Diagnosis, Differential; Drug | 2007 |
Sustained response versus relapse: the pharmacotherapeutic goal for obsessive-compulsive disorder.
Topics: Clomipramine; Fluoxetine; Humans; Meta-Analysis as Topic; Obsessive-Compulsive Disorder; Randomized | 2007 |
Pharmacologic treatment of anxiety disorders.
Topics: Adrenergic beta-Antagonists; Anti-Anxiety Agents; Antidepressive Agents; Anxiety Disorders; Benzodia | 1982 |
Behaviour therapy in phobic and obsessional disorders.
Topics: Agoraphobia; Arousal; Behavior Therapy; Clomipramine; Cognition; Combined Modality Therapy; Desensit | 1983 |
The psychopharmacological treatment of obsessive-compulsive disorder: a review.
Topics: Anti-Anxiety Agents; Antipsychotic Agents; Clinical Trials as Topic; Clomipramine; Double-Blind Meth | 1981 |
Are there anticompulsive or antiphobic drugs? Review of the evidence.
Topics: Adult; Antidepressive Agents; Child; Clomipramine; Depressive Disorder; Female; Humans; Male; Middle | 1983 |
Clomipramine in obsessive-compulsive disorder: a review.
Topics: Behavior Therapy; Clomipramine; Depression; Double-Blind Method; Humans; Obsessive Behavior; Obsessi | 1983 |
Obsessive-compulsive disorder of childhood and adolescence. A neurobiological viewpoint.
Topics: Adolescent; Child; Child, Preschool; Clomipramine; Diseases in Twins; Encephalitis; Female; Frontal | 1980 |
Review of behavioral psychotherapy, I: Obsessive-compulsive disorders.
Topics: Behavior Therapy; Clinical Trials as Topic; Clomipramine; Double-Blind Method; Follow-Up Studies; Hu | 1981 |
Dopamine antagonists in tic-related and psychotic spectrum obsessive compulsive disorder.
Topics: Adult; Antipsychotic Agents; Clinical Trials as Topic; Clomipramine; Clozapine; Dopamine Antagonists | 1994 |
Selective serotonin reuptake inhibitors in obsessive-compulsive disorder.
Topics: Clomipramine; Humans; Obsessive-Compulsive Disorder; Randomized Controlled Trials as Topic; Selectiv | 1995 |
[Drug treatment of obsessive-compulsive disorders--a comparative study of the effectiveness of clomipramine and fluoxetine].
Topics: Clomipramine; Fluoxetine; Humans; Obsessive-Compulsive Disorder; Treatment Outcome | 1995 |
Current knowledge of medications for the treatment of childhood anxiety disorders.
Topics: Adolescent; Age of Onset; Anti-Anxiety Agents; Anxiety Disorders; Child; Clomipramine; Fluoxetine; H | 1995 |
Efficacy of drug treatment in obsessive-compulsive disorder. A meta-analytic review.
Topics: 1-Naphthylamine; Adolescent; Adult; Antidepressive Agents; Child; Clomipramine; Double-Blind Method; | 1995 |
Efficacy and tolerability of serotonin transport inhibitors in obsessive-compulsive disorder. A meta-analysis.
Topics: 1-Naphthylamine; Adolescent; Adult; Clomipramine; Double-Blind Method; Female; Fluoxetine; Fluvoxami | 1995 |
Pharmacologic therapy of obsessive compulsive disorder.
Topics: Clomipramine; Humans; Obsessive-Compulsive Disorder; Selective Serotonin Reuptake Inhibitors | 1994 |
Obsessive-compulsive disorder in Tourette's syndrome.
Topics: Behavior Therapy; Clomipramine; Clonidine; Fluvoxamine; Humans; Obsessive-Compulsive Disorder; Toure | 1995 |
[The "obsessive-compulsive spectrum": a useful concept?].
Topics: Adolescent; Adult; Clinical Trials as Topic; Clomipramine; Desipramine; Female; Humans; Male; Neuroc | 1994 |
Childhood movement disorders and obsessive compulsive disorder.
Topics: Antipsychotic Agents; Child; Chorea; Clinical Trials as Topic; Clomipramine; Comorbidity; Female; Fl | 1994 |
Positron emission tomography studies of cerebral glucose metabolism in obsessive compulsive disorder.
Topics: Brain; Clomipramine; Deoxyglucose; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Models, Ne | 1994 |
Behavior therapy for obsessive compulsive disorder.
Topics: Behavior Therapy; Clinical Trials as Topic; Clomipramine; Combined Modality Therapy; Humans; Obsessi | 1994 |
Management of treatment-refractory obsessive compulsive disorder patients.
Topics: Antipsychotic Agents; Behavior Therapy; Clomipramine; Clonazepam; Combined Modality Therapy; Control | 1994 |
Exposure with response prevention and serotonergic antidepressants in the treatment of obsessive compulsive disorder: a review and implications for interdisciplinary treatment.
Topics: Antidepressive Agents; Clomipramine; Combined Modality Therapy; Desensitization, Psychologic; Humans | 1993 |
Clomipramine, fluoxetine, and behavior therapy in the treatment of obsessive-compulsive disorder: a meta-analysis.
Topics: Behavior Therapy; Clomipramine; Combined Modality Therapy; Fluoxetine; Humans; Obsessive-Compulsive | 1993 |
Obsessive compulsive disorder in children and adolescents: issues in management.
Topics: Adolescent; Age Factors; Behavior Therapy; Child; Child, Preschool; Clomipramine; Comorbidity; Couns | 1993 |
A calendar savant with autism and Tourette syndrome. Response to treatment and thoughts on the interrelationships of these conditions.
Topics: Aptitude; Autistic Disorder; Clomipramine; Comorbidity; Humans; Intellectual Disability; Male; Middl | 1993 |
The pharmacotherapy of obsessive-compulsive disorder.
Topics: 1-Naphthylamine; Buspirone; Clomipramine; Desipramine; Fluoxetine; Fluvoxamine; Humans; Obsessive-Co | 1993 |
Obsessive compulsive disorder. An update.
Topics: Adult; Child; Clomipramine; Cognitive Behavioral Therapy; Combined Modality Therapy; Female; Humans; | 1993 |
Antidepressant treatments in children and adolescents: II. Anxiety, physical, and behavioral disorders.
Topics: Adolescent; Antidepressive Agents; Anxiety Disorders; Attention Deficit Disorder with Hyperactivity; | 1993 |
Neuropsychiatry of obsessive-compulsive disorder in children and adolescents.
Topics: Adolescent; Child; Clomipramine; Humans; Nervous System; Neural Pathways; Neurologic Examination; Ne | 1995 |
Eating disorder and obsessive-compulsive disorder: neurochemical and phenomenological commonalities.
Topics: Anorexia Nervosa; Bulimia; Clomipramine; Comorbidity; Female; Fluoxetine; Humans; Male; Obsessive-Co | 1996 |
OCD: where the serotonin selectivity story begins.
Topics: Antidepressive Agents; Clinical Trials as Topic; Clomipramine; Humans; Meta-Analysis as Topic; Obses | 1996 |
A risk-benefit assessment of drugs used in the management of obsessive-compulsive disorder.
Topics: 1-Naphthylamine; Adult; Aged; Antidepressive Agents; Buspirone; Child; Clomipramine; Clonazepam; Cos | 1996 |
Refining treatment approaches in obsessive-compulsive disorder.
Topics: Clomipramine; Humans; Obsessive-Compulsive Disorder | 1996 |
Morbid jealousy as a variant of obsessive-compulsive disorder.
Topics: Anxiety Disorders; Clomipramine; Cognitive Behavioral Therapy; Combined Modality Therapy; Depressive | 1997 |
Effectiveness of psychological and pharmacological treatments for obsessive-compulsive disorder: a quantitative review.
Topics: Behavior Therapy; Clomipramine; Cognitive Behavioral Therapy; Controlled Clinical Trials as Topic; H | 1997 |
Fluvoxamine in the treatment of obsessive-compulsive disorder and related conditions.
Topics: Adolescent; Child; Clinical Trials as Topic; Clomipramine; Compulsive Behavior; Disruptive, Impulse | 1997 |
Pharmacologic treatment of obsessive-compulsive disorder: comparative studies.
Topics: 1-Naphthylamine; Adult; Antidepressive Agents; Clinical Trials as Topic; Clomipramine; Fluoxetine; F | 1997 |
New developments in the treatment of obsessive-compulsive disorder.
Topics: Adjuvants, Immunologic; Adolescent; Adult; Age Factors; Age of Onset; Antidepressive Agents, Second- | 1997 |
Recognition and treatment of obsessive-compulsive disorder.
Topics: Adolescent; Adult; Age of Onset; Clomipramine; Combined Modality Therapy; Female; Humans; Male; Obse | 1998 |
A review of the efficacy of selective serotonin reuptake inhibitors in obsessive-compulsive disorder.
Topics: Clinical Trials as Topic; Clomipramine; Double-Blind Method; Humans; Meta-Analysis as Topic; Multice | 1999 |
On the pharmacotherapy of obsessive-compulsive disorder: is a consensus possible?
Topics: Clomipramine; Double-Blind Method; Expert Testimony; Fluoxetine; Fluvoxamine; Guidelines as Topic; H | 2000 |
Treating obsessive compulsive disorder.
Topics: Antipsychotic Agents; Clomipramine; Cognitive Behavioral Therapy; Humans; Obsessive-Compulsive Disor | 2002 |
Multivariate meta-analysis of controlled drug studies for obsessive-compulsive disorder.
Topics: Clomipramine; Humans; Multivariate Analysis; Obsessive-Compulsive Disorder; Placebo Effect; Randomiz | 2002 |
Management of treatment resistant obsessive-compulsive disorder. Algorithms for pharmacotherapy.
Topics: Algorithms; Citalopram; Clomipramine; Cognitive Behavioral Therapy; Combined Modality Therapy; Dopam | 2002 |
Obsessive compulsive neurosis.
Topics: Age Factors; Behavior Therapy; Clomipramine; Compulsive Personality Disorder; Humans; Monoamine Oxid | 1978 |
[A limit of anxiety disorders. Obsessive-compulsive disorders in children and adolescents].
Topics: Adolescent; Anxiety Disorders; Child; Clomipramine; Family; Humans; Neuropsychology; Obsessive-Compu | 1992 |
Current concepts in the pharmacological treatment of obsessive-compulsive disorder.
Topics: Clomipramine; Humans; Obsessive-Compulsive Disorder | 1992 |
Buspirone in obsessive-compulsive disorder.
Topics: Adult; Buspirone; Clinical Trials as Topic; Clomipramine; Drug Therapy, Combination; Female; Fluoxet | 1992 |
Serotonergic antidepressants and their efficacy in obsessive compulsive disorder.
Topics: Clomipramine; Double-Blind Method; Fluoxetine; Humans; Obsessive-Compulsive Disorder; Randomized Con | 1992 |
Sertraline in the treatment of obsessive compulsive disorder: two double-blind, placebo-controlled studies.
Topics: 1-Naphthylamine; Clomipramine; Dose-Response Relationship, Drug; Double-Blind Method; Humans; Obsess | 1992 |
The role of serotonin and dopamine in the pathophysiology of obsessive compulsive disorder.
Topics: Brain; Clomipramine; Dopamine; Fluoxetine; Fluvoxamine; Humans; Obsessive-Compulsive Disorder; Serot | 1992 |
Serotonergic probes in obsessive compulsive disorder.
Topics: Brain; Clomipramine; Fluoxetine; Fluvoxamine; Humans; Obsessive-Compulsive Disorder; Receptors, Sero | 1992 |
Serotonin reuptake inhibitors are the treatment of choice in obsessive compulsive disorder.
Topics: 1-Naphthylamine; Behavior Therapy; Clomipramine; Combined Modality Therapy; Depressive Disorder; Flu | 1992 |
Serotonin and effect sizes of antiobsessive agents.
Topics: Buspirone; Clinical Trials as Topic; Clomipramine; Humans; Meta-Analysis as Topic; Obsessive-Compuls | 1992 |
The serotonin hypothesis of obsessive compulsive disorder: implications of pharmacologic challenge studies.
Topics: Biomarkers; Clomipramine; Humans; Neurotransmitter Uptake Inhibitors; Obsessive-Compulsive Disorder; | 1992 |
Pharmacotherapy of obsessive compulsive disorder.
Topics: 1-Naphthylamine; Antidepressive Agents; Clomipramine; Depressive Disorder; Fluoxetine; Fluvoxamine; | 1992 |
An integrated approach to treatment of obsessive compulsive disorder.
Topics: Behavior Therapy; Clomipramine; Combined Modality Therapy; Humans; Neurotransmitter Uptake Inhibitor | 1992 |
Obsessive-compulsive disorder. Characteristic features, pharmacologic management.
Topics: Clomipramine; Fluoxetine; Humans; Obsessive-Compulsive Disorder | 1992 |
Obsessive-compulsive disorder.
Topics: Clomipramine; Fluoxetine; Fluvoxamine; Humans; Obsessive-Compulsive Disorder | 1991 |
Assessment and treatment of obsessive-compulsive disorder in children.
Topics: Behavior Therapy; Child; Clomipramine; Combined Modality Therapy; Humans; Obsessive-Compulsive Disor | 1991 |
Obsessive-compulsive disorder: treatment with serotonin-selective uptake inhibitors, azapirones, and other agents.
Topics: Anti-Anxiety Agents; Antidepressive Agents, Tricyclic; Buspirone; Clinical Trials as Topic; Clomipra | 1990 |
Clomipramine for obsessive-compulsive disorder.
Topics: Clinical Trials as Topic; Clomipramine; Humans; Incidence; Obsessive-Compulsive Disorder; Seizures | 1991 |
New pharmacologic approaches to obsessive compulsive disorder.
Topics: Behavior Therapy; Clinical Trials as Topic; Clomipramine; Combined Modality Therapy; Fluoxetine; Flu | 1990 |
Clomipramine versus fluoxetine in obsessive-compulsive disorder: a retrospective comparison of side effects and efficacy.
Topics: Clomipramine; Fluoxetine; Humans; Meta-Analysis as Topic; Obsessive-Compulsive Disorder; Psychiatric | 1990 |
A controlled trial of fluvoxamine in obsessive-compulsive disorder: implications for a serotonergic theory.
Topics: 1-Naphthylamine; Adult; Ambulatory Care; Clinical Trials as Topic; Clomipramine; Double-Blind Method | 1990 |
Treating the anxiety: therapeutic options in obsessive compulsive disorder.
Topics: Anxiety Disorders; Behavior Therapy; Benzodiazepines; Clomipramine; Decision Trees; Humans; Neurotra | 1990 |
Therapeutic effects of anafranil in obsessive compulsive disorder. Recent clinical findings.
Topics: Adult; Clomipramine; Double-Blind Method; Female; Humans; Male; Meta-Analysis as Topic; Obsessive-Co | 1990 |
Clomipramine. An overview of its pharmacological properties and a review of its therapeutic use in obsessive compulsive disorder and panic disorder.
Topics: Animals; Clomipramine; Humans; Obsessive-Compulsive Disorder; Panic; Randomized Controlled Trials as | 1990 |
Clomipramine: an antiobsessional tricyclic antidepressant.
Topics: Clomipramine; Humans; Obsessive-Compulsive Disorder | 1990 |
Pharmacotherapy of obsessive-compulsive disorder.
Topics: Clinical Trials as Topic; Clomipramine; Double-Blind Method; Humans; Obsessive-Compulsive Disorder; | 1990 |
Worldwide use of clomipramine.
Topics: Anxiety Disorders; Clinical Trials as Topic; Clomipramine; Depressive Disorder; Double-Blind Method; | 1990 |
Serotonin and treatment in obsessive-compulsive disorder.
Topics: Behavior Therapy; Clomipramine; Fluvoxamine; Humans; Obsessive-Compulsive Disorder; Oximes; Receptor | 1989 |
[The role of drug therapy in the treatment of obsessive-compulsive disorders].
Topics: Anti-Anxiety Agents; Antidepressive Agents; Antipsychotic Agents; Behavior Therapy; Benzodiazepines; | 1989 |
The biology of obsessions and compulsions.
Topics: Animals; Animals, Domestic; Antidepressive Agents; Basal Ganglia; Clomipramine; Compulsive Behavior; | 1989 |
Treatment of body-dysmorphic disorder with serotonin reuptake blockers.
Topics: Adult; Body Image; Clomipramine; Diagnosis, Differential; Female; Fluoxetine; Humans; Male; Middle A | 1989 |
Pharmacotherapy of childhood obsessive-compulsive disorder.
Topics: Adolescent; Adult; Child; Clinical Trials as Topic; Clomipramine; Humans; Obsessive-Compulsive Disor | 1989 |
Obsessive-compulsive disorder as a 5-HT subsystem-related behavioural disorder.
Topics: Brain; Clomipramine; Humans; Obsessive-Compulsive Disorder; Receptors, Serotonin; Serotonin | 1989 |
Successful treatment of obsessive-compulsive disorders.
Topics: Anti-Anxiety Agents; Antidepressive Agents; Behavior Therapy; Clomipramine; Depressive Disorder; Ele | 1986 |
Tricyclic therapy of the DSM-III anxiety disorders: a review with implications for further research.
Topics: Adolescent; Antidepressive Agents, Tricyclic; Anxiety Disorders; Child; Clomipramine; Humans; Obsess | 1988 |
Psychopharmacologic treatment of obsessive-compulsive disorder.
Topics: Antidepressive Agents; Behavior Therapy; Clomipramine; Humans; Obsessive-Compulsive Disorder | 1988 |
Treatment of obsessive-compulsive disorder.
Topics: Behavior Therapy; Clomipramine; Female; Humans; Male; Obsessive-Compulsive Disorder | 1988 |
Antidepressant drugs in anxiety disorders.
Topics: Antidepressive Agents; Anxiety Disorders; Clomipramine; Humans; Imipramine; Monoamine Oxidase Inhibi | 1987 |
Clomipramine: an antiobsessive drug.
Topics: Anxiety; Behavior Therapy; Clinical Trials as Topic; Clomipramine; Compulsive Behavior; Depressive D | 1986 |
Obsessive-compulsive disorder.
Topics: Antidepressive Agents, Tricyclic; Anxiety Disorders; Behavior Therapy; Clinical Trials as Topic; Clo | 1985 |
165 trials available for clomipramine and Anankastic Personality
| Article | Year |
|---|---|
In a double-blind, randomized and placebo-controlled trial, adjuvant memantine improved symptoms in inpatients suffering from refractory obsessive-compulsive disorders (OCD).
Topics: Adult; Clomipramine; Double-Blind Method; Drug Therapy, Combination; Excitatory Amino Acid Antagonis | 2013 |
The impact of comorbid body dysmorphic disorder on the response to sequential pharmacological trials for obsessive-compulsive disorder.
Topics: Adult; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Antipsychotic Age | 2014 |
Plasma oxytocin changes and anti-obsessive response during serotonin reuptake inhibitor treatment: a placebo controlled study.
Topics: Adolescent; Adult; Clomipramine; Double-Blind Method; Humans; Middle Aged; Obsessive-Compulsive Diso | 2013 |
Clomipramine demethylation rate is important on the outcome of obsessive-compulsive disorder treatment.
Topics: Adult; Antidepressive Agents, Tricyclic; Biotransformation; Brazil; Clomipramine; Dealkylation; Drug | 2015 |
Intravenous Clomipramine for Treatment-Resistant Obsessive-Compulsive Disorder.
Topics: Administration, Intravenous; Adolescent; Adult; Clomipramine; Female; Follow-Up Studies; Humans; Mal | 2015 |
Highly efficacious cognitive-coping therapy for overt or covert compulsions.
Topics: Adaptation, Psychological; Adult; Clomipramine; Cognition; Cognitive Behavioral Therapy; Female; Fol | 2015 |
Transcutaneous electrical acupoint stimulation as an adjunct therapy for obsessive-compulsive disorder: A randomized controlled study.
Topics: Acupuncture Points; Adolescent; Adult; Aged; Clomipramine; Cognitive Behavioral Therapy; Combined Mo | 2016 |
Normalisation of immune cell imbalance after pharmacological treatments of patients suffering from obsessive-compulsive disorder.
Topics: Adolescent; Adult; Antigens, CD; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Clomipramin | 2009 |
Treatment for late-onset obsessive-compulsive disorder with parkinsonism.
Topics: Adult; Aged; Antidepressive Agents, Tricyclic; Antiparkinson Agents; Clomipramine; Humans; Male; Mid | 2008 |
Individual versus group cognitive-behavioral treatment for obsessive-compulsive disorder: a controlled pilot study.
Topics: Adult; Clomipramine; Cognitive Behavioral Therapy; Cohort Studies; Combined Modality Therapy; Female | 2008 |
Effectiveness of long-term augmentation with citalopram to clomipramine in treatment-resistant OCD patients.
Topics: Adult; Citalopram; Clomipramine; Demography; Drug Resistance; Drug Synergism; Female; Humans; Male; | 2008 |
Quetiapine versus clomipramine in the augmentation of selective serotonin reuptake inhibitors for the treatment of obsessive-compulsive disorder: a randomized, open-label trial.
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Clomipramine; Dibenzothiazepines; Dose-Response Relat | 2010 |
Effect of aripiprazole augmentation of serotonin reuptake inhibitors or clomipramine in treatment-resistant obsessive-compulsive disorder: a double-blind, placebo-controlled study.
Topics: Adult; Aged; Aripiprazole; Clomipramine; Double-Blind Method; Drug Therapy, Combination; Female; Hum | 2011 |
Myth of the pure obsessional type in obsessive--compulsive disorder.
Topics: Adult; Ceremonial Behavior; Clomipramine; Cognitive Behavioral Therapy; Combined Modality Therapy; F | 2011 |
A double-blind, randomized, controlled trial of fluoxetine plus quetiapine or clomipramine versus fluoxetine plus placebo for obsessive-compulsive disorder.
Topics: Adolescent; Adult; Antipsychotic Agents; Clomipramine; Dibenzothiazepines; Double-Blind Method; Drug | 2011 |
Venlafaxine versus clomipramine in the treatment of obsessive-compulsive disorder: a preliminary single-blind, 12-week, controlled study.
Topics: Acute Disease; Adult; Ambulatory Care; Clomipramine; Cyclohexanols; Dose-Response Relationship, Drug | 2002 |
Long-term efficacy of exposure and ritual prevention therapy and serotonergic medications for obsessive-compulsive disorder.
Topics: Clomipramine; Cognitive Behavioral Therapy; Combined Modality Therapy; Double-Blind Method; Fluvoxam | 2003 |
Weight gain during long-term treatment of obsessive-compulsive disorder: a prospective comparison between serotonin reuptake inhibitors.
Topics: Adult; Ambulatory Care; Citalopram; Clomipramine; Female; Fluoxetine; Fluvoxamine; Follow-Up Studies | 2004 |
Randomized, placebo-controlled trial of exposure and ritual prevention, clomipramine, and their combination in the treatment of obsessive-compulsive disorder.
Topics: Adolescent; Adult; Aged; Antidepressive Agents, Tricyclic; Behavior Therapy; Clomipramine; Combined | 2005 |
Randomized, placebo-controlled trial of exposure and ritual prevention, clomipramine, and their combination in the treatment of obsessive-compulsive disorder.
Topics: Adolescent; Adult; Aged; Antidepressive Agents, Tricyclic; Behavior Therapy; Clomipramine; Combined | 2005 |
Randomized, placebo-controlled trial of exposure and ritual prevention, clomipramine, and their combination in the treatment of obsessive-compulsive disorder.
Topics: Adolescent; Adult; Aged; Antidepressive Agents, Tricyclic; Behavior Therapy; Clomipramine; Combined | 2005 |
Randomized, placebo-controlled trial of exposure and ritual prevention, clomipramine, and their combination in the treatment of obsessive-compulsive disorder.
Topics: Adolescent; Adult; Aged; Antidepressive Agents, Tricyclic; Behavior Therapy; Clomipramine; Combined | 2005 |
Standard criteria for relapse are needed in obsessive-compulsive disorder.
Topics: Antidepressive Agents, Tricyclic; Clomipramine; Cognitive Behavioral Therapy; Combined Modality Ther | 2005 |
Elevated thyroid indices in children and adolescents with obsessive-compulsive disorder: effects of clomipramine treatment.
Topics: Adolescent; Antidepressive Agents, Tricyclic; Child; Clomipramine; Female; Humans; Hypothalamo-Hypop | 2005 |
[Clinical study on treatment of obsessive compulsive neurosis by acupoint stimulating control].
Topics: Acupuncture Points; Adolescent; Adult; Aged; Behavior Control; Behavior Therapy; Clomipramine; Femal | 2005 |
Pulse-loaded intravenous clomipramine in treatment-resistant obsessive-compulsive disorder.
Topics: Administration, Oral; Adolescent; Adult; Clomipramine; Drug Administration Schedule; Humans; Infusio | 2006 |
Response versus remission in obsessive-compulsive disorder.
Topics: Adult; Ambulatory Care; Antidepressive Agents, Tricyclic; Clomipramine; Cognitive Behavioral Therapy | 2006 |
A randomized, controlled trial of cognitive-behavioral therapy for augmenting pharmacotherapy in obsessive-compulsive disorder.
Topics: Adolescent; Adult; Aged; Chromatography, Gas; Clomipramine; Cognitive Behavioral Therapy; Combined M | 2008 |
Naltrexone augmentation in OCD: a double-blind placebo-controlled cross-over study.
Topics: Adolescent; Adult; Aged; Clomipramine; Cross-Over Studies; Double-Blind Method; Drug Synergism; Fema | 2008 |
Pharmacologic treatment of anxiety disorders.
Topics: Adrenergic beta-Antagonists; Anti-Anxiety Agents; Antidepressive Agents; Anxiety Disorders; Benzodia | 1982 |
Clomipramine treatment of obsessive-compulsive disorder. II. Biochemical aspects.
Topics: Adult; Clomipramine; Female; Glycols; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Male; Met | 1980 |
The psychopharmacological treatment of obsessive-compulsive disorder: a review.
Topics: Anti-Anxiety Agents; Antipsychotic Agents; Clinical Trials as Topic; Clomipramine; Double-Blind Meth | 1981 |
Obsessive-compulsive disorder. A double-blind trial of clomipramine and clorgyline.
Topics: Adult; Clinical Trials as Topic; Clomipramine; Clorgyline; Double-Blind Method; Female; Humans; Male | 1983 |
Tricyclic antidepressants in obsessive-compulsive disorder. Antiobsessional or antidepressant agents?
Topics: Adolescent; Adult; Aged; Anxiety; Clinical Trials as Topic; Clomipramine; Depression; Female; Humans | 1983 |
Psychophysiological changes during pharmacological treatment of patients with obsessive compulsive disorder.
Topics: Adolescent; Adult; Aged; Clinical Trials as Topic; Clomipramine; Clorgyline; Double-Blind Method; Fe | 1984 |
Lithium and tryptophan augmentation in clomipramine-resistant obsessive-compulsive disorder.
Topics: Adult; Clinical Trials as Topic; Clomipramine; Double-Blind Method; Drug Therapy, Combination; Human | 1984 |
Clomipramine and exposure for obsessive-compulsive rituals: i.
Topics: Adolescent; Adult; Behavior Therapy; Clinical Trials as Topic; Clomipramine; Depression; Double-Blin | 1980 |
Clinical controlled trial of chlorimipramine in adolescents with obsessive-compulsive disorder.
Topics: Adolescent; Clinical Trials as Topic; Clomipramine; Double-Blind Method; Female; Humans; Male; Obses | 1980 |
Review of behavioral psychotherapy, I: Obsessive-compulsive disorders.
Topics: Behavior Therapy; Clinical Trials as Topic; Clomipramine; Double-Blind Method; Follow-Up Studies; Hu | 1981 |
Double-blind comparative study of clomipramine and amitriptyline in obsessive neurosis.
Topics: Adult; Amitriptyline; Anxiety Disorders; Clinical Trials as Topic; Clomipramine; Depressive Disorder | 1981 |
Clomipramine and exposure for chronic obsessive-compulsive rituals: III. Two year follow-up and further findings.
Topics: Anxiety; Clinical Trials as Topic; Clomipramine; Depressive Disorder; Double-Blind Method; Female; F | 1982 |
Clomipramine and exposure for compulsive rituals: II. Plasma levels, side effects and outcome.
Topics: Clomipramine; Dose-Response Relationship, Drug; Humans; Obsessive-Compulsive Disorder; Time Factors | 1980 |
Clomipramine: plasma levels, side effects and outcome in obsessive-compulsive neurosis.
Topics: Adolescent; Adult; Clomipramine; Female; Humans; Male; Middle Aged; Obsessive-Compulsive Disorder | 1980 |
Clomipramine treatment of obsessive-compulsive disorder. I. A controlled clinical trial.
Topics: Adult; Clomipramine; Depressive Disorder; Female; Humans; Male; Middle Aged; Nortriptyline; Obsessiv | 1980 |
Disabling compulsions in 11 mentally retarded adults: an open trial of clomipramine SR.
Topics: Adult; Clomipramine; Comorbidity; Delayed-Action Preparations; Drug Administration Schedule; Female; | 1995 |
Predictors of drug treatment response in obsessive-compulsive disorder.
Topics: Adolescent; Adult; Age of Onset; Clomipramine; Comorbidity; Fluoxetine; Follow-Up Studies; Humans; M | 1995 |
Predictors of drug treatment response in obsessive-compulsive disorder.
Topics: Adolescent; Adult; Age of Onset; Clomipramine; Comorbidity; Fluoxetine; Follow-Up Studies; Humans; M | 1995 |
Predictors of drug treatment response in obsessive-compulsive disorder.
Topics: Adolescent; Adult; Age of Onset; Clomipramine; Comorbidity; Fluoxetine; Follow-Up Studies; Humans; M | 1995 |
Predictors of drug treatment response in obsessive-compulsive disorder.
Topics: Adolescent; Adult; Age of Onset; Clomipramine; Comorbidity; Fluoxetine; Follow-Up Studies; Humans; M | 1995 |
Treatment of obsessive-compulsive symptoms in schizophrenic patients with clomipramine.
Topics: Adult; Clomipramine; Double-Blind Method; Female; Humans; Male; Middle Aged; Obsessive-Compulsive Di | 1995 |
Efficacy of drug treatment in obsessive-compulsive disorder. A meta-analytic review.
Topics: 1-Naphthylamine; Adolescent; Adult; Antidepressive Agents; Child; Clomipramine; Double-Blind Method; | 1995 |
Predictors of treatment response in obsessive-compulsive disorder: multivariate analyses from a multicenter trial of clomipramine.
Topics: Adolescent; Adult; Age Factors; Clomipramine; Depressive Disorder; Female; Humans; Male; Middle Aged | 1994 |
The Yale-Brown Obsessive-Compulsive Scale: measures of internal consistency.
Topics: Adult; Clomipramine; Factor Analysis, Statistical; Female; Humans; Male; Obsessive-Compulsive Disord | 1994 |
Fluvoxamine versus clomipramine in the treatment of obsessive compulsive disorder: a multicenter, randomized, double-blind, parallel group comparison.
Topics: Adult; Ambulatory Care; Clomipramine; Double-Blind Method; Female; Fluvoxamine; Headache; Humans; Ma | 1994 |
Inert placebo versus active medication. Patient blindability in clinical pharmacological trials.
Topics: Clinical Trials as Topic; Clomipramine; Depressive Disorder; Double-Blind Method; Humans; Obsessive- | 1994 |
Symptoms and physiologic manifestations in obsessive compulsive patients before and after treatment with clomipramine.
Topics: Adult; Arousal; Blood Pressure; Clomipramine; Double-Blind Method; Female; Galvanic Skin Response; H | 1993 |
A pilot study of biological predictors of treatment outcome in obsessive-compulsive disorder.
Topics: Adolescent; Adult; Ambulatory Care; Clomipramine; Dose-Response Relationship, Drug; Double-Blind Met | 1993 |
Quantitative EEG in obsessive-compulsive disorder.
Topics: Adult; Cerebral Cortex; Clomipramine; Dominance, Cerebral; Electroencephalography; Evoked Potentials | 1993 |
A 2- to 7-year follow-up study of 54 obsessive-compulsive children and adolescents.
Topics: Adolescent; Adult; Age Factors; Behavior Therapy; Child; Clomipramine; Cohort Studies; Combined Moda | 1993 |
A double-blind comparison of clomipramine, desipramine, and placebo in the treatment of autistic disorder.
Topics: Adolescent; Adult; Ambulatory Care; Autistic Disorder; Child; Clomipramine; Desipramine; Double-Blin | 1993 |
Effects of acute intravenous clomipramine on obsessive-compulsive symptoms and response to chronic treatment.
Topics: Administration, Oral; Adult; Clomipramine; Drug Administration Schedule; Female; Humans; Infusions, | 1995 |
Combination treatment with clomipramine and fluvoxamine: drug monitoring, safety, and tolerability data.
Topics: Adult; Aged; Antidepressive Agents, Tricyclic; Clomipramine; Depressive Disorder; Dose-Response Rela | 1996 |
Fluvoxamine versus clomipramine for obsessive-compulsive disorder: a double-blind comparison.
Topics: Adolescent; Adult; Aged; Clomipramine; Dose-Response Relationship, Drug; Double-Blind Method; Drug A | 1996 |
Double-blind comparison of fluoxetine versus clomipramine in the treatment of obsessive compulsive disorder.
Topics: Adult; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Clomipramine; Dou | 1996 |
Relationship between early side effects and therapeutic effects of clomipramine therapy in obsessive-compulsive disorder.
Topics: Adult; Clomipramine; Constipation; Dizziness; Humans; Male; Obsessive-Compulsive Disorder; Selective | 1996 |
Paroxetine versus clomipramine in the treatment of obsessive-compulsive disorder. OCD Paroxetine Study Investigators.
Topics: Adolescent; Adult; Aged; Clomipramine; Double-Blind Method; Female; Humans; Male; Middle Aged; Obses | 1996 |
Drug treatment of obsessive-compulsive disorder (OCD): long-term trial with clomipramine and selective serotonin reuptake inhibitors (SSRIs).
Topics: Adult; Clomipramine; Dose-Response Relationship, Drug; Female; Fluoxetine; Fluvoxamine; Follow-Up St | 1996 |
Therapeutic effect and safety of adjunctive risperidone in refractory obsessive-compulsive disorder (OCD).
Topics: Adult; Clomipramine; Female; Humans; Male; Middle Aged; Obsessive-Compulsive Disorder; Risperidone | 1996 |
Long-term pharmacotherapy of obsessive-compulsive disorder: a double-blind controlled study.
Topics: Adult; Clomipramine; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Sche | 1997 |
Rapid benefit of intravenous pulse loading of clomipramine in obsessive-compulsive disorder.
Topics: Administration, Oral; Adult; Age of Onset; Clomipramine; Double-Blind Method; Drug Administration Sc | 1997 |
Predictive value of obsessive-compulsive personality disorder in antiobsessional pharmacological treatment.
Topics: Adult; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Clomipramine; Fem | 1997 |
A double-blind study of fluvoxamine and clomipramine in the treatment of obsessive-compulsive disorder.
Topics: Adolescent; Adult; Aged; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; | 1997 |
Addition of desipramine to serotonin reuptake inhibitors in treatment-resistant obsessive-compulsive disorder.
Topics: 1-Naphthylamine; Adrenergic Uptake Inhibitors; Adult; Clomipramine; Desipramine; Double-Blind Method | 1997 |
Changes in platelet markers of obsessive-compulsive patients during a double-blind trial of fluvoxamine versus clomipramine.
Topics: Adult; Anti-Anxiety Agents; Arylsulfotransferase; Biomarkers; Blood Platelets; Carrier Proteins; Clo | 1997 |
Fenfluramine challenge test in obsessive-compulsive disorder--first results.
Topics: Adult; Citalopram; Clomipramine; Double-Blind Method; Female; Fenfluramine; Humans; Male; Obsessive- | 1997 |
Pulse loading versus gradual dosing of intravenous clomipramine in obsessive-compulsive disorder.
Topics: Administration, Oral; Adult; Antidepressive Agents, Tricyclic; Clomipramine; Female; Humans; Injecti | 1998 |
Combination treatment with clomipramine and selective serotonin reuptake inhibitors for obsessive-compulsive disorder in children and adolescents.
Topics: Adolescent; Adult; Antidepressive Agents, Tricyclic; Child; Clomipramine; Drug Therapy, Combination; | 1998 |
Intravenous clomipramine challenge in obsessive-compulsive disorder: predicting response to oral therapy at eight weeks.
Topics: Administration, Oral; Adolescent; Adult; Affect; Clomipramine; Double-Blind Method; Drug Administrat | 1998 |
Intravenous clomipramine for obsessive-compulsive disorder refractory to oral clomipramine: a placebo-controlled study.
Topics: Administration, Oral; Adult; Clomipramine; Double-Blind Method; Drug Administration Schedule; Female | 1998 |
Behavior therapy versus clomipramine for the treatment of obsessive-compulsive disorder in children and adolescents.
Topics: Behavior Therapy; Child; Clomipramine; Combined Modality Therapy; Female; Humans; Male; Obsessive-Co | 1998 |
Combination of clomipramine and nortriptyline in the treatment of obsessive-compulsive disorder: a double-blind, placebo-controlled trial.
Topics: Adrenergic Uptake Inhibitors; Adult; Clomipramine; Double-Blind Method; Drug Administration Schedule | 1998 |
FDG-PET predictors of response to behavioral therapy and pharmacotherapy in obsessive compulsive disorder.
Topics: Adult; Antidepressive Agents, Tricyclic; Behavior Therapy; Brain; Clomipramine; Female; Humans; Male | 1998 |
Effect of acute intravenous clomipramine and antiobsessional response to proserotonergic drugs: is gender a predictive variable?
Topics: Administration, Oral; Adult; Analysis of Variance; Chi-Square Distribution; Clomipramine; Double-Bli | 1999 |
Side effects as predictors of drug response in obsessive-compulsive disorder.
Topics: Adolescent; Adult; Anxiety; Clomipramine; Dose-Response Relationship, Drug; Ejaculation; Female; Flu | 1999 |
Citalopram for treatment-resistant obsessive-compulsive disorder.
Topics: Adolescent; Adult; Citalopram; Clomipramine; Dose-Response Relationship, Drug; Double-Blind Method; | 1999 |
Multicentre, double-blind, comparison of fluvoxamine and clomipramine in the treatment of obsessive-compulsive disorder.
Topics: Adult; Anti-Anxiety Agents; Antidepressive Agents, Tricyclic; Clomipramine; Double-Blind Method; Fem | 2000 |
On the pharmacotherapy of obsessive-compulsive disorder: is a consensus possible?
Topics: Clomipramine; Double-Blind Method; Expert Testimony; Fluoxetine; Fluvoxamine; Guidelines as Topic; H | 2000 |
Olanzapine augmentation of serotonin uptake inhibitors in obsessive-compulsive disorder: an open study.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Clomipramine; Dose-Response Relationship, Drug; Drug A | 2001 |
Long-term follow-up and predictors of clinical outcome in obsessive-compulsive patients treated with serotonin reuptake inhibitors and behavioral therapy.
Topics: Adolescent; Adult; Age of Onset; Ambulatory Care; Behavior Therapy; Clomipramine; Combined Modality | 2001 |
Neuroendocrine predictors of response to intravenous clomipramine therapy for refractory obsessive-compulsive disorder.
Topics: Administration, Oral; Adolescent; Adult; Clomipramine; Dose-Response Relationship, Drug; Double-Blin | 2001 |
Clomipramine (Anafranil) and behaviour therapy in obsessive-compulsive and phobic disorders.
Topics: Adult; Behavior Therapy; Clinical Trials as Topic; Clomipramine; Dibenzazepines; Double-Blind Method | 1977 |
Double-blind controlled study in phobias and obsessions.
Topics: Adult; Clinical Trials as Topic; Clomipramine; Dibenzazepines; Double-Blind Method; Female; Humans; | 1977 |
A preliminary report on clinical response and plasma levels of clomipramine and desmethylclomipramine in obsessive-compulsive neurosis.
Topics: Adolescent; Adult; Behavior Therapy; Clinical Trials as Topic; Clomipramine; Dibenzazepines; Double- | 1977 |
A clinical trial of clomipramine and diazepam in the treatment of phobic and obsessional illness.
Topics: Adolescent; Adult; Aged; Clomipramine; Diazepam; Dibenzazepines; Female; Humans; Male; Medical Histo | 1977 |
Anafranil in obsessive compulsive neurosis.
Topics: Adult; Anxiety; Clinical Trials as Topic; Clomipramine; Depression; Dibenzazepines; Female; Humans; | 1975 |
Changes in obsessive/compulsive patients as measured by the Leyton Inventory before and after treatment with clomipramine.
Topics: Clinical Trials as Topic; Clomipramine; Depression; Dibenzazepines; Humans; Obsessive-Compulsive Dis | 1975 |
Drug treatment of canine acral lick. An animal model of obsessive-compulsive disorder.
Topics: 1-Naphthylamine; Animals; Clomipramine; Dermatitis; Desipramine; Disease Models, Animal; Dog Disease | 1992 |
Clomipramine versus phenelzine in obsessive-compulsive disorder. A controlled clinical trial.
Topics: Adult; Clomipramine; Depressive Disorder; Dexamethasone; Dose-Response Relationship, Drug; Double-Bl | 1992 |
Serotonergic antidepressants and their efficacy in obsessive compulsive disorder.
Topics: Clomipramine; Double-Blind Method; Fluoxetine; Humans; Obsessive-Compulsive Disorder; Randomized Con | 1992 |
Effect of axis II diagnoses on treatment outcome with clomipramine in 55 patients with obsessive-compulsive disorder.
Topics: Adult; Analysis of Variance; Clomipramine; Double-Blind Method; Female; Humans; Male; Obsessive-Comp | 1992 |
Trichotillomania. An obsessive compulsive spectrum disorder?
Topics: Adolescent; Adult; Child; Child, Preschool; Clomipramine; Combined Modality Therapy; Desipramine; Do | 1992 |
Clomipramine, clonazepam, and clonidine treatment of obsessive-compulsive disorder.
Topics: Adult; Analysis of Variance; Anxiety; Clomipramine; Clonazepam; Clonidine; Depression; Double-Blind | 1992 |
Sertraline in the treatment of obsessive compulsive disorder: two double-blind, placebo-controlled studies.
Topics: 1-Naphthylamine; Clomipramine; Dose-Response Relationship, Drug; Double-Blind Method; Humans; Obsess | 1992 |
Low-dose pimozide augmentation of serotonin reuptake blockers in the treatment of trichotillomania.
Topics: Adult; Clomipramine; Comorbidity; Dopamine; Drug Therapy, Combination; Female; Fluoxetine; Humans; M | 1992 |
Clomipramine hydrochloride in childhood and adolescent obsessive-compulsive disorder--a multicenter trial.
Topics: Adolescent; Child; Clomipramine; Dose-Response Relationship, Drug; Double-Blind Method; Female; Huma | 1992 |
A double-blind study of adjuvant buspirone hydrochloride in clomipramine-treated patients with obsessive-compulsive disorder.
Topics: Adult; Analysis of Variance; Buspirone; Clomipramine; Double-Blind Method; Drug Therapy, Combination | 1992 |
The Symptom Checklist-90: Obsessive-Compulsive Subscale: A reliability and validity study.
Topics: Adult; Clomipramine; Female; Humans; Male; Obsessive-Compulsive Disorder; Psychiatric Status Rating | 1992 |
Platelet 3H-imipramine binding sites in obsessive-compulsive behavior.
Topics: Adult; Blood Platelets; Carrier Proteins; Clomipramine; Female; Humans; Imipramine; Male; Middle Age | 1991 |
Clomipramine test: serum level determination in three groups of psychiatric patients.
Topics: Adolescent; Adult; Clomipramine; Female; Gambling; Humans; Male; Middle Aged; Obsessive-Compulsive D | 1991 |
Dopamine blocking activity of clomipramine in patients with obsessive-compulsive disorder.
Topics: Adolescent; Adult; Aged; Clomipramine; Double-Blind Method; Female; Humans; Male; Middle Aged; Obses | 1991 |
Clomipramine in the treatment of patients with obsessive-compulsive disorder. The Clomipramine Collaborative Study Group.
Topics: Adult; Ambulatory Care; Clomipramine; Double-Blind Method; Female; Follow-Up Studies; Hospitalizatio | 1991 |
A controlled comparison of adjuvant lithium carbonate or thyroid hormone in clomipramine-treated patients with obsessive-compulsive disorder.
Topics: Adult; Clomipramine; Double-Blind Method; Drug Resistance; Drug Therapy, Combination; Electrocardiog | 1991 |
A double-blind desipramine substitution during long-term clomipramine treatment in children and adolescents with obsessive-compulsive disorder.
Topics: Adolescent; Age Factors; Child; Clomipramine; Desipramine; Double-Blind Method; Drug Administration | 1991 |
A double-blind comparison of clomipramine and desipramine treatment of severe onychophagia (nail biting).
Topics: Adult; Ambulatory Care; Clomipramine; Desipramine; Dose-Response Relationship, Drug; Double-Blind Me | 1991 |
Obsessive-compulsive disorder: treatment with serotonin-selective uptake inhibitors, azapirones, and other agents.
Topics: Anti-Anxiety Agents; Antidepressive Agents, Tricyclic; Buspirone; Clinical Trials as Topic; Clomipra | 1990 |
Controlled comparison of buspirone and clomipramine in obsessive-compulsive disorder.
Topics: Adult; Ambulatory Care; Buspirone; Clomipramine; Double-Blind Method; Humans; Obsessive-Compulsive D | 1991 |
Six-year follow-up after exposure and clomipramine therapy for obsessive compulsive disorder.
Topics: Antidepressive Agents, Tricyclic; Behavior Therapy; Chronic Disease; Clomipramine; Double-Blind Meth | 1991 |
Clomipramine in obsessive compulsive disorder.
Topics: Adult; Ambulatory Care; Behavior Therapy; Clomipramine; Double-Blind Method; Ethics, Medical; Female | 1991 |
Clomipramine versus fluoxetine in obsessive-compulsive disorder: a retrospective comparison of side effects and efficacy.
Topics: Clomipramine; Fluoxetine; Humans; Meta-Analysis as Topic; Obsessive-Compulsive Disorder; Psychiatric | 1990 |
A controlled trial of fluvoxamine in obsessive-compulsive disorder: implications for a serotonergic theory.
Topics: 1-Naphthylamine; Adult; Ambulatory Care; Clinical Trials as Topic; Clomipramine; Double-Blind Method | 1990 |
Therapeutic effects of anafranil in obsessive compulsive disorder. Recent clinical findings.
Topics: Adult; Clomipramine; Double-Blind Method; Female; Humans; Male; Meta-Analysis as Topic; Obsessive-Co | 1990 |
Tritiated imipramine binding in obsessive-compulsive volunteers and psychiatrically normal controls.
Topics: Adult; Blood Platelets; Carrier Proteins; Clinical Trials as Topic; Clomipramine; Double-Blind Metho | 1990 |
Clomipramine. An overview of its pharmacological properties and a review of its therapeutic use in obsessive compulsive disorder and panic disorder.
Topics: Animals; Clomipramine; Humans; Obsessive-Compulsive Disorder; Panic; Randomized Controlled Trials as | 1990 |
The antiobsessional effects of clomipramine do not require concomitant affective disorder.
Topics: Adult; Clomipramine; Depressive Disorder; Double-Blind Method; Female; Humans; Male; Multicenter Stu | 1990 |
Clomipramine and obsessive compulsive disorder: a placebo-controlled double-blind study of 32 patients.
Topics: Adult; Aged; Ambulatory Care; Clinical Trials as Topic; Clomipramine; Double-Blind Method; Female; H | 1990 |
Pharmacotherapy of obsessive-compulsive disorder.
Topics: Clinical Trials as Topic; Clomipramine; Double-Blind Method; Humans; Obsessive-Compulsive Disorder; | 1990 |
Clinical predictors of treatment response in obsessive compulsive disorder: exploratory analyses from multicenter trials of clomipramine.
Topics: Adult; Clomipramine; Humans; Multicenter Studies as Topic; Obsessive-Compulsive Disorder; Prognosis | 1990 |
Worldwide use of clomipramine.
Topics: Anxiety Disorders; Clinical Trials as Topic; Clomipramine; Depressive Disorder; Double-Blind Method; | 1990 |
Clomipramine in obsessive-compulsive disorder.
Topics: Adolescent; Adult; Aged; Clomipramine; Double-Blind Method; Female; Follow-Up Studies; Humans; Male; | 1990 |
Controlled comparisons of clomipramine and fluoxetine in the treatment of obsessive-compulsive disorder. Behavioral and biological results.
Topics: Adult; Blood Platelets; Clomipramine; Double-Blind Method; Female; Fluoxetine; Humans; Male; Obsessi | 1990 |
A clomipramine dosage reduction study in the course of long-term treatment of obsessive-compulsive disorder patients.
Topics: Adult; Clomipramine; Double-Blind Method; Humans; Middle Aged; Obsessive-Compulsive Disorder | 1990 |
The Yale-Brown Obsessive-Compulsive Scale: a reliability and validity study.
Topics: Adult; Clomipramine; Female; Humans; Male; Middle Aged; Obsessive-Compulsive Disorder; Personality I | 1990 |
Treatment of adolescent obsessive-compulsive disorder with a clomipramine-fluoxetine combination.
Topics: Adolescent; Clomipramine; Drug Therapy, Combination; Female; Fluoxetine; Humans; Male; Obsessive-Com | 1990 |
Clomipramine in obsessive-compulsive disorder: clinical response and plasma levels.
Topics: Adult; Clomipramine; Double-Blind Method; Female; Humans; Male; Middle Aged; Obsessive-Compulsive Di | 1990 |
Pharmacological responsiveness of dermatitis secondary to compulsive washing.
Topics: Clomipramine; Cohort Studies; Hand Dermatoses; Hand Disinfection; Humans; Obsessive-Compulsive Disor | 1990 |
Drug versus behavioral treatment of obsessive-compulsive disorder.
Topics: Behavior Therapy; Clomipramine; Follow-Up Studies; Humans; Obsessive-Compulsive Disorder | 1990 |
Early response with clomipramine in obsessive compulsive disorder--a placebo controlled study.
Topics: Adult; Clomipramine; Female; Humans; Male; Obsessive-Compulsive Disorder; Phobic Disorders; Placebos | 1990 |
Urinary free cortisol levels in obsessive-compulsive disorder.
Topics: Adult; Clomipramine; Depressive Disorder; Dexamethasone; Female; Humans; Hydrocortisone; Male; Middl | 1990 |
Preliminary results from a multicenter trial of clomipramine in obsessive-compulsive disorder.
Topics: Clinical Trials as Topic; Clomipramine; Double-Blind Method; Humans; Multicenter Studies as Topic; O | 1989 |
Obsessive-compulsive disorder: a double-blind, placebo-controlled trial of clomipramine in 27 patients.
Topics: Adult; Ambulatory Care; Clinical Trials as Topic; Clomipramine; Double-Blind Method; Female; Humans; | 1989 |
Treatment of obsessive-compulsive disorder with clomipramine and desipramine in children and adolescents. A double-blind crossover comparison.
Topics: Adolescent; Adult; Age Factors; Child; Clinical Trials as Topic; Clomipramine; Desipramine; Double-B | 1989 |
Obsessive-compulsive rituals.
Topics: Clinical Trials as Topic; Clomipramine; Humans; Obsessive-Compulsive Disorder | 1989 |
Pharmacotherapy of childhood obsessive-compulsive disorder.
Topics: Adolescent; Adult; Child; Clinical Trials as Topic; Clomipramine; Humans; Obsessive-Compulsive Disor | 1989 |
Rebound withdrawal reactions due to clomipramine.
Topics: Adult; Aged; Clomipramine; Double-Blind Method; Female; Humans; Male; Middle Aged; Obsessive-Compuls | 1989 |
HPA axis disturbance in obsessive-compulsive disorder.
Topics: Clinical Trials as Topic; Clomipramine; Dexamethasone; Double-Blind Method; Female; Humans; Hydrocor | 1989 |
A double-blind comparison of clomipramine and desipramine in the treatment of trichotillomania (hair pulling)
Topics: Adolescent; Adult; Clomipramine; Desipramine; Double-Blind Method; Female; Humans; Obsessive-Compuls | 1989 |
A double-blind comparison of clomipramine and desipramine in the treatment of trichotillomania (hair pulling)
Topics: Adolescent; Adult; Clomipramine; Desipramine; Double-Blind Method; Female; Humans; Obsessive-Compuls | 1989 |
A double-blind comparison of clomipramine and desipramine in the treatment of trichotillomania (hair pulling)
Topics: Adolescent; Adult; Clomipramine; Desipramine; Double-Blind Method; Female; Humans; Obsessive-Compuls | 1989 |
A double-blind comparison of clomipramine and desipramine in the treatment of trichotillomania (hair pulling)
Topics: Adolescent; Adult; Clomipramine; Desipramine; Double-Blind Method; Female; Humans; Obsessive-Compuls | 1989 |
A double-blind comparison of clomipramine and desipramine in the treatment of trichotillomania (hair pulling)
Topics: Adolescent; Adult; Clomipramine; Desipramine; Double-Blind Method; Female; Humans; Obsessive-Compuls | 1989 |
A double-blind comparison of clomipramine and desipramine in the treatment of trichotillomania (hair pulling)
Topics: Adolescent; Adult; Clomipramine; Desipramine; Double-Blind Method; Female; Humans; Obsessive-Compuls | 1989 |
A double-blind comparison of clomipramine and desipramine in the treatment of trichotillomania (hair pulling)
Topics: Adolescent; Adult; Clomipramine; Desipramine; Double-Blind Method; Female; Humans; Obsessive-Compuls | 1989 |
A double-blind comparison of clomipramine and desipramine in the treatment of trichotillomania (hair pulling)
Topics: Adolescent; Adult; Clomipramine; Desipramine; Double-Blind Method; Female; Humans; Obsessive-Compuls | 1989 |
A double-blind comparison of clomipramine and desipramine in the treatment of trichotillomania (hair pulling)
Topics: Adolescent; Adult; Clomipramine; Desipramine; Double-Blind Method; Female; Humans; Obsessive-Compuls | 1989 |
Obsessive-compulsive beliefs and treatment outcome.
Topics: Adult; Attitude; Behavior Therapy; Clinical Trials as Topic; Clomipramine; Combined Modality Therapy | 1988 |
Clomipramine in obsessive-compulsive disorder. Further evidence for a serotonergic mechanism of action.
Topics: Adult; Affect; Clomipramine; Dose-Response Relationship, Drug; Drug Interactions; Female; Humans; Ma | 1989 |
Obsessive-compulsive disorder: psychobiological approaches to diagnosis, treatment, and pathophysiology.
Topics: Adult; Brain; Clomipramine; Depressive Disorder; Desipramine; Diagnosis, Differential; Female; Human | 1987 |
Clomipramine for obsessive compulsive disorder.
Topics: Adult; Child; Clinical Trials as Topic; Clomipramine; Double-Blind Method; Humans; Obsessive-Compuls | 1988 |
Return of symptoms after discontinuation of clomipramine in patients with obsessive-compulsive disorder.
Topics: Adult; Clinical Trials as Topic; Clomipramine; Combined Modality Therapy; Double-Blind Method; Femal | 1988 |
Obsessive-compulsive rituals.
Topics: Clinical Trials as Topic; Clomipramine; Humans; Obsessive-Compulsive Disorder | 1988 |
Effect of serotonin uptake inhibitors in anxiety disorders; a double-blind comparison of clomipramine and fluvoxamine.
Topics: Adult; Agoraphobia; Anxiety Disorders; Clinical Trials as Topic; Clomipramine; Double-Blind Method; | 1987 |
Clomipramine in obsessive-compulsive ritualisers treated with exposure therapy: relations between dose, plasma levels, outcome and side effects.
Topics: Adolescent; Adult; Clinical Trials as Topic; Clomipramine; Humans; Middle Aged; Obsessive-Compulsive | 1988 |
Clomipramine, self-exposure and therapist-aided exposure for obsessive-compulsive rituals.
Topics: Adolescent; Adult; Behavior Therapy; Clomipramine; Combined Modality Therapy; Female; Humans; Male; | 1988 |
Serotonergic responsivity in obsessive-compulsive disorder. Effects of chronic clomipramine treatment.
Topics: Adult; Aged; Brain Chemistry; Clinical Trials as Topic; Clomipramine; Double-Blind Method; Female; H | 1988 |
Clonidine and clomipramine in obsessive-compulsive disorder.
Topics: Administration, Oral; Clinical Trials as Topic; Clomipramine; Clonidine; Double-Blind Method; Drug T | 1988 |
Clomipramine for obsessive-compulsive symptoms.
Topics: Clinical Trials as Topic; Clomipramine; Humans; MMPI; Obsessive-Compulsive Disorder; Psychiatric Sta | 1988 |
Treatment of childhood obsessive compulsive disorder with clomipramine and desmethylimipramine: a double-blind crossover comparison.
Topics: Adolescent; Adult; Child; Clinical Trials as Topic; Clomipramine; Desipramine; Double-Blind Method; | 1988 |
Effect of a serotonin precursor and uptake inhibitor in anxiety disorders; a double-blind comparison of 5-hydroxytryptophan, clomipramine and placebo.
Topics: 5-Hydroxytryptophan; Adult; Agoraphobia; Anxiety Disorders; Clinical Trials as Topic; Clomipramine; | 1987 |
Anorgasmia from clomipramine in obsessive-compulsive disorder. A controlled trial.
Topics: Clinical Trials as Topic; Clomipramine; Humans; Obsessive-Compulsive Disorder; Orgasm; Random Alloca | 1987 |
Clomipramine: an antiobsessive drug.
Topics: Anxiety; Behavior Therapy; Clinical Trials as Topic; Clomipramine; Compulsive Behavior; Depressive D | 1986 |
Biochemical changes during clomipramine treatment of childhood obsessive-compulsive disorder.
Topics: Adolescent; Blood Platelets; Blood Pressure; Clinical Trials as Topic; Clomipramine; Double-Blind Me | 1987 |
[A cross-over treatment of obsessive-compulsive neurosis with imipramine and chlorimipramine].
Topics: Adolescent; Adult; Clinical Trials as Topic; Clomipramine; Double-Blind Method; Female; Humans; Imip | 1986 |
[A double-blind trial of chlorimipramine and doxepin in obsessive-compulsive neurosis].
Topics: Adolescent; Adult; Clinical Trials as Topic; Clomipramine; Double-Blind Method; Doxepin; Female; Hum | 1986 |
Effects of imipramine on depression and obsessive-compulsive symptoms.
Topics: Adolescent; Adult; Aged; Clomipramine; Depressive Disorder; Humans; Imipramine; Middle Aged; Obsessi | 1987 |
A controlled trial of clomipramine in childhood obsessive compulsive disorder.
Topics: Adolescent; Child; Clinical Trials as Topic; Clomipramine; Double-Blind Method; Female; Humans; Male | 1985 |
Tricyclic antidepressants in obsessive-compulsive disorder: antiobsessional or antidepressant agents? II.
Topics: Adult; Clinical Trials as Topic; Clomipramine; Depressive Disorder; Double-Blind Method; Female; Hum | 1985 |
Obsessive-compulsive disorder.
Topics: Antidepressive Agents, Tricyclic; Anxiety Disorders; Behavior Therapy; Clinical Trials as Topic; Clo | 1985 |
Clomipramine and imipramine in obsessive-compulsive disorder.
Topics: Adult; Blood Pressure; Clinical Trials as Topic; Clomipramine; Double-Blind Method; Female; Humans; | 1985 |
Clomipramine treatment of childhood obsessive-compulsive disorder. A double-blind controlled study.
Topics: Adolescent; Adult; Age Factors; Antidepressive Agents, Tricyclic; Child; Clinical Trials as Topic; C | 1985 |
280 other studies available for clomipramine and Anankastic Personality
| Article | Year |
|---|---|
Clomipramine as an alternative to selective serotonin reuptake inhibitors for patients at haemorrhagic risk.
Topics: Clomipramine; Humans; Obsessive-Compulsive Disorder; Selective Serotonin Reuptake Inhibitors; Treatm | 2022 |
Personalized Medicine in the Treatment of a Patient With Obsessive-Compulsive Disorder With Clomipramine.
Topics: Clomipramine; Humans; Obsessive-Compulsive Disorder; Precision Medicine; Selective Serotonin Reuptak | 2023 |
Relapse of obsessive-compulsive disorder after cerebral venous sinus thrombosis: a case report.
Topics: Adolescent; Adult; Clomipramine; Female; Humans; Obsessive-Compulsive Disorder; Recurrence; Sertrali | 2020 |
The Osler's view: Treating comorbid bipolar disorder and obsessive-compulsive disorder.
Topics: Adult; Affect; Antidepressive Agents; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Clomipra | 2017 |
Obsession of pregnancy: Does it exist?
Topics: Attitude to Health; Citalopram; Clomipramine; Clonazepam; Cognitive Behavioral Therapy; Depressive D | 2017 |
In the Mirror: Depression With Dysmorphia and Obsessive-Compulsive Disorder.
Topics: Adult; Body Dysmorphic Disorders; Clomipramine; Depressive Disorder; Face; Female; Humans; Obsessive | 2018 |
Augmenting selective serotonin reuptake inhibitors with clomipramine in obsessive-compulsive disorder: benefits and risks.
Topics: Adolescent; Antidepressive Agents; Clomipramine; Dose-Response Relationship, Drug; Drug Monitoring; | 2013 |
[Olfactory reference syndrome and hyperhidrosis: comorbidity in one patient].
Topics: Adult; Body Dysmorphic Disorders; Clomipramine; Cognitive Behavioral Therapy; Combined Modality Ther | 2014 |
A case study in treating chronic comorbid obsessive-compulsive disorder and depression with behavioral activation and pharmacotherapy.
Topics: Amitriptyline; Antidepressive Agents; Behavior Therapy; Chronic Disease; Clomipramine; Depressive Di | 2015 |
Developmental emergence of an obsessive-compulsive phenotype and binge behavior in rats.
Topics: Adaptation, Psychological; Aging; Animals; Antidepressive Agents, Tricyclic; Anxiety; Behavior, Anim | 2015 |
Hyponatremia-induced stress cardiomyopathy due to psychogenic polydipsia.
Topics: Adult; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Aripiprazole; Chest Pain; Clomipramin | 2016 |
Recurrent brief depressive disorder in Dhat syndrome: A biological or psychological phenomenon!
Topics: Adult; Clomipramine; Cognitive Behavioral Therapy; Depressive Disorder; Fluoxetine; Humans; Male; Ob | 2016 |
Pharmacotherapy for obsessive compulsive disorder in clinical practice - Data of 842 inpatients from the International AMSP Project between 1994 and 2012.
Topics: Adult; Antidepressive Agents; Antipsychotic Agents; Clomipramine; Cognitive Behavioral Therapy; Cros | 2016 |
Detrimental effect of clomipramine on hippocampus-dependent learning in an animal model of obsessive-compulsive disorder induced by sensitization with d2/d3 agonist quinpirole.
Topics: Analysis of Variance; Animals; Avoidance Learning; Clomipramine; Disease Models, Animal; Dopamine Ag | 2017 |
Aggravation of schizophrenia by clomipramine in a patient with comorbid obsessive-compulsive disorder.
Topics: Antidepressive Agents, Tricyclic; Clomipramine; Clozapine; Humans; Male; Middle Aged; Obsessive-Comp | 2008 |
Pareidolias in obsessive-compulsive disorder: neglected symptoms that may respond to serotonin reuptake inhibitors.
Topics: Adult; Clomipramine; Female; Humans; Illusions; Obsessive-Compulsive Disorder; Selective Serotonin R | 2008 |
Lamotrigine as an augmentation agent in treatment-resistant obsessive-compulsive disorder: a case report.
Topics: Anticonvulsants; Antidepressive Agents, Tricyclic; Clomipramine; Dose-Response Relationship, Drug; D | 2010 |
Obsessional jealousy: unusual presentation.
Topics: Clomipramine; Family; Humans; Islam; Jealousy; Male; Obsessive-Compulsive Disorder; Religion and Psy | 2008 |
Long-term follow-up study of patients with refractory obsessive-compulsive disorder.
Topics: Adolescent; Adult; Antidepressive Agents, Tricyclic; Clomipramine; Drug Resistance; Female; Follow-U | 2008 |
Obsessive-compulsive disorder.
Topics: Antidepressive Agents, Tricyclic; Clomipramine; Humans; Obsessive-Compulsive Disorder; Psychiatric S | 2008 |
Onychophagia as a spectrum of obsessive-compulsive disorder.
Topics: Adolescent; Adult; Clomipramine; Female; Humans; Nail Biting; Obsessive-Compulsive Disorder; Selecti | 2009 |
Dimensional predictors of response to SRI pharmacotherapy in obsessive-compulsive disorder.
Topics: Adult; Clomipramine; Connecticut; Female; Fluoxetine; Fluvoxamine; Humans; Male; Middle Aged; Obsess | 2010 |
Musical obsession: repeated auditory imagery of a cell phone ring tone.
Topics: Adaptation, Psychological; Adult; Auditory Perception; Cell Phone; Clomipramine; Fluvoxamine; Humans | 2009 |
Obsessive compulsive disorder as a cause of atypical eating disorder: a case report.
Topics: Adult; Anorexia Nervosa; Antidepressive Agents, Tricyclic; Clomipramine; Cognitive Behavioral Therap | 2009 |
Amantadine augmentation for refractory obsessive-compulsive disorder: a case report.
Topics: Adult; Amantadine; Clomipramine; Drug Therapy, Combination; Humans; Male; Obsessive-Compulsive Disor | 2010 |
A novel, multiple symptom model of obsessive-compulsive-like behaviors in animals.
Topics: Animals; Animals, Newborn; Antidepressive Agents, Tricyclic; Behavior, Animal; Clomipramine; Corpus | 2010 |
Association study between genetic monoaminergic polymorphisms and OCD response to clomipramine treatment.
Topics: Adult; Antidepressive Agents, Tricyclic; Clomipramine; Dopamine Plasma Membrane Transport Proteins; | 2011 |
Blepharospasm as an obsessive-compulsive phenomenon.
Topics: Adult; Blepharospasm; Clomipramine; Humans; Male; Obsessive-Compulsive Disorder; Selective Serotonin | 2011 |
Essential role for orbitofrontal serotonin 1B receptors in obsessive-compulsive disorder-like behavior and serotonin reuptake inhibitor response in mice.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Acoustic Stimulation; Adrenergic beta-Antagonists; Adrenergi | 2011 |
Plasma clomipramine levels in adult patients with obsessive-compulsive disorder.
Topics: Adult; Biotransformation; Chromatography, High Pressure Liquid; Clomipramine; Dealkylation; Drug Mon | 2012 |
Serotonin reuptake inhibitor treatment of obsessive-compulsive symptoms in clozapine-medicated schizophrenia.
Topics: Adult; Antipsychotic Agents; Aryl Hydrocarbon Hydroxylases; Clomipramine; Clozapine; Comorbidity; Cy | 2012 |
Ritualistic chewing behavior induced by mCPP in the rat is an animal model of obsessive compulsive disorder.
Topics: Animals; Behavior, Animal; Clomipramine; Diazepam; Disease Models, Animal; Dopamine Antagonists; Flu | 2013 |
Evaluation of animal models of obsessive-compulsive disorder: correlation with phasic dopamine neuron activity.
Topics: Action Potentials; Animals; Animals, Newborn; Clomipramine; Compulsive Behavior; Conditioning, Opera | 2013 |
[Disguised Tourette's syndrome. A contribution to the differential diagnosis on phobia and fear].
Topics: Adult; Anxiety Disorders; Clomipramine; Clonazepam; Cognitive Behavioral Therapy; Combined Modality | 2002 |
Clinical features and outcome in dogs and cats with obsessive-compulsive disorder: 126 cases (1989-2000).
Topics: Age of Onset; Amitriptyline; Animals; Antidepressive Agents, Tricyclic; Behavior Therapy; Behavior, | 2002 |
Clomipramine-resistant, fluoxetine-responsive obsessive compulsive disorder: a case report.
Topics: Adult; Clomipramine; Drug Resistance; Fluoxetine; Humans; Male; Obsessive-Compulsive Disorder; Selec | 2002 |
Clinical features in two cases with musical obsessions who successfully responded to clomipramine.
Topics: Adult; Clomipramine; Diagnosis, Differential; Diagnostic and Statistical Manual of Mental Disorders; | 2003 |
Obsessive-compulsive-bipolar comorbidity: a systematic exploration of clinical features and treatment outcome.
Topics: Adolescent; Adult; Aged; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Bipolar Disorder; C | 2002 |
Reply to Dr Mahendran. We have not found reported cases of [obsessive-compulsive] OC arising from de novo with olanzapine treatment.
Topics: Adult; Benzodiazepines; Clomipramine; Fluoxetine; Humans; Male; Obsessive-Compulsive Disorder; Olanz | 2003 |
Age differences in the sensitivity to clomipramine in an animal model of obsessive-compulsive disorder.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Aging; Animals; Antidepressive Agents, Tricyclic; Clomiprami | 2003 |
Quetiapine treatment in a patient with Tourette's syndrome, obsessive-compulsive disorder and drug-induced mania.
Topics: Adult; Antipsychotic Agents; Bipolar Disorder; Clomipramine; Dibenzothiazepines; Humans; Male; Obses | 2003 |
Intravenous clomipramine in severe and refractory obsessive-compulsive disorder.
Topics: Adult; Clomipramine; Female; Humans; Infusions, Intravenous; Male; Obsessive-Compulsive Disorder; Se | 2003 |
Age differences in an animal model of obsessive-compulsive disorder: participation of dopamine: dopamine in an animal model of OCD.
Topics: Aging; Animals; Antidepressive Agents, Tricyclic; Clomipramine; Dopamine; Dopamine Agonists; Male; M | 2004 |
Case study: successful medication withdrawal using cognitive-behavioral therapy for a preadolescent with OCD.
Topics: Child; Clomipramine; Cognitive Behavioral Therapy; Female; Fluoxetine; Humans; Obsessive-Compulsive | 2004 |
Treatment-response by age at onset in obsessive-compulsive disorder.
Topics: Age Factors; Antidepressive Agents, Tricyclic; Clinical Trials as Topic; Clomipramine; Comorbidity; | 2004 |
Nicotine augmentation for refractory obsessive-compulsive disorder. A case report.
Topics: Acetylcholine; Adult; Antidepressive Agents, Tricyclic; Clomipramine; Drug Resistance; GABA Agents; | 2005 |
Increased maintenance of obsessive-compulsive disorder remission after integrated serotonergic treatment and cognitive psychotherapy compared with medication alone.
Topics: Adult; Age Factors; Clomipramine; Combined Modality Therapy; Female; Humans; Male; Obsessive-Compuls | 2005 |
Obsessions with aggressive content emerging during the course of panic disorder: a different subtype of obsessive-compulsive disorder?
Topics: Adult; Aggression; Anti-Anxiety Agents; Antidepressive Agents, Tricyclic; Benzodiazepines; Clomipram | 2005 |
Memantine for treatment-resistant OCD.
Topics: Adult; Clomipramine; Dopamine Antagonists; Drug Therapy, Combination; Excitatory Amino Acid Antagoni | 2005 |
Shared obsessive-compulsive disorder.
Topics: Adult; Antidepressive Agents, Tricyclic; Clomipramine; Combined Modality Therapy; Desensitization, P | 2006 |
Sexual pleasure in women with obsessive-compulsive disorder?
Topics: Adult; Antipsychotic Agents; Clomipramine; Coitus; Drive; Female; Humans; Middle Aged; Obsessive-Com | 2006 |
Cognitive behavioral therapy versus psychosurgery for refractory obsessive-compulsive disorder.
Topics: Clomipramine; Cognitive Behavioral Therapy; Combined Modality Therapy; Female; Fluoxetine; Fluvoxami | 2006 |
Female hormones affect symptom severity in obsessive-compulsive disorder.
Topics: Adult; Antidepressive Agents; Antipsychotic Agents; Clomipramine; Contraceptives, Oral, Hormonal; De | 2006 |
Oral contraceptive pill use and changes in obsessive-compulsive symptoms.
Topics: Adult; Clomipramine; Contraceptives, Oral, Hormonal; Drug Therapy, Combination; Female; Fluoxetine; | 2006 |
Generalised urticaria in a young woman treated with clomipramine and after ingestion of codfish.
Topics: Adult; Alprazolam; Animals; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricycl | 2006 |
[Case report: taeniasis, is it a cause of psychiatric and neural symptoms?].
Topics: Adult; Animals; Anticestodal Agents; Antidepressive Agents, Tricyclic; Cathartics; Clomipramine; Con | 2006 |
Treatment of compulsive sexual behaviour with clomipramine and valproic acid.
Topics: Adult; Antidepressive Agents, Tricyclic; Antimanic Agents; Clomipramine; Drug Administration Schedul | 2007 |
Age onset subtypes of obsessive compulsive disorder: differences in clinical response to treatment with clomipramine.
Topics: Adolescent; Adult; Age Factors; Child; Clomipramine; Dose-Response Relationship, Drug; Female; Follo | 2007 |
Aripiprazole augmentation of clomipramine-refractory obsessive-compulsive disorder.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Clomipramine; Drug Resistance; Drug Therapy, Combination; | 2007 |
Changes in cognitive dysfunction in children and adolescents with obsessive-compulsive disorder after treatment.
Topics: Adolescent; Child; Chronic Disease; Clomipramine; Cognition Disorders; Counseling; Female; Follow-Up | 2008 |
Successful augmentation with aripiprazole in clomipramine-refractory obsessive-compulsive disorder.
Topics: Adult; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Aripiprazole; Clomipramine; Drug Resi | 2007 |
Obsessive-compulsive disorder followed by psychotic episode in long-term ecstasy misuse.
Topics: Adolescent; Amphetamine-Related Disorders; Antidepressive Agents, Tricyclic; Antipsychotic Agents; B | 2009 |
Reversible acute renal failure associated with clomipramine-induced interstitial nephritis.
Topics: Acute Kidney Injury; Adult; Clomipramine; Humans; Male; Nephritis, Interstitial; Obsessive-Compulsiv | 2007 |
Statistical choices can affect inferences about treatment efficacy: a case study from obsessive-compulsive disorder research.
Topics: Adolescent; Adult; Aged; Choice Behavior; Clomipramine; Cognitive Behavioral Therapy; Combined Modal | 2008 |
Addition of cognitive-behavioral therapy for nonresponders to medication for obsessive-compulsive disorder: a naturalistic study.
Topics: Adult; Citalopram; Clomipramine; Cognitive Behavioral Therapy; Combined Modality Therapy; Cyclohexan | 2007 |
Obsessive-compulsive disorder revisited from a treatment perspective.
Topics: Antidepressive Agents, Tricyclic; Antipsychotic Agents; Brain; Clomipramine; Deep Brain Stimulation; | 2007 |
Changes in thalamus-hypothalamus serotonin transporter availability during clomipramine administration in patients with obsessive-compulsive disorder.
Topics: Adult; Binding, Competitive; Citalopram; Clomipramine; Down-Regulation; Female; Humans; Hypothalamus | 2008 |
Cortisol in the CSF of depressed and suicidal patients.
Topics: Adjustment Disorders; Clomipramine; Depression; Female; Homovanillic Acid; Humans; Hydrocortisone; H | 1980 |
Behavior therapy.
Topics: Behavior Therapy; Clomipramine; Combined Modality Therapy; Humans; Obsessive-Compulsive Disorder; Re | 1984 |
Biological markers in obsessive-compulsive and affective disorders.
Topics: Blood Platelets; Clomipramine; Clonidine; Depressive Disorder; Dexamethasone; Electroencephalography | 1984 |
Severe obsessive compulsive disorder in adolescence: a report of eight cases.
Topics: Adolescent; Aggression; Behavior Therapy; Child; Clomipramine; Combined Modality Therapy; Fantasy; F | 1984 |
Clomipramine in premature ejaculation.
Topics: Adult; Clomipramine; Ejaculation; Female; Humans; Male; Obsessive-Compulsive Disorder; Sexual Dysfun | 1984 |
Use of clomipramine in treatment of obsessive-compulsive symptomatology.
Topics: Adolescent; Adult; Aged; Clomipramine; Female; Humans; Male; Middle Aged; MMPI; Obsessive-Compulsive | 1984 |
The use of intravenous chlorimipramine in the treatment of obsessive compulsive disorder.
Topics: Adult; Clomipramine; Combined Modality Therapy; Drug Therapy, Combination; Female; Humans; Injection | 1984 |
Antidepressant drugs in the treatment of obsessive-compulsive disorders.
Topics: Clomipramine; Depressive Disorder; Humans; Obsessive-Compulsive Disorder; Social Adjustment | 1983 |
The treatment of obsessive-compulsive disorder in adolescence. A report of fifteen cases.
Topics: Adolescent; Behavior Therapy; Child; Clomipramine; Family Therapy; Female; Humans; Male; Milieu Ther | 1983 |
Clomipramine and severe obsessive-compulsive neurosis.
Topics: Adult; Clomipramine; Humans; Male; Obsessive-Compulsive Disorder | 1982 |
Possible development of the serotonin syndrome in man.
Topics: Adult; Clomipramine; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; My | 1982 |
Plasma steady-state concentrations of hydroxylated metabolites of clomipramine.
Topics: Adult; Biotransformation; Blood Platelets; Clomipramine; Female; Humans; In Vitro Techniques; Male; | 1982 |
Psychopharmacologic treatment of obsessive-compulsive disorder.
Topics: Clomipramine; Humans; Obsessive-Compulsive Disorder | 1982 |
Antiobsessional and antidepressant effects of clomipramine in the treatment of obsessive-compulsive disorder.
Topics: Adult; Antidepressive Agents; Clomipramine; Female; Humans; Male; Middle Aged; Obsessive-Compulsive | 1982 |
Sexual dysfunction and clomipramine.
Topics: Adult; Clomipramine; Depressive Disorder; Drug Administration Schedule; Ejaculation; Erectile Dysfun | 1982 |
Psychotropic drugs and behaviour therapy.
Topics: Adult; Behavior Therapy; Clomipramine; Diazepam; Female; Humans; Male; Middle Aged; Obsessive-Compul | 1981 |
Obsessional compulsive neurosis--a method of treatment.
Topics: Adolescent; Adult; Clomipramine; Female; Humans; Male; Middle Aged; Obsessive-Compulsive Disorder | 1981 |
Plasma concentrations of clomipramine and desmethylclomipramine in obsessive-compulsive neurosis.
Topics: Adolescent; Adult; Clomipramine; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Ob | 1980 |
Amitriptyline therapy of obsessive-compulsive neurosis.
Topics: Adult; Amitriptyline; Brain; Clomipramine; Female; Humans; Obsessive-Compulsive Disorder; Serotonin | 1980 |
Antidepressant-induced tardive dyskinesia: review and case report.
Topics: Aged; Antidepressive Agents; Clomipramine; Dyskinesia, Drug-Induced; Follow-Up Studies; Humans; Male | 1995 |
Changes in cerebrospinal fluid neurochemistry during treatment of obsessive-compulsive disorder with clomipramine.
Topics: Adolescent; Child; Clomipramine; Corticotropin-Releasing Hormone; Female; Homovanillic Acid; Humans; | 1994 |
Structured abstracts.
Topics: Aged; Cerebral Infarction; Clomipramine; Cognitive Behavioral Therapy; Combined Modality Therapy; Hu | 1995 |
[Diagnosis and therapy of obsessive-compulsive disorders].
Topics: Behavior Therapy; Clomipramine; Combined Modality Therapy; Humans; Obsessive-Compulsive Disorder; Se | 1995 |
[Personality disorders and obsessive-compulsive disorder: critical analysis of the literature data and our studies].
Topics: Clomipramine; Comorbidity; Depressive Disorder; Fluoxetine; Humans; Obsessive-Compulsive Disorder; P | 1995 |
Interim analysis clarification.
Topics: Behavior Therapy; Clomipramine; Combined Modality Therapy; Humans; Obsessive-Compulsive Disorder; Pa | 1995 |
Fluoxetine-clomipramine interaction.
Topics: Adult; Clomipramine; Drug Administration Schedule; Drug Interactions; Drug Therapy, Combination; Fem | 1995 |
Animal behavior case of the month. The owners observed tail chasing and left hind lameness in their dog.
Topics: Amputation, Surgical; Animals; Anterior Cruciate Ligament Injuries; Behavior, Animal; Clomipramine; | 1995 |
Serum clomipramine and metabolite levels in four nursing mother-infant pairs.
Topics: Adult; Breast Feeding; Clomipramine; Female; Half-Life; Humans; Infant; Infant, Newborn; Male; Obses | 1995 |
Selective serotonin re-uptake inhibitors decrease schedule-induced polydipsia in rats: a potential model for obsessive compulsive disorder.
Topics: Animals; Clomipramine; Conditioning, Operant; Desipramine; Diazepam; Disease Models, Animal; Drinkin | 1993 |
Clomipramine treatment of obsessive compulsive symptomatology in schizophrenic patients.
Topics: Adolescent; Adult; Antipsychotic Agents; Clomipramine; Drug Therapy, Combination; Female; Humans; Ma | 1993 |
Discontinuing obsessive-compulsive disorder medication with behavior therapy.
Topics: Adult; Behavior Therapy; Clomipramine; Combined Modality Therapy; Female; Fluoxetine; Follow-Up Stud | 1994 |
Valproate pretreatment for the difficult-to-treat patient with OCD.
Topics: 1-Naphthylamine; Antidepressive Agents; Clomipramine; Drug Therapy, Combination; Fluoxetine; Humans; | 1994 |
Treatment of obsessive-compulsive symptoms in schizophrenia with a neuroleptic-selective serotonin reuptake inhibitor combination: two case reports.
Topics: Adult; Aged; Antipsychotic Agents; Clomipramine; Drug Therapy, Combination; Fluoxetine; Humans; Male | 1994 |
Intravenous clomipramine for obsessive-compulsive disorder.
Topics: Adult; Aged; Clomipramine; Female; Humans; Infusions, Intravenous; Middle Aged; Obsessive-Compulsive | 1994 |
Fluvoxamine in obsessive-compulsive nonresponders to clomipramine or fluoxetine.
Topics: Adult; Clomipramine; Fluoxetine; Fluvoxamine; Humans; Obsessive-Compulsive Disorder; Severity of Ill | 1994 |
REM sleep behavior disorder.
Topics: Adult; Clomipramine; Female; Humans; Obsessive-Compulsive Disorder; Panic Disorder; Sleep Wake Disor | 1994 |
Pharmacologic management of obsessive-compulsive disorder.
Topics: 1-Naphthylamine; Antidepressive Agents; Anxiety Disorders; Clomipramine; Depression; Dopamine; Fluox | 1994 |
A case of chronic haircutting.
Topics: Body Image; Clomipramine; Delusions; Diagnosis, Differential; Drug Therapy, Combination; Female; Hai | 1993 |
Obsessive compulsive disorder manifesting as demonic attack.
Topics: Adult; Clomipramine; Humans; Magic; Male; Obsessive-Compulsive Disorder; Religion and Psychology | 1993 |
Individual differences in cerebral metabolic patterns during pharmacotherapy in obsessive-compulsive disorder: a multiple regression/discriminant analysis of positron emission tomographic data.
Topics: Adult; Brain; Clomipramine; Discriminant Analysis; Female; Fluoxetine; Humans; Male; Middle Aged; Ob | 1993 |
Serotonin reuptake blockers for the treatment of obsessional jealousy.
Topics: 1-Naphthylamine; Adult; Clomipramine; Drug Therapy, Combination; Female; Fluoxetine; Humans; Jealous | 1994 |
Drug-induced mania.
Topics: Bipolar Disorder; Clomipramine; Dose-Response Relationship, Drug; Fluoxetine; Fluvoxamine; Humans; O | 1993 |
A predictive study of obsessive-compulsive disorder response to clomipramine.
Topics: Adult; Clomipramine; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; | 1993 |
Exhibitionism treated with clomipramine.
Topics: Adult; Clomipramine; Disruptive, Impulse Control, and Conduct Disorders; Exhibitionism; Humans; Male | 1993 |
Clomipramine for obsessive-compulsive symptoms in schizophrenia.
Topics: Adult; Clomipramine; Humans; Male; Obsessive-Compulsive Disorder; Schizophrenia | 1993 |
The platelet benzodiazepine receptor is unaltered in obsessive-compulsive disorder.
Topics: Adult; Blood Platelets; Clomipramine; Female; Humans; Isoquinolines; Male; Middle Aged; Mitochondria | 1993 |
Schizophrenia, obsessive-compulsive disorder, and Tourette's syndrome: a case of triple comorbidity.
Topics: Adult; Basal Ganglia Diseases; Brain; Clomipramine; Comorbidity; Female; Haloperidol; Humans; Obsess | 1993 |
Postpartum obsessive compulsive disorder: a case series.
Topics: Adult; Clomipramine; Desipramine; Diagnosis, Differential; Female; Fluoxetine; Follow-Up Studies; Hu | 1993 |
The benefits of clomipramine-fluoxetine combination in obsessive compulsive disorder.
Topics: Adult; Clomipramine; Depressive Disorder; Dose-Response Relationship, Drug; Drug Therapy, Combinatio | 1993 |
Drug therapy and cerebral perfusion in obsessive-compulsive disorder.
Topics: Adult; Brain; Case-Control Studies; Cerebrovascular Circulation; Clomipramine; Female; Humans; Obses | 1995 |
Course of obsessive-compulsive disorder in children and adolescents: a prospective follow-up study of 23 Danish cases.
Topics: Adolescent; Child; Child, Preschool; Clomipramine; Combined Modality Therapy; Denmark; Female; Follo | 1995 |
Tardive dyskinesia associated with fluoxetine.
Topics: Adult; Clomipramine; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Fluoxetine; Humans; Male; | 1996 |
Regional 133xenon cerebral blood flow and cerebral 99mTc-HMPAO uptake in patients with obsessive-compulsive disorder before and during treatment.
Topics: Adult; Brain; Caudate Nucleus; Cerebral Cortex; Clomipramine; Contrast Media; Dominance, Cerebral; D | 1995 |
Psychiatric illness and the serotonin syndrome: an emerging adverse drug effect leading to intensive care unit admission.
Topics: Alcohol Withdrawal Delirium; Buspirone; Clomipramine; Diagnosis, Differential; Drug Therapy, Combina | 1996 |
Case study: obsessive difficult temperament and its response to serotonergic medication.
Topics: Child; Clomipramine; Combined Modality Therapy; Drug Therapy, Combination; Female; Humans; Male; Obs | 1996 |
Will pindolol augment the response to a serotonin reuptake inhibitor in obsessive-compulsive disorder?
Topics: 1-Naphthylamine; Adrenergic beta-Antagonists; Adult; Antidepressive Agents; Clomipramine; Drug Syner | 1996 |
Antidepressant induced mania in obsessive compulsive disorder.
Topics: Adult; Antidepressive Agents; Bipolar Disorder; Citalopram; Clomipramine; Female; Fluoxetine; Follow | 1996 |
Cytokine production in obsessive-compulsive disorder.
Topics: Adult; Clomipramine; Cytokines; Female; Humans; Interleukin-1; Interleukin-2; Interleukin-3; Male; M | 1996 |
Antidepressant-induced hypomania in obsessive-compulsive disorder.
Topics: Adolescent; Adult; Affective Disorders, Psychotic; Antidepressive Agents; Clomipramine; Female; Fluv | 1996 |
[Utilization of thought stopping in the treatment of obsessive- compulsive disorder in a 9 year old girl].
Topics: Child; Clomipramine; Female; Humans; Obsessive-Compulsive Disorder; Psychiatric Status Rating Scales | 1996 |
A case report of risperidone-induced obsessive-compulsive symptoms.
Topics: Adult; Antipsychotic Agents; Clomipramine; Drug Therapy, Combination; Female; Humans; Obsessive-Comp | 1997 |
Grapefruit juice and clomipramine: shifting metabolitic ratios.
Topics: Adolescent; Autistic Disorder; Beverages; Biological Availability; Child; Citrus; Clomipramine; Drug | 1997 |
Juvenile obsessive-compulsive disorder.
Topics: Adolescent; Child; Clomipramine; Cognitive Behavioral Therapy; Combined Modality Therapy; Comorbidit | 1997 |
Efficacy of clomipramine in obsessive-compulsive disorder.
Topics: Clomipramine; Humans; Obsessive-Compulsive Disorder; Selective Serotonin Reuptake Inhibitors; Treatm | 1996 |
Stereotypic movement disorder.
Topics: Adult; Antipsychotic Agents; Clomipramine; Desipramine; Drug Therapy, Combination; Female; Humans; M | 1997 |
Obsessive-compulsive disorder with unusual themes.
Topics: Adolescent; Adult; Antidepressive Agents, Tricyclic; Clomipramine; Comorbidity; Humans; Male; Monoam | 1996 |
Pica and the obsessive-compulsive spectrum disorders.
Topics: 1-Naphthylamine; Adolescent; Adult; Antidepressive Agents; Child; Citalopram; Clomipramine; Female; | 1996 |
The wish to be held: female patients with borderline personality disorder.
Topics: Adult; Borderline Personality Disorder; Clomipramine; Combined Modality Therapy; Female; Handling, P | 1996 |
Differential response of psychotic and obsessive symptoms to risperidone in an adolescent.
Topics: 1-Naphthylamine; Adolescent; Antidepressive Agents; Antipsychotic Agents; Clomipramine; Hallucinatio | 1996 |
Effectiveness of clomipramine for obsessive-compulsive symptoms and chronic pain in two patients with schizophrenia.
Topics: Adult; Antidepressive Agents, Tricyclic; Chronic Disease; Clomipramine; Humans; Male; Obsessive-Comp | 1997 |
Clomipramine-induced tourettism in obsessive-compulsive disorder: clinical and theoretical implications.
Topics: Adult; Antidepressive Agents, Tricyclic; Clomipramine; Humans; Male; Obsessive-Compulsive Disorder; | 1994 |
Serotonin syndrome presenting with migrainelike stroke.
Topics: Adult; Brain Ischemia; Cerebrovascular Circulation; Cerebrovascular Disorders; Clomipramine; Confusi | 1997 |
Gender identity disorder in a girl with autism--a case report.
Topics: Adolescent; Autistic Disorder; Clomipramine; Female; Follow-Up Studies; Gender Identity; Humans; Int | 1997 |
Olfactory reference syndrome responds to clomipramine but not fluoxetine: a case report.
Topics: Adult; Clomipramine; Comorbidity; Delusions; Depressive Disorder; Fluoxetine; Humans; Male; Obsessiv | 1997 |
5HT2C CYS23/SER23 polymorphism is not associated with obsessive-compulsive disorder.
Topics: Adult; Alleles; Clomipramine; Female; Genotype; Humans; Male; Middle Aged; Obsessive-Compulsive Diso | 1998 |
When fluvoxamine treats only depression and clomipramine treats only obsessive-compulsive disorder--combine them?
Topics: Adult; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Attention Deficit | 1998 |
What is the optimal approach to the pharmacological management of obsessive-compulsive disorder?
Topics: Adult; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Clomipramine; Fem | 1998 |
Use of clomipramine in the treatment of anxiety-related and obsessive-compulsive disorders in cats.
Topics: Animals; Antidepressive Agents, Tricyclic; Anxiety Disorders; Behavior Therapy; Behavior, Animal; Ca | 1998 |
Intravenous clomipramine for a schizophrenic patient with obsessive-compulsive symptoms.
Topics: Adult; Antipsychotic Agents; Clomipramine; Comorbidity; Drug Administration Schedule; Drug Therapy, | 1998 |
Attacks of jealousy that responded to clomipramine.
Topics: Adult; Clomipramine; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; | 1998 |
Concerns regarding study of obsessive-compulsive disorder in dogs.
Topics: Animals; Antidepressive Agents, Tricyclic; Behavior, Animal; Clomipramine; Contraindications; Dog Di | 1998 |
Response to high doses of citalopram in treatment-resistant obsessive-compulsive disorder.
Topics: Adult; Anti-Anxiety Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricycl | 1998 |
Quinpirole induces compulsive checking behavior in rats: a potential animal model of obsessive-compulsive disorder (OCD).
Topics: Animals; Clomipramine; Disease Models, Animal; Dopamine Agonists; Male; Obsessive-Compulsive Disorde | 1998 |
Olanzapine-induced obsessive-compulsive disorder.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Clomipramine; Fluoxetine; Humans; Male; Obsessive-Comp | 1999 |
Treatment of obsessive-compulsive disorder using clomipramine in a very old patient.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Anti-Anxiety Agents; Antidepressive Agents, Tricyclic; B | 1999 |
Use of factor-analyzed symptom dimensions to predict outcome with serotonin reuptake inhibitors and placebo in the treatment of obsessive-compulsive disorder.
Topics: Adolescent; Adult; Aged; Ambulatory Care; Clomipramine; Comorbidity; Controlled Clinical Trials as T | 1999 |
Citalopram: an interaction study with clomipramine in a patient heterozygous for CYP2D6 genotype.
Topics: Adult; Antidepressive Agents; Antidepressive Agents, Tricyclic; Citalopram; Clomipramine; Cytochrome | 1999 |
[Obsessive-compulsive disorder, frontostriatal system and the effect of the serotonergic system].
Topics: Adolescent; Behavior Therapy; Child; Clomipramine; Combined Modality Therapy; Female; Fluvoxamine; H | 2000 |
Animal behavior case of the month. Congo African Grey parrot examined because of feather picking and self-injurious behavior.
Topics: Animals; Anti-Anxiety Agents; Antidepressive Agents, Tricyclic; Behavior, Animal; Bird Diseases; Bus | 2000 |
Lamotrigine augmentation of serotonin re-uptake inhibitors in obsessive-compulsive disorder.
Topics: Antidepressive Agents; Clomipramine; Dose-Response Relationship, Drug; Humans; Lamotrigine; Obsessiv | 2000 |
Carbamazepine augmentation of clomipramine in the treatment of refractory obsessive-compulsive disorder.
Topics: Adult; Anticonvulsants; Carbamazepine; Clomipramine; Drug Therapy, Combination; Female; Humans; Obse | 2000 |
Sertraline in the treatment of anxiety disorders.
Topics: Adult; Clinical Trials as Topic; Clomipramine; Dose-Response Relationship, Drug; Drug Administration | 2000 |
A case report of refractory obsessive-compulsive disorder improved by risperidone augmentation of clomipramine treatment.
Topics: Adult; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Clomipramine; Drug Therapy, Combinati | 2000 |
Sertraline and obsessive compulsive disorder: new indication. Limited assessment.
Topics: Adult; Clinical Trials as Topic; Clomipramine; Drug Approval; France; Humans; Obsessive-Compulsive D | 2000 |
Serotonin and dopamine antagonism in obsessive-compulsive disorder: effect of atypical antipsychotic drugs.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Clomipramine; Dopamine Antagonists; Female; Humans; Ma | 2000 |
Possible serotonin syndrome associated with clomipramine after withdrawal of clozapine.
Topics: Adult; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Clomipramine; Clozapine; Humans; Male | 2001 |
Auditory P300 event related potential and serotonin reuptake inhibitor treatment in obsessive-compulsive disorder patients.
Topics: Adult; Cerebral Cortex; Clomipramine; Electroencephalography; Electrooculography; Event-Related Pote | 2001 |
Use of clomipramine in treatment of obsessive-compulsive disorder, separation anxiety and noise phobia in dogs: a preliminary, clinical study.
Topics: Animals; Antidepressive Agents, Tricyclic; Anxiety, Separation; Behavior Therapy; Behavior, Animal; | 2001 |
In-patient treatment for resistant obsessive-compulsive disorder.
Topics: Adult; Clomipramine; Combined Modality Therapy; Desensitization, Psychologic; Female; Fluoxetine; Ho | 2000 |
Vasopressin-dependent flank marking in golden hamsters is suppressed by drugs used in the treatment of obsessive-compulsive disorder.
Topics: Adrenergic Uptake Inhibitors; Aggression; Animals; Arginine Vasopressin; Behavior, Animal; Clomipram | 2001 |
Obsessive-compulsive symptoms during treatment with clozapine in a patient with schizophrenia.
Topics: Adult; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Clomipramine; Clozapine; Drug Therapy | 2001 |
Clomipramine discontinuation-emergent dystonia.
Topics: Acute Disease; Adult; Antidepressive Agents, Tricyclic; Clomipramine; Dystonic Disorders; Humans; Ma | 2001 |
Clinical predictors of drug response in obsessive-compulsive disorder.
Topics: Adolescent; Adult; Aged; Analysis of Variance; Citalopram; Clomipramine; Drug Resistance; Female; Fl | 2001 |
Adults with early-onset obsessive-compulsive disorder.
Topics: Adolescent; Adult; Age Factors; Child; Clomipramine; Female; Humans; Male; Obsessive-Compulsive Diso | 2001 |
Are gender differences in antiobsessional response related to different clomipramine metabolism?
Topics: Adult; Antidepressive Agents, Tricyclic; Clomipramine; Female; Humans; Male; Obsessive-Compulsive Di | 2002 |
Simultaneous determination of clomipramine and its desmethyl and hydroxy metabolites in plasma of patients by high-performance liquid chromatography after solid-phase extraction.
Topics: Antidepressive Agents, Tricyclic; Chromatography, High Pressure Liquid; Clomipramine; Humans; Obsess | 2002 |
Sertraline: new indication. May help children with obsessive-compulsive disorder.
Topics: Adolescent; Behavior Therapy; Child; Clomipramine; Drug Approval; France; Humans; Obsessive-Compulsi | 2002 |
Chlorimipramine therapy for obsessive-compulsive neurosis.
Topics: Adult; Clomipramine; Dibenzazepines; Female; Humans; Male; Middle Aged; Obsessive-Compulsive Disorde | 1979 |
The behavioural treatment of obsessional-compulsive disorders, with and without clomipramine.
Topics: Adult; Behavior Therapy; Clomipramine; Female; Humans; Male; Obsessive-Compulsive Disorder | 1979 |
An uncontrolled trial of clomipramine (Anafranil) in the treatment of phobic and obsessional states in general practice.
Topics: Adult; Agoraphobia; Clomipramine; Dibenzazepines; Female; Humans; Male; Obsessive-Compulsive Disorde | 1977 |
Clomipramine (Anafranil) in depressive patients with obsessive neurosis.
Topics: Adult; Clomipramine; Depression; Dibenzazepines; Female; Humans; Male; Obsessive-Compulsive Disorder | 1977 |
Treatment of obsessive-compulsive neurosis with clomipramine (Anafranil).
Topics: Adult; Aged; Anxiety; Clomipramine; Depression; Dibenzazepines; Female; Humans; Male; Middle Aged; O | 1977 |
A comparison of clomipramine hydrochloride (Anafranil) and behaviour therapy in the treatment of obsessive neurosis.
Topics: Adult; Behavior Therapy; Clomipramine; Dibenzazepines; Female; Humans; Male; Middle Aged; Obsessive- | 1977 |
Clinical experience in the treatment of obsessional states (1).
Topics: Adult; Clomipramine; Dibenzazepines; Female; Humans; Male; Obsessive-Compulsive Disorder; Personalit | 1977 |
Clinical experience in the treatment of obsessional states (2).
Topics: Clomipramine; Depression; Dibenzazepines; Humans; Obsessive-Compulsive Disorder; Phobic Disorders | 1977 |
Pharmacokinetic studies in obsessional patients.
Topics: Adolescent; Adult; Clomipramine; Dibenzazepines; Female; Humans; Male; Middle Aged; Obsessive-Compul | 1977 |
The action of chlorimipramine in obsessive-compulsive neurosis: a pilot study.
Topics: Adult; Clomipramine; Dibenzazepines; Female; Humans; Male; Middle Aged; Obsessive-Compulsive Disorde | 1975 |
Depressive subtypes, blood pressure changes and response to treatment.
Topics: Adult; Age Factors; Aged; Anxiety Disorders; Bipolar Disorder; Blood Pressure; Clomipramine; Depress | 1977 |
The assessment of drugs in obsessional states.
Topics: Antidepressive Agents, Tricyclic; Clomipramine; Female; Humans; Male; Obsessive-Compulsive Disorder; | 1976 |
Clomipramine in phobic and obsessional states: preliminary report.
Topics: Adult; Clomipramine; Dibenzazepines; Female; Humans; Male; Middle Aged; Obsessive-Compulsive Disorde | 1976 |
[Clomipramine in the treatment of obsessive-compulsive neuroses].
Topics: Clomipramine; Dibenzazepines; Female; Humans; Middle Aged; Obsessive-Compulsive Disorder | 1975 |
The Shapiro cards scale as a method of assessment of obsessional symptoms in clomipramine therapy.
Topics: Adult; Clomipramine; Dibenzazepines; Drug Evaluation; Female; Humans; Male; Obsessive-Compulsive Dis | 1975 |
The role of intravenous clomipramine in the treatment of obsessional and phobic disorders.
Topics: Adult; Clomipramine; Dibenzazepines; Drug Evaluation; Female; Histrionic Personality Disorder; Human | 1975 |
Depressive reactions in the course of clomipramine therapy used in the treatment of obsessional conditions.
Topics: Adult; Aged; Amitriptyline; Clomipramine; Depression; Dibenzazepines; Female; Flupenthixol; Humans; | 1975 |
An investigation into the use of anafranil in phobic and obsessional disorders.
Topics: Administration, Oral; Adolescent; Adult; Aged; Clomipramine; Dibenzazepines; Drug Evaluation; Family | 1975 |
Physiological measurements in phobic and obsessional disorders.
Topics: Anxiety; Behavior Therapy; Blood Pressure; Cardiac Output; Chlordiazepoxide; Clomipramine; Diazepam; | 1975 |
Clomipramine in the treatment of the true obsessional state. A report on four patients.
Topics: Adult; Clomipramine; Dibenzazepines; Female; Humans; Male; Obsessive-Compulsive Disorder | 1975 |
[Changes in somatosensory evoked potentials in pharmacogenic myoclonia].
Topics: Adolescent; Adult; Aged; Antidepressive Agents; Antipsychotic Agents; Clomipramine; Depressive Disor | 1992 |
Cerebrospinal fluid neurochemistry in children and adolescents with obsessive-compulsive disorder.
Topics: Adolescent; Adrenocorticotropic Hormone; Adult; Arginine Vasopressin; Child; Clomipramine; Corticotr | 1992 |
Serotonergic medications for sexual obsessions, sexual addictions, and paraphilias.
Topics: Adolescent; Adult; Behavior, Addictive; Clomipramine; Fenfluramine; Fluoxetine; Fluvoxamine; Humans; | 1992 |
Acute exacerbation of body dysmorphic disorder during tryptophan depletion.
Topics: Acute Disease; Adult; Body Image; Buspirone; Clomipramine; Delusions; Female; Humans; Neurotransmitt | 1992 |
Obsessive-compulsive disorder and paraphilia in a monozygotic twin pair.
Topics: Adult; Behavior Therapy; Clomipramine; Combined Modality Therapy; Cyproterone Acetate; Diseases in T | 1992 |
Intravenous clomipramine for OCD.
Topics: Clomipramine; Humans; Infusions, Intravenous; Obsessive-Compulsive Disorder | 1992 |
Obsessions and compulsions across time in 79 children and adolescents with obsessive-compulsive disorder.
Topics: Adolescent; Arousal; Child; Clomipramine; Cohort Studies; Cross-Sectional Studies; Female; Follow-Up | 1992 |
Clomipramine side effects.
Topics: Attention Deficit Disorder with Hyperactivity; Child; Clomipramine; Humans; Male; Obsessive-Compulsi | 1992 |
Treatment outcome of obsessive compulsive disorder with comorbid social phobia.
Topics: Adult; Clomipramine; Comorbidity; Female; Fluoxetine; Fluvoxamine; Humans; Male; Middle Aged; Obsess | 1992 |
Increased right caudate nucleus size in obsessive-compulsive disorder: detection with magnetic resonance imaging.
Topics: Adult; Basal Ganglia; Brain; Clomipramine; Female; Fluvoxamine; Functional Laterality; Humans; Magne | 1992 |
Selective serotonin reuptake inhibitors in OCD.
Topics: 1-Naphthylamine; Clomipramine; Humans; Obsessive-Compulsive Disorder; Serotonin Antagonists; Sertral | 1992 |
Antidepressant-induced mania in obsessive-compulsive disorder.
Topics: Bipolar Disorder; Clomipramine; Fluoxetine; Humans; Norepinephrine; Obsessive-Compulsive Disorder; S | 1992 |
Cerebral glucose metabolism in childhood-onset obsessive-compulsive disorder. Revisualization during pharmacotherapy.
Topics: Adult; Age Factors; Brain; Caudate Nucleus; Cerebral Cortex; Clomipramine; Female; Fluoxetine; Follo | 1992 |
The clomipramine challenge test in obsessive compulsive disorder.
Topics: Clomipramine; Hand Disinfection; Humans; Hydrocortisone; Obsessive-Compulsive Disorder; Prolactin | 1992 |
Clomipramine for comorbid conditions.
Topics: Attention Deficit Disorder with Hyperactivity; Child; Clomipramine; Female; Humans; Obsessive-Compul | 1992 |
Neuropsychological performance in obsessive-compulsive disorder.
Topics: Adult; Clomipramine; Cognition; Education; Female; Humans; Male; Memory, Short-Term; Obsessive-Compu | 1992 |
Suicidality with clomipramine.
Topics: Child; Clomipramine; Dose-Response Relationship, Drug; Humans; Male; Obsessive-Compulsive Disorder; | 1992 |
The treatment of children with obsessive-compulsive disorder.
Topics: Adolescent; Adolescent Behavior; Age Factors; Behavior Therapy; Child; Child Behavior; Clomipramine; | 1992 |
Open trial of intravenous clomipramine in five treatment-refractory patients with obsessive-compulsive disorder.
Topics: Administration, Oral; Adult; Clomipramine; Dose-Response Relationship, Drug; Drug Administration Sch | 1992 |
Clomipramine in autism: preliminary evidence of efficacy.
Topics: Adolescent; Adult; Aggression; Autistic Disorder; Clomipramine; Dose-Response Relationship, Drug; Dr | 1992 |
Clomipramine for obsessive pain-type syndromes.
Topics: Clomipramine; Facial Pain; Humans; Obsessive-Compulsive Disorder; Rhytidoplasty | 1992 |
Ineffectiveness of clomipramine for obsessive-compulsive symptoms in a patient with schizophrenia.
Topics: Adult; Chronic Disease; Clomipramine; Humans; Male; Obsessive-Compulsive Disorder; Schizophrenia; Sc | 1992 |
Response of obsessive-compulsive disorder and trichotillomania to serotonin reuptake blockers.
Topics: Adolescent; Clomipramine; Female; Fluoxetine; Humans; Obsessive-Compulsive Disorder; Trichotillomani | 1992 |
Paranoid and aggressive behavior in two obsessive-compulsive adolescents treated with clomipramine.
Topics: Adolescent; Aggression; Carbamazepine; Child; Clomipramine; Dose-Response Relationship, Drug; Fluoxe | 1991 |
Tourette's syndrome and treatment with clomipramine hydrochloride.
Topics: Adult; Clomipramine; Drug Administration Schedule; Haloperidol; Humans; Male; Obsessive-Compulsive D | 1991 |
Fluoxetine treatment of obsessive-compulsive disorder.
Topics: Adult; Arousal; Clomipramine; Combined Modality Therapy; Depressive Disorder; Drive; Female; Fluoxet | 1991 |
[A control study of clomipramine and amitriptyline for treating obsessive-compulsive disorder].
Topics: Adolescent; Adult; Amitriptyline; Clomipramine; Female; Humans; Male; Obsessive-Compulsive Disorder | 1991 |
Academic medical center/industry collaboration.
Topics: Academic Medical Centers; Adolescent; Adult; Anxiety Disorders; Child; Clomipramine; Double-Blind Me | 1991 |
Three cases of pharmacotherapy of obsessive-compulsive disorder in the elderly.
Topics: Age Factors; Aged; Clomipramine; Female; Fluoxetine; Humans; Male; Obsessive-Compulsive Disorder; Tr | 1991 |
Clomipramine for obsessive-compulsive disorder: prescribing guidelines.
Topics: Clomipramine; Drug Interactions; Drug Prescriptions; Humans; Obsessive-Compulsive Disorder | 1991 |
Regional cerebral glucose metabolism of women with trichotillomania.
Topics: Adult; Brain; Cerebellum; Clomipramine; Deoxyglucose; Female; Fluorodeoxyglucose F18; Frontal Lobe; | 1991 |
Compulsive feather picking in birds.
Topics: Animals; Animals, Domestic; Bird Diseases; Clomipramine; Disease Models, Animal; Female; Humans; Mal | 1991 |
Are effective antiobsessional drugs interchangeable?
Topics: Clomipramine; Fluoxetine; Fluvoxamine; Humans; Obsessive-Compulsive Disorder; Research Design; Serot | 1991 |
Intravenous clomipramine and obsessive-compulsive disorder.
Topics: Clomipramine; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; Infusions, Intrav | 1991 |
Ritualistic behavior: breaking the cycle.
Topics: Adult; Behavior Therapy; Ceremonial Behavior; Clomipramine; Cues; Female; Humans; Nursing Diagnosis; | 1991 |
Fenfluramine augmentation of clomipramine treatment of obsessive compulsive disorder.
Topics: Adult; Clomipramine; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, C | 1991 |
Potential antidopaminergic effects of serotonin reuptake inhibitors.
Topics: Animals; Clomipramine; Dopamine Antagonists; Fluoxetine; Humans; Obsessive-Compulsive Disorder; Rats | 1991 |
Prolactin in childhood obsessive-compulsive disorder: clinical correlates and response to clomipramine.
Topics: Adolescent; Child; Clomipramine; Dopamine; Female; Humans; Male; Obsessive-Compulsive Disorder; Prol | 1991 |
Test of dopamine-blocking potential of clomipramine.
Topics: Blinking; Clomipramine; Dopamine Antagonists; Humans; Obsessive-Compulsive Disorder | 1991 |
Desensitization of terminal 5-HT autoreceptors by 5-HT reuptake blockers.
Topics: Animals; Citalopram; Clomipramine; Clorgyline; Humans; Monoamine Oxidase Inhibitors; Obsessive-Compu | 1991 |
Neurologic soft signs in obsessive-compulsive disorder.
Topics: Adult; Anxiety Disorders; Central Nervous System Diseases; Clomipramine; Clonidine; Depressive Disor | 1991 |
A case of obsessive-compulsive disorder related to AIDS: psychopharmacologic treatment.
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS Serodiagnosis; Clomipramine; Delusions; Dose-Respons | 1991 |
Fenfluramine augmentation of serotonin reuptake blockade antiobsessional treatment.
Topics: Adult; Clomipramine; Drug Administration Schedule; Drug Therapy, Combination; Female; Fenfluramine; | 1990 |
Treatment of depersonalization with serotonin reuptake blockers.
Topics: Adolescent; Adult; Clomipramine; Depersonalization; Dose-Response Relationship, Drug; Female; Fluoxe | 1990 |
Trazodone treatment in clomipramine-resistant obsessive-compulsive disorder.
Topics: Adult; Analysis of Variance; Clinical Trials as Topic; Clomipramine; Depression; Drug Resistance; Fe | 1990 |
Panic and phobic disorders in patients with obsessive compulsive disorder.
Topics: Acute Disease; Adolescent; Adult; Aged; Anxiety Disorders; Clomipramine; Comorbidity; Female; Humans | 1990 |
The pharmacotherapy of moral or religious scrupulosity.
Topics: Adolescent; Adult; Aged; Catholicism; Clomipramine; Drug Therapy, Combination; Female; Fluoxetine; H | 1990 |
Clomipramine treatment of possible atypical obsessive-compulsive disorder.
Topics: Adult; Awareness; Clomipramine; Humans; Male; Music; Neurocognitive Disorders; Obsessive-Compulsive | 1990 |
Clomipramine for OCD.
Topics: Clomipramine; Humans; Obsessive-Compulsive Disorder | 1990 |
Treatment of clomipramine-induced anorgasmia with yohimbine: a case report.
Topics: Adult; Clomipramine; Depressive Disorder; Humans; Male; Obsessive-Compulsive Disorder; Orgasm; Place | 1990 |
Clomipramine efficacy for tics, obsessions, and compulsions in Tourette's syndrome and obsessive-compulsive disorder: a case study.
Topics: Adolescent; Clomipramine; Humans; Male; Obsessive-Compulsive Disorder; Stereotyped Behavior; Tic Dis | 1990 |
From the Food and Drug Administration.
Topics: Apnea; Carbamazepine; Clomipramine; Food Labeling; Humans; Humidity; Monitoring, Physiologic; Obsess | 1990 |
Childhood obsessive-compulsive disorder: a prospective follow-up study.
Topics: Adolescent; Adult; Anxiety Disorders; Child; Clomipramine; Depressive Disorder; Dexamethasone; Femal | 1990 |
Absence of placebo response in obsessive-compulsive disorder.
Topics: Adolescent; Adult; Aged; Anxiety; Clomipramine; Depression; Double-Blind Method; Fear; Female; Human | 1990 |
The relationship of plasma clomipramine and N-desmethylclomipramine to response in obsessive-compulsive disorder.
Topics: Adult; Clomipramine; Female; Humans; Male; Middle Aged; Obsessive-Compulsive Disorder | 1990 |
Local cerebral glucose metabolic rates in obsessive-compulsive disorder. Patients treated with clomipramine.
Topics: Adult; Basal Ganglia; Brain; Caudate Nucleus; Clomipramine; Deoxyglucose; Female; Fluorodeoxyglucose | 1990 |
Childhood obsessive compulsive disorder.
Topics: Adolescent; Anorexia Nervosa; Behavior Therapy; Child; Child, Preschool; Clomipramine; Epilepsy, Tem | 1986 |
Obsessive-compulsive disorder.
Topics: Adult; Behavior Therapy; Clomipramine; Diagnosis, Differential; Female; Fluoxetine; Fluvoxamine; Hum | 1989 |
Obsessive compulsive disorder.
Topics: Behavior Therapy; Clomipramine; Fluoxetine; Fluvoxamine; Humans; Obsessive-Compulsive Disorder; Oxim | 1989 |
[Is an obsessive-compulsive disorder in children an anxiety disorder?].
Topics: Adolescent; Anxiety Disorders; Child; Clomipramine; Compulsive Personality Disorder; Female; Humans; | 1989 |
Drug response assessed by the Modified Maudsley Obsessive-Compulsive Inventory.
Topics: Adult; Clomipramine; Female; Fluoxetine; Humans; Male; Obsessive-Compulsive Disorder; Psychiatric St | 1989 |
[A manic episode in a female patient with obsessive-compulsive disorder treated with chlorimipramine].
Topics: Adult; Bipolar Disorder; Clomipramine; Female; Humans; Obsessive-Compulsive Disorder | 1989 |
Intravenous chlorimipramine therapy in obsessive-compulsive disorder.
Topics: Administration, Oral; Adult; Clomipramine; Depressive Disorder; Dose-Response Relationship, Drug; Fo | 1989 |
Catatonic signs in severe obsessive compulsive disorder.
Topics: Adult; Behavior Therapy; Catatonia; Clomipramine; Diagnosis, Differential; Humans; Male; Obsessive-C | 1989 |
Drug treatment of obsessive-compulsive disorder.
Topics: Antipsychotic Agents; Behavior Therapy; Benzodiazepines; Clomipramine; Humans; Monoamine Oxidase Inh | 1986 |
Clomipramine for bowel obsessions.
Topics: Adult; Clomipramine; Fecal Incontinence; Humans; Male; Obsessive-Compulsive Disorder | 1989 |
An inverse relationship between mania and obsessive-compulsive disorder: a case report.
Topics: Adult; Bipolar Disorder; Clomipramine; Humans; Lithium; Lithium Carbonate; Male; Obsessive-Compulsiv | 1986 |
One-carbon cycle metabolism in obsessive-compulsive disorder.
Topics: Clomipramine; Erythrocytes; Humans; Methionine Adenosyltransferase; Methylation; Obsessive-Compulsiv | 1988 |
The neurobiology of obsessive-compulsive disorder.
Topics: Adolescent; Behavior Therapy; Clomipramine; Female; Humans; Obsessive-Compulsive Disorder | 1988 |
Fear of AIDS.
Topics: Acquired Immunodeficiency Syndrome; Adult; Clomipramine; Diagnosis, Differential; Humans; Male; Obse | 1988 |
Combined lithium-tricyclic treatment of obsessive-compulsive disorder.
Topics: Adult; Antidepressive Agents, Tricyclic; Clomipramine; Doxepin; Drug Therapy, Combination; Female; H | 1988 |
Psychopharmacology of drugs effective in obsessive-compulsive disorder.
Topics: Clomipramine; Dopamine Antagonists; Humans; Monoamine Oxidase Inhibitors; Obsessive-Compulsive Disor | 1988 |
Bowel obsession responsive to clomipramine.
Topics: Adult; Clomipramine; Humans; Male; Obsessive-Compulsive Disorder | 1988 |
Clomipramine treatment of delusional disorder-somatic type.
Topics: Adolescent; Body Image; Clomipramine; Delusions; Humans; Hypochondriasis; Male; Obsessive-Compulsive | 1988 |
Clomipramine in obsessional disorders: a cautionary tale.
Topics: Adult; Clomipramine; Combined Modality Therapy; Dose-Response Relationship, Drug; Female; Humans; Ob | 1988 |
Partial status epilepticus following single low dose of chlorimipramine in a patient on MAO-inhibitor treatment.
Topics: Adult; Clomipramine; Humans; Male; Obsessive-Compulsive Disorder; Phenelzine; Status Epilepticus | 1987 |
Obsessive disorder with self-mutilation: a subgroup responsive to pharmacotherapy.
Topics: Adult; Clomipramine; Female; Fluoxetine; Humans; Male; Obsessive-Compulsive Disorder; Propylamines; | 1987 |
Clonidine and clomipramine in obsessive-compulsive disorder.
Topics: Adolescent; Adult; Clomipramine; Clonidine; Drug Therapy, Combination; Female; Humans; Male; Obsessi | 1987 |
Clomipramine-induced urinary dysfunction in an obsessive-compulsive adolescent.
Topics: Adolescent; Clomipramine; Humans; Male; Obsessive-Compulsive Disorder; Urination Disorders | 1987 |
Pharmacotherapy of primary obsessional illness.
Topics: Clomipramine; Humans; Obsessive-Compulsive Disorder | 1987 |
Antiobsessive effect of fluoxetine.
Topics: Clomipramine; Fluoxetine; Humans; Obsessive-Compulsive Disorder; Propylamines; Psychiatric Status Ra | 1985 |
The Leyton Obsessional Inventory-Child Version.
Topics: Adolescent; Child; Clomipramine; Compulsive Behavior; Female; Humans; Male; Obsessive Behavior; Obse | 1986 |
Intravenous chlorimipramine in the treatment of obsessional disorder in adolescence: case report.
Topics: Adolescent; Age Factors; Behavior Therapy; Child; Clomipramine; Family Therapy; Female; Humans; Infu | 1985 |
Tricyclic response in obsessive compulsive disorder.
Topics: Adolescent; Adult; Clomipramine; Clorgyline; Desipramine; Dexamethasone; Double-Blind Method; Electr | 1985 |
[Treatment of obsessive compulsive neurosis].
Topics: Behavior Therapy; Clomipramine; Humans; Obsessive-Compulsive Disorder | 1985 |
[Psychopharmacological treatment of obsessive neurosis].
Topics: Administration, Oral; Adolescent; Adult; Aged; Child; Child, Preschool; Clomipramine; Dibenzazepines | 1974 |